From e1acf045117fcbbf3bdaebba90ca60ec273a95e0 Mon Sep 17 00:00:00 2001 From: Kamran Date: Wed, 11 Dec 2024 01:46:07 +0600 Subject: [PATCH] regular backup --- .obsidian/app.json | 6 +- .obsidian/appearance.json | 4 +- .obsidian/community-plugins.json | 3 + .obsidian/graph.json | 34 +- .obsidian/hotkeys.json | 12 + .../plugins/obsidian-living-graph/data.json | 6 + .../plugins/obsidian-living-graph/main.js | 608 ++++++++++++++++++ .../obsidian-living-graph/manifest.json | 9 + .obsidian/workspace.json | 70 +- Hemoptysis.md | 0 Lung Abscess.md | 0 MCNS.md | 0 Scabies.md | 0 Serum Sickness.md | 0 Untitled.md | 0 journals/2024_12_10.md | 8 +- logseq/.recycle/pages_Cholesteatoma.md | 0 .../2024-12-10T15_30_39.473Z.Desktop.md | 3 + .../2024-12-10T15_30_39.478Z.Desktop.md | 3 + .../2024-12-10T15_30_39.475Z.Desktop.md | 78 +++ .../2024-12-10T15_30_39.497Z.Desktop.md | 104 +++ .../2024-12-10T15_30_39.503Z.Desktop.md | 82 +++ .../2024-12-10T15_30_39.523Z.Desktop.md | 80 +++ .../2024-12-10T15_30_39.474Z.Desktop.md | 80 +++ .../2024-12-10T15_30_39.520Z.Desktop.md | 91 +++ .../2024-12-10T15_30_39.507Z.Desktop.md | 8 + .../2024-12-10T15_30_39.488Z.Desktop.md | 79 +++ .../2024-12-10T17_34_38.441Z.Desktop.md | 52 ++ .../2024-12-10T17_34_38.494Z.Desktop.md | 23 + .../2024-12-10T15_30_39.479Z.Desktop.md | 14 + .../2024-12-10T15_30_39.496Z.Desktop.md | 10 + .../2024-12-10T15_30_39.494Z.Desktop.md | 6 + .../2024-12-10T15_30_39.470Z.Desktop.md | 81 +++ .../2024-12-10T15_30_39.502Z.Desktop.md | 9 + .../2024-12-10T15_30_39.478Z.Desktop.md | 77 +++ .../2024-12-10T17_34_46.861Z.Desktop.md | 43 ++ .../2024-12-10T17_34_46.308Z.Desktop.md | 10 + .../2024-12-10T15_30_39.515Z.Desktop.md | 83 +++ .../2024-12-10T15_30_39.476Z.Desktop.md | 11 + .../2024-12-10T15_30_39.494Z.Desktop.md | 93 +++ .../2024-12-10T15_30_39.495Z.Desktop.md | 79 +++ .../2024-12-10T15_30_39.525Z.Desktop.md | 97 +++ .../2024-12-10T16_03_25.730Z.Desktop.md | 81 +++ .../2024-12-10T15_30_39.496Z.Desktop.md | 3 + .../2024-12-10T15_30_39.489Z.Desktop.md | 78 +++ .../2024-12-10T15_30_39.102Z.Desktop.md | 83 +++ .../2024-12-10T17_34_38.489Z.Desktop.md | 23 + .../2024-12-10T15_30_39.514Z.Desktop.md | 53 ++ .../2024-12-10T15_30_39.109Z.Desktop.md | 85 +++ .../2024-12-10T15_30_39.113Z.Desktop.md | 79 +++ .../2024-12-10T15_30_39.493Z.Desktop.md | 15 + .../2024-12-10T17_34_38.435Z.Desktop.md | 26 + .../2024-12-10T17_34_38.442Z.Desktop.md | 7 + .../IUFGR/2024-12-10T17_34_46.320Z.Desktop.md | 46 ++ .../2024-12-10T15_30_39.474Z.Desktop.md | 3 + .../2024-12-10T15_30_39.486Z.Desktop.md | 1 + .../2024-12-10T15_30_39.518Z.Desktop.md | 8 + .../LASIK/2024-12-10T15_30_39.476Z.Desktop.md | 2 + .../2024-12-10T17_34_38.493Z.Desktop.md | 39 ++ .../Labor/2024-12-10T17_34_38.490Z.Desktop.md | 39 ++ .../2024-12-10T15_30_39.481Z.Desktop.md | 12 + .../2024-12-10T15_30_39.501Z.Desktop.md | 77 +++ .../2024-12-10T15_30_39.509Z.Desktop.md | 76 +++ .../2024-12-10T15_30_39.504Z.Desktop.md | 19 + .../2024-12-10T15_30_39.491Z.Desktop.md | 79 +++ .../2024-12-10T15_30_39.506Z.Desktop.md | 76 +++ .../2024-12-10T15_30_39.510Z.Desktop.md | 3 + .../2024-12-10T15_30_39.493Z.Desktop.md | 3 + .../2024-12-10T15_30_39.480Z.Desktop.md | 84 +++ .../2024-12-10T15_30_39.513Z.Desktop.md | 114 ++++ .../2024-12-10T17_34_38.443Z.Desktop.md | 6 + .../2024-12-10T17_34_46.863Z.Desktop.md | 27 + .../2024-12-10T17_34_46.862Z.Desktop.md | 20 + .../2024-12-10T15_30_39.507Z.Desktop.md | 1 + .../2024-12-10T15_30_39.505Z.Desktop.md | 3 + .../2024-12-10T15_30_39.482Z.Desktop.md | 72 +++ .../2024-12-10T15_30_39.522Z.Desktop.md | 91 +++ .../2024-12-10T15_30_39.508Z.Desktop.md | 5 + .../2024-12-10T15_30_39.502Z.Desktop.md | 82 +++ .../2024-12-10T15_30_39.492Z.Desktop.md | 3 + .../2024-12-10T15_30_39.492Z.Desktop.md | 9 + .../2024-12-10T15_30_39.527Z.Desktop.md | 79 +++ .../2024-12-10T15_30_39.472Z.Desktop.md | 3 + .../2024-12-10T15_30_39.500Z.Desktop.md | 81 +++ .../2024-12-10T15_30_39.103Z.Desktop.md | 9 + .../2024-12-10T15_30_39.528Z.Desktop.md | 37 +- .../2024-12-10T15_30_39.530Z.Desktop.md | 79 +++ .../2024-12-10T15_30_39.104Z.Desktop.md | 18 + .../2024-12-10T17_34_38.477Z.Desktop.md | 166 +++++ .../2024-12-10T17_34_46.308Z.Desktop.md | 12 + .../2024-12-10T15_30_39.471Z.Desktop.md | 19 + .../2024-12-10T15_30_39.449Z.Desktop.md | 72 +++ .../2024-12-10T15_30_39.525Z.Desktop.md | 3 + .../2024-12-10T15_30_39.482Z.Desktop.md | 28 + .../2024-12-10T17_34_46.310Z.Desktop.md | 35 + .../2024-12-10T15_30_39.506Z.Desktop.md | 3 + .../2024-12-10T17_34_38.488Z.Desktop.md | 31 + .../2024-12-10T15_30_39.504Z.Desktop.md | 15 + .../2024-12-10T15_30_39.096Z.Desktop.md | 8 + .../2024-12-10T15_30_39.486Z.Desktop.md | 5 + .../2024-12-10T17_34_46.307Z.Desktop.md | 12 + pages/Abruptio Placentae.md | 6 +- pages/Absolute Bone Conduction Test.md | 4 +- pages/Accidental Hemorrhage.md | 2 +- pages/Accomodation.md | 4 +- pages/Achalasia Cardia.md | 88 +-- pages/Acute Dacrocystitis.md | 2 +- pages/Acute Epiglottitis.md | 96 +-- pages/Acute Mastoiditis.md | 96 +-- pages/Acute Maxillary Sinusitis.md | 92 +-- pages/Acute Retropharyngeal Abscess.md | 112 ++-- pages/Acute Suppurative Otitis Media.md | 38 +- pages/Adenoidectomy.md | 3 +- pages/Allergic Rhinitis.md | 92 +-- pages/Antenatal Care.md | 26 +- pages/Antepartum Hemorrhage.md | 38 +- ...antral Chronic Suppurative Otitis Media.md | 48 +- pages/Antral Washout.md | 4 +- pages/Aphakia.md | 10 +- pages/Apyrexial Laryngeal Stridor.md | 6 +- pages/Atrophic Rhinitis.md | 92 +-- pages/Atropine 1% Sulphate.md | 8 +- pages/Branchial Cyst.md | 88 +-- pages/Breast Feeding.md | 21 +- pages/Caesarean Section.md | 16 +- pages/Carcinoma Larynx.md | 96 +-- pages/Central Placenta Praevia.md | 14 +- pages/Chalazion.md | 2 +- pages/Chronic Retropharyngeal Abscess.md | 94 +-- pages/Chronic Suppurative Otitis Media.md | 124 ++-- pages/Cochlear Implant.md | 4 +- pages/Deviated Nasal Septum.md | 88 +-- pages/Eclampsia.md | 4 +- pages/Enlarged Adenoid.md | 88 +-- pages/Fallopian Tube.md | 34 +- pages/Foreign Body in Ear.md | 84 +-- pages/Foreign Body in Esophagus.md | 106 +-- pages/Foreign Body in Nose.md | 94 +-- pages/Functional Endoscopic Sinus Surgery.md | 4 +- pages/Furunculosis.md | 17 +- pages/Gestational Diabetes Mellitus.md | 12 +- pages/Glue Ear.md | 93 +-- pages/Grand Multipara.md | 52 +- pages/High Risk Pregnancy.md | 18 +- pages/IUFGR.md | 88 +-- pages/Impedance Audiogram.md | 4 +- pages/Jones II test.md | 2 +- pages/LASIK.md | 3 +- pages/Labor Pain.md | 54 +- pages/Labor.md | 13 +- pages/Littles Area.md | 4 +- pages/Ludwig's Angina.md | 88 +-- pages/Mastoid Abscess.md | 96 +-- pages/Mastoidectomy.md | 4 +- pages/Meniere's Disease.md | 88 +-- pages/Multiple Papilloma of Larynx.md | 88 +-- pages/Myringoplasty.md | 4 +- pages/Myringotomy.md | 4 +- pages/Nephrotic Syndrome.md | 398 ++++++------ pages/Obstructed Labor.md | 8 +- pages/Otitis Media with Effusion.md | 13 +- pages/Otitis Media.md | 17 +- pages/Otomycosis.md | 25 +- pages/Pathology.md | 8 +- pages/Perinatal Mortality.md | 48 +- pages/Peurperial Pyrexia.md | 40 +- pages/Phylectenular Conjunctivitis.md | 2 +- pages/Placenta Praevia.md | 16 +- pages/Plummer Vinson Syndrome.md | 4 +- pages/Pre-auricular Sinus.md | 88 +-- pages/Pterygium.md | 118 ++-- pages/Pure Tone Audiometry.md | 4 +- pages/Quinsy.md | 2 +- pages/Ranula.md | 4 +- pages/Recurrent Miscarriage.md | 1 + pages/Referred Otalgia.md | 4 +- pages/Retropharyngeal abscess.md | 96 +-- pages/Rhinoplasty.md | 4 +- pages/Rhinosporidiosis.md | 88 +-- pages/Rinne's Test.md | 6 +- pages/Rough Query.md | 5 +- pages/Septal Abscess.md | 92 +-- pages/Septal Hematoma.md | 92 +-- pages/Septoplasty.md | 4 +- pages/Stages of Labor.md | 17 +- pages/Stillbirth.md | 8 +- pages/Stridor.md | 6 +- pages/Thryroglossal Duct.md | 88 +-- pages/Tongue Ulcer.md | 4 +- pages/Tracheostomy.md | 8 +- ...mpanic Chronic Suppurative Otitis Media.md | 12 +- pages/Twin Pregnancy.md | 69 +- pages/Tympanoplasty.md | 4 +- pages/Uterus.md | 62 +- pages/Waldeyer's Ring.md | 4 +- pages/White Patches on the tonsil.md | 4 +- pages/contents.md | 1 + pages/juvenile nasopharyngeal angiofibroma.md | 4 +- pages/mydriasis.md | 2 +- pages/oligohydramnios.md | 24 +- 200 files changed, 6328 insertions(+), 2040 deletions(-) create mode 100644 .obsidian/community-plugins.json create mode 100644 .obsidian/hotkeys.json create mode 100644 .obsidian/plugins/obsidian-living-graph/data.json create mode 100644 .obsidian/plugins/obsidian-living-graph/main.js create mode 100644 .obsidian/plugins/obsidian-living-graph/manifest.json create mode 100644 Hemoptysis.md create mode 100644 Lung Abscess.md create mode 100644 MCNS.md create mode 100644 Scabies.md create mode 100644 Serum Sickness.md create mode 100644 Untitled.md create mode 100644 logseq/.recycle/pages_Cholesteatoma.md create mode 100644 logseq/bak/pages/Absolute Bone Conduction Test/2024-12-10T15_30_39.473Z.Desktop.md create mode 100644 logseq/bak/pages/Accomodation/2024-12-10T15_30_39.478Z.Desktop.md create mode 100644 logseq/bak/pages/Achalasia Cardia/2024-12-10T15_30_39.475Z.Desktop.md create mode 100644 logseq/bak/pages/Acute Dacrocystitis/2024-12-10T15_30_39.497Z.Desktop.md create mode 100644 logseq/bak/pages/Acute Epiglottitis/2024-12-10T15_30_39.503Z.Desktop.md create mode 100644 logseq/bak/pages/Acute Mastoiditis/2024-12-10T15_30_39.523Z.Desktop.md create mode 100644 logseq/bak/pages/Acute Maxillary Sinusitis/2024-12-10T15_30_39.474Z.Desktop.md create mode 100644 logseq/bak/pages/Acute Retropharyngeal Abscess/2024-12-10T15_30_39.520Z.Desktop.md create mode 100644 logseq/bak/pages/Adenoidectomy/2024-12-10T15_30_39.507Z.Desktop.md create mode 100644 logseq/bak/pages/Allergic Rhinitis/2024-12-10T15_30_39.488Z.Desktop.md create mode 100644 logseq/bak/pages/Antenatal Care/2024-12-10T17_34_38.441Z.Desktop.md create mode 100644 logseq/bak/pages/Antepartum Hemorrhage/2024-12-10T17_34_38.494Z.Desktop.md create mode 100644 logseq/bak/pages/Antral Washout/2024-12-10T15_30_39.479Z.Desktop.md create mode 100644 logseq/bak/pages/Aphakia/2024-12-10T15_30_39.496Z.Desktop.md create mode 100644 logseq/bak/pages/Apyrexial Laryngeal Stridor/2024-12-10T15_30_39.494Z.Desktop.md create mode 100644 logseq/bak/pages/Atrophic Rhinitis/2024-12-10T15_30_39.470Z.Desktop.md create mode 100644 logseq/bak/pages/Atropine 1% Sulphate/2024-12-10T15_30_39.502Z.Desktop.md create mode 100644 logseq/bak/pages/Branchial Cyst/2024-12-10T15_30_39.478Z.Desktop.md create mode 100644 logseq/bak/pages/Breast Feeding/2024-12-10T17_34_46.861Z.Desktop.md create mode 100644 logseq/bak/pages/Caesarean Section/2024-12-10T17_34_46.308Z.Desktop.md create mode 100644 logseq/bak/pages/Carcinoma Larynx/2024-12-10T15_30_39.515Z.Desktop.md create mode 100644 logseq/bak/pages/Central Placenta Praevia/2024-12-10T15_30_39.476Z.Desktop.md create mode 100644 logseq/bak/pages/Chalazion/2024-12-10T15_30_39.494Z.Desktop.md create mode 100644 logseq/bak/pages/Chronic Retropharyngeal Abscess/2024-12-10T15_30_39.495Z.Desktop.md create mode 100644 logseq/bak/pages/Chronic Suppurative Otitis Media/2024-12-10T15_30_39.525Z.Desktop.md create mode 100644 logseq/bak/pages/Clubbing/2024-12-10T16_03_25.730Z.Desktop.md create mode 100644 logseq/bak/pages/Cochlear Implant/2024-12-10T15_30_39.496Z.Desktop.md create mode 100644 logseq/bak/pages/Deviated Nasal Septum/2024-12-10T15_30_39.489Z.Desktop.md create mode 100644 logseq/bak/pages/Enlarged Adenoid/2024-12-10T15_30_39.102Z.Desktop.md create mode 100644 logseq/bak/pages/Fallopian Tube/2024-12-10T17_34_38.489Z.Desktop.md create mode 100644 logseq/bak/pages/Foreign Body in Ear/2024-12-10T15_30_39.514Z.Desktop.md create mode 100644 logseq/bak/pages/Foreign Body in Esophagus/2024-12-10T15_30_39.109Z.Desktop.md create mode 100644 logseq/bak/pages/Foreign Body in Nose/2024-12-10T15_30_39.113Z.Desktop.md create mode 100644 logseq/bak/pages/Functional Endoscopic Sinus Surgery/2024-12-10T15_30_39.493Z.Desktop.md create mode 100644 logseq/bak/pages/Grand Multipara/2024-12-10T17_34_38.435Z.Desktop.md create mode 100644 logseq/bak/pages/High Risk Pregnancy/2024-12-10T17_34_38.442Z.Desktop.md create mode 100644 logseq/bak/pages/IUFGR/2024-12-10T17_34_46.320Z.Desktop.md create mode 100644 logseq/bak/pages/Impedance Audiogram/2024-12-10T15_30_39.474Z.Desktop.md create mode 100644 logseq/bak/pages/Jones II test/2024-12-10T15_30_39.486Z.Desktop.md create mode 100644 logseq/bak/pages/Juvenile Nasopharyngeal Angiofibroma/2024-12-10T15_30_39.518Z.Desktop.md create mode 100644 logseq/bak/pages/LASIK/2024-12-10T15_30_39.476Z.Desktop.md create mode 100644 logseq/bak/pages/Labor Pain/2024-12-10T17_34_38.493Z.Desktop.md create mode 100644 logseq/bak/pages/Labor/2024-12-10T17_34_38.490Z.Desktop.md create mode 100644 logseq/bak/pages/Littles Area/2024-12-10T15_30_39.481Z.Desktop.md create mode 100644 logseq/bak/pages/Ludwig's Angina/2024-12-10T15_30_39.501Z.Desktop.md create mode 100644 logseq/bak/pages/Mastoid Abscess/2024-12-10T15_30_39.509Z.Desktop.md create mode 100644 logseq/bak/pages/Mastoidectomy/2024-12-10T15_30_39.504Z.Desktop.md create mode 100644 logseq/bak/pages/Meniere's Disease/2024-12-10T15_30_39.491Z.Desktop.md create mode 100644 logseq/bak/pages/Multiple Papilloma of Larynx/2024-12-10T15_30_39.506Z.Desktop.md create mode 100644 logseq/bak/pages/Myringoplasty/2024-12-10T15_30_39.510Z.Desktop.md create mode 100644 logseq/bak/pages/Myringotomy/2024-12-10T15_30_39.493Z.Desktop.md create mode 100644 logseq/bak/pages/Otitis Media with Effusion/2024-12-10T15_30_39.480Z.Desktop.md create mode 100644 logseq/bak/pages/Otomycosis/2024-12-10T15_30_39.513Z.Desktop.md create mode 100644 logseq/bak/pages/Pathology/2024-12-10T17_34_38.443Z.Desktop.md create mode 100644 logseq/bak/pages/Perinatal Mortality/2024-12-10T17_34_46.863Z.Desktop.md create mode 100644 logseq/bak/pages/Peurperial Pyrexia/2024-12-10T17_34_46.862Z.Desktop.md create mode 100644 logseq/bak/pages/Phylectenular Conjunctivitis/2024-12-10T15_30_39.507Z.Desktop.md create mode 100644 logseq/bak/pages/Plummer Vinson Syndrome/2024-12-10T15_30_39.505Z.Desktop.md create mode 100644 logseq/bak/pages/Pre-auricular Sinus/2024-12-10T15_30_39.482Z.Desktop.md create mode 100644 logseq/bak/pages/Pterygium/2024-12-10T15_30_39.522Z.Desktop.md create mode 100644 logseq/bak/pages/Pure Tone Audiometry/2024-12-10T15_30_39.508Z.Desktop.md create mode 100644 logseq/bak/pages/Quinsy/2024-12-10T15_30_39.502Z.Desktop.md create mode 100644 logseq/bak/pages/Ranula/2024-12-10T15_30_39.492Z.Desktop.md create mode 100644 logseq/bak/pages/Referred Otalgia/2024-12-10T15_30_39.492Z.Desktop.md create mode 100644 logseq/bak/pages/Retropharyngeal abscess/2024-12-10T15_30_39.527Z.Desktop.md create mode 100644 logseq/bak/pages/Rhinoplasty/2024-12-10T15_30_39.472Z.Desktop.md create mode 100644 logseq/bak/pages/Rhinosporidiosis/2024-12-10T15_30_39.500Z.Desktop.md create mode 100644 logseq/bak/pages/Rinne's Test/2024-12-10T15_30_39.103Z.Desktop.md rename pages/Cholesteatoma.md => logseq/bak/pages/Septal Abscess/2024-12-10T15_30_39.528Z.Desktop.md (65%) create mode 100644 logseq/bak/pages/Septal Hematoma/2024-12-10T15_30_39.530Z.Desktop.md create mode 100644 logseq/bak/pages/Septoplasty/2024-12-10T15_30_39.104Z.Desktop.md create mode 100644 logseq/bak/pages/Stages of Labor/2024-12-10T17_34_38.477Z.Desktop.md create mode 100644 logseq/bak/pages/Stillbirth/2024-12-10T17_34_46.308Z.Desktop.md create mode 100644 logseq/bak/pages/Stridor/2024-12-10T15_30_39.471Z.Desktop.md create mode 100644 logseq/bak/pages/Thryroglossal Duct/2024-12-10T15_30_39.449Z.Desktop.md create mode 100644 logseq/bak/pages/Tongue Ulcer/2024-12-10T15_30_39.525Z.Desktop.md create mode 100644 logseq/bak/pages/Tracheostomy/2024-12-10T15_30_39.482Z.Desktop.md create mode 100644 logseq/bak/pages/Twin Pregnancy/2024-12-10T17_34_46.310Z.Desktop.md create mode 100644 logseq/bak/pages/Tympanoplasty/2024-12-10T15_30_39.506Z.Desktop.md create mode 100644 logseq/bak/pages/Uterus/2024-12-10T17_34_38.488Z.Desktop.md create mode 100644 logseq/bak/pages/Waldeyer's Ring/2024-12-10T15_30_39.504Z.Desktop.md create mode 100644 logseq/bak/pages/White Patches on the tonsil/2024-12-10T15_30_39.096Z.Desktop.md create mode 100644 logseq/bak/pages/mydriasis/2024-12-10T15_30_39.486Z.Desktop.md create mode 100644 logseq/bak/pages/oligohydramnios/2024-12-10T17_34_46.307Z.Desktop.md diff --git a/.obsidian/app.json b/.obsidian/app.json index 9e26dfe..b976031 100644 --- a/.obsidian/app.json +++ b/.obsidian/app.json @@ -1 +1,5 @@ -{} \ No newline at end of file +{ + "userIgnoreFilters": [ + "logseq/" + ] +} \ No newline at end of file diff --git a/.obsidian/appearance.json b/.obsidian/appearance.json index 9e26dfe..2ac78be 100644 --- a/.obsidian/appearance.json +++ b/.obsidian/appearance.json @@ -1 +1,3 @@ -{} \ No newline at end of file +{ + "translucency": true +} \ No newline at end of file diff --git a/.obsidian/community-plugins.json b/.obsidian/community-plugins.json new file mode 100644 index 0000000..6d301a7 --- /dev/null +++ b/.obsidian/community-plugins.json @@ -0,0 +1,3 @@ +[ + "obsidian-living-graph" +] \ No newline at end of file diff --git a/.obsidian/graph.json b/.obsidian/graph.json index 08e07b7..12de8f3 100644 --- a/.obsidian/graph.json +++ b/.obsidian/graph.json @@ -6,17 +6,39 @@ "hideUnresolved": false, "showOrphans": true, "collapse-color-groups": true, - "colorGroups": [], + "colorGroups": [ + { + "query": "#disease", + "color": { + "a": 1, + "rgb": 14112342 + } + }, + { + "query": "#signs", + "color": { + "a": 1, + "rgb": 14701269 + } + }, + { + "query": "a", + "color": { + "a": 1, + "rgb": 2017383 + } + } + ], "collapse-display": true, "showArrow": false, "textFadeMultiplier": 0, "nodeSizeMultiplier": 1, "lineSizeMultiplier": 1, "collapse-forces": true, - "centerStrength": 0.518713248970312, - "repelStrength": 10, - "linkStrength": 1, - "linkDistance": 250, - "scale": 0.15975046351469732, + "centerStrength": 0.47, + "repelStrength": 18.7796524891285, + "linkStrength": 0.643086883767123, + "linkDistance": 165, + "scale": 0.061065864744578376, "close": true } \ No newline at end of file diff --git a/.obsidian/hotkeys.json b/.obsidian/hotkeys.json new file mode 100644 index 0000000..758180d --- /dev/null +++ b/.obsidian/hotkeys.json @@ -0,0 +1,12 @@ +{ + "obsidian-living-graph:toggle": [ + { + "modifiers": [ + "Alt", + "Ctrl", + "Mod" + ], + "key": "Enter" + } + ] +} \ No newline at end of file diff --git a/.obsidian/plugins/obsidian-living-graph/data.json b/.obsidian/plugins/obsidian-living-graph/data.json new file mode 100644 index 0000000..3534b03 --- /dev/null +++ b/.obsidian/plugins/obsidian-living-graph/data.json @@ -0,0 +1,6 @@ +{ + "activeComposites": [ + "Organism" + ], + "includeLocal": true +} \ No newline at end of file diff --git a/.obsidian/plugins/obsidian-living-graph/main.js b/.obsidian/plugins/obsidian-living-graph/main.js new file mode 100644 index 0000000..31dc36a --- /dev/null +++ b/.obsidian/plugins/obsidian-living-graph/main.js @@ -0,0 +1,608 @@ +/* +THIS IS A GENERATED/BUNDLED FILE BY ESBUILD +if you want to view the source, please visit the github repository of this plugin +*/ + +var __create = Object.create; +var __defProp = Object.defineProperty; +var __getOwnPropDesc = Object.getOwnPropertyDescriptor; +var __getOwnPropNames = Object.getOwnPropertyNames; +var __getProtoOf = Object.getPrototypeOf; +var __hasOwnProp = Object.prototype.hasOwnProperty; +var __markAsModule = (target) => __defProp(target, "__esModule", { value: true }); +var __export = (target, all) => { + __markAsModule(target); + for (var name in all) + __defProp(target, name, { get: all[name], enumerable: true }); +}; +var __reExport = (target, module2, desc) => { + if (module2 && typeof module2 === "object" || typeof module2 === "function") { + for (let key of __getOwnPropNames(module2)) + if (!__hasOwnProp.call(target, key) && key !== "default") + __defProp(target, key, { get: () => module2[key], enumerable: !(desc = __getOwnPropDesc(module2, key)) || desc.enumerable }); + } + return target; +}; +var __toModule = (module2) => { + return __reExport(__markAsModule(__defProp(module2 != null ? __create(__getProtoOf(module2)) : {}, "default", module2 && module2.__esModule && "default" in module2 ? { get: () => module2.default, enumerable: true } : { value: module2, enumerable: true })), module2); +}; +var __async = (__this, __arguments, generator) => { + return new Promise((resolve, reject) => { + var fulfilled = (value) => { + try { + step(generator.next(value)); + } catch (e) { + reject(e); + } + }; + var rejected = (value) => { + try { + step(generator.throw(value)); + } catch (e) { + reject(e); + } + }; + var step = (x) => x.done ? resolve(x.value) : Promise.resolve(x.value).then(fulfilled, rejected); + step((generator = generator.apply(__this, __arguments)).next()); + }); +}; + +// main.ts +__export(exports, { + default: () => LivingGraphPlugin +}); +var import_obsidian = __toModule(require("obsidian")); + +// Functories.ts +var PeriodicFunctory = class { + constructor(_func) { + this._func = _func; + this._scale = 1; + } + call(x, min, max, delta) { + return this._func.apply(this, arguments); + } + period(dilation) { + return dilation / this._scale * Math.PI; + } + static createHelp(type, ...args) { + const instance = new type(...args); + return Object.assign((...innerargs) => instance.call(...innerargs), { period: (dilation) => instance.period(dilation) }); + } + static create(...args) { + return PeriodicFunctory.createHelp(FunctoryStandin, ...args); + } +}; +var FunctoryStandin = class extends PeriodicFunctory { + constructor(func) { + super(func); + } +}; +var WaveFunctory = class extends PeriodicFunctory { + constructor(func, coefficients, normalize = true) { + super(func); + this.coefficients = coefficients; + this._scale = normalize ? coefficients.reduce((a, b) => a + Math.abs(b[1]), 0) : 1; + } + call(x, min, max, delta) { + return this._func.apply(this, [x, min, max, delta, this.coefficients]); + } + static create(...args) { + return super.createHelp(WaveFunctory, ...args); + } +}; +function scaledWave(x, min, max, delta, coefficients, normalize = true) { + return min + (max - min) * wave.apply(this, [Math.sin, x, coefficients, normalize]); +} +function wave(func, x, coefficients, normalize = true) { + if (normalize) + x *= this._scale * 2; + let sum = coefficients.reduce((a, b) => [a[0] + b[1] * func(x * b[0]), 0], [0, 0])[0]; + return normalize ? (sum / this._scale + 1) / 2 : sum; +} + +// graphManip.ts +function getScaleConversion(from, for_) { + var _a; + const scaleConversions = new Map([ + ["setRepelStrength", [0, 20]], + ["setLinkDistance", [30, 500]] + ]); + let [low, high] = (_a = scaleConversions.get(from.replace(/bound /, ""))) != null ? _a : [0, 1]; + let [lower, upper] = for_; + lower *= high - low; + upper *= high - low; + return [lower, upper]; +} +function setCenterForce(centerForce, leaves) { + leaves.forEach((leaf) => getEngine(leaf).forceOptions.optionListeners.centerStrength(centerForce)); +} +function setLinkDistance(linkDistance, leaves) { + leaves.forEach((leaf) => getEngine(leaf).forceOptions.optionListeners.linkDistance(linkDistance)); +} +function setLinkStrength(linkStrength, leaves) { + leaves.forEach((leaf) => getEngine(leaf).forceOptions.optionListeners.linkStrength(linkStrength)); +} +function setRepelStrength(repelStrength, leaves) { + leaves.forEach((leaf) => getEngine(leaf).forceOptions.optionListeners.repelStrength(repelStrength)); +} +function getEngine(leaf) { + var _a; + return (_a = leaf.view.dataEngine) != null ? _a : leaf.view.engine; +} + +// interval.ts +var Interval = class { + constructor(interval, plugin) { + this.plugin = plugin; + this._interval = null; + this._desiredUpdatesPerPeriod = 24; + this._desiredUpdatesPerSecond = 5; + this._maxUpdatesPerSecond = 27; + Object.assign(this, interval); + [this.lower, this.upper] = getScaleConversion(this.g_x.name, [this.lower, this.upper]); + this._inversionCenter = (this.lower + this.upper) / 2; + this._periodMs = this.f_x.period(this.timeDilation) * 1e3; + this._updatesPerSecond = Math.min(this._maxUpdatesPerSecond, Math.max(this._desiredUpdatesPerSecond, Math.ceil(1e3 * this._desiredUpdatesPerPeriod / this._periodMs))); + this._updatePeriodMs = 1e3 / this._updatesPerSecond; + this._tslices = Math.ceil(this._periodMs / this._updatePeriodMs); + this.evaluator = this._tslices > 10 ? this.memodEvaluate.bind(this) : this.evaluate.bind(this); + if (this._tslices > 10) + this.memoizeInterval(); + } + isActive() { + return this._interval !== null; + } + start(leaves) { + var _a; + if (this._interval) + return; + let offset = Date.now() % this._periodMs + ((_a = this.relativeOfsset) != null ? _a : 0) * this._periodMs; + this._interval = setInterval(() => { + this.g_x(this.evaluator(Date.now() - offset), leaves); + }, this._updatePeriodMs); + } + clear() { + clearInterval(this._interval); + this._interval = null; + } + evaluate(time) { + var _a; + let res = this.f_x(time / (this.timeDilation * 1e3), this.lower, this.upper, this._updatePeriodMs); + res = this.invert ? this._inversionCenter + (this._inversionCenter - res) : res; + res = this.multiplier ? (res - this._inversionCenter) * this.multiplier + this._inversionCenter : res; + return ((_a = this.verticalOffset) != null ? _a : 0) + (this.preventClamp ? res : Math.clamp(res, this.lower, this.upper)); + } + memodEvaluate(time) { + if (!this._memoized) + this.memoizeInterval(); + return this._memoized[Math.floor(time % this._periodMs / this._updatePeriodMs)]; + } + memoizeInterval() { + this._memoized = []; + for (let i = 0, time = 0; i < this._tslices; i++, time += this._updatePeriodMs) + this._memoized.push(this.evaluate(time)); + } +}; + +// main.ts +function scaledSine(x, min, max, delta) { + return min + (max - min) * Math.sin(x); +} +function simpleSine2(x, min, max, delta) { + return min + (max - min) * (2 * Math.sin(x)); +} +var intervals = [ + { + name: "Breathing", + repelForce: 15.33 / 20, + linkForce: 0.12, + linkDistance: 0.2, + intervals: [ + { + lower: 0.25, + upper: 0.4, + timeDilation: 2, + g_x: setCenterForce, + f_x: WaveFunctory.create(scaledWave, [[1, 0.5]], false) + } + ] + }, + { + name: "Breathing Network", + repelForce: 18.5 / 20, + linkForce: 0.92, + linkDistance: 0.1, + intervals: [ + { + lower: 0.25, + upper: 0.4, + timeDilation: 2, + g_x: setCenterForce, + f_x: WaveFunctory.create(scaledWave, [[1, 0.5]], false) + } + ] + }, + { + name: "Breathing Colonies", + intervals: [ + { + lower: 0.7, + upper: 0.99, + timeDilation: 0.35, + g_x: setLinkDistance, + f_x: PeriodicFunctory.create(scaledSine) + }, + { + lower: 0.45, + upper: 0.5, + timeDilation: 0.6, + g_x: setCenterForce, + f_x: WaveFunctory.create(scaledWave, [[1, 1], [2, 1], [0.5, 1]]) + }, + { + lower: 0.7, + upper: 0.99, + timeDilation: 0.35, + g_x: setLinkStrength, + f_x: PeriodicFunctory.create(scaledSine) + }, + { + lower: 0.5, + upper: 0.55, + timeDilation: 0.6, + g_x: setRepelStrength, + f_x: WaveFunctory.create(scaledWave, [[1, 1], [2, 1], [0.5, 1]]) + } + ] + }, + { + name: "Jellyfish Bloom", + centerForce: 0.1, + linkDistance: 1, + intervals: [ + { + lower: 0.1, + upper: 0.99, + timeDilation: 50, + g_x: setLinkStrength, + f_x: WaveFunctory.create(scaledWave, [[3, 1], [5, 1], [7, 1]]) + }, + { + lower: 0.85, + upper: 0.99, + timeDilation: 60, + g_x: setRepelStrength, + f_x: WaveFunctory.create(scaledWave, [[3, 1], [5, 1], [7, 1]]) + } + ] + }, + { + name: "Muscle", + centerForce: 0.35, + linkForce: 0.75, + linkDistance: 0.1, + intervals: [ + { + lower: 0.6, + upper: 1.2, + timeDilation: 1.5, + g_x: setRepelStrength, + f_x: WaveFunctory.create(scaledWave, [[1, 0.5]], false) + }, + { + lower: 0.2, + upper: 0.5, + multiplier: 1.5, + timeDilation: 1.5, + g_x: setCenterForce, + f_x: WaveFunctory.create(scaledWave, [[1, 0.5]], false) + } + ] + }, + { + name: "Heart", + intervals: [ + { + lower: 0.7, + upper: 1.1, + timeDilation: 0.35 * 4, + invert: true, + g_x: setLinkDistance, + f_x: PeriodicFunctory.create(simpleSine2) + }, + { + lower: 0.4, + upper: 0.45, + timeDilation: 0.6 * 4, + multiplier: 1.5, + g_x: setCenterForce, + f_x: WaveFunctory.create(scaledWave, [[1, 1], [2, 1], [0.5, 1]]) + }, + { + lower: 0.7, + upper: 1.1, + timeDilation: 0.35 * 4, + invert: true, + g_x: setLinkStrength, + f_x: PeriodicFunctory.create(simpleSine2) + }, + { + lower: 0.9, + upper: 0.99, + verticalOffset: -0.2, + multiplier: 2, + timeDilation: 0.6 * 4, + g_x: setRepelStrength, + f_x: WaveFunctory.create(scaledWave, [[1, 1], [2, 1], [0.5, 1]]) + } + ] + }, + { + name: "Squid", + intervals: [ + { + lower: 0, + upper: 1, + timeDilation: 40, + g_x: setLinkStrength, + f_x: WaveFunctory.create(scaledWave, [[3, 2], [5, 5], [4.5, -6]]) + }, + { + lower: 0.3, + upper: 1, + timeDilation: 40, + g_x: setRepelStrength, + f_x: WaveFunctory.create(scaledWave, [[3, 2], [5, 5], [4.5, -6]]) + }, + { + lower: 0.2, + upper: 0.35, + timeDilation: 40, + invert: true, + g_x: setCenterForce, + f_x: WaveFunctory.create(scaledWave, [[3, 2], [5, 5], [4.5, -6]]) + }, + { + lower: 0, + upper: 1, + invert: true, + timeDilation: 40, + g_x: setLinkDistance, + f_x: WaveFunctory.create(scaledWave, [[3, 2], [5, 5], [4.5, -6]]) + } + ] + }, + { + name: "Organism", + centerForce: 0.47, + linkDistance: 0.35, + intervals: [ + { + lower: 0.15, + upper: 1, + timeDilation: 50, + g_x: setLinkStrength, + f_x: WaveFunctory.create(scaledWave, [[3, 5], [5, 4], [7, 2]]) + }, + { + lower: 0.87, + upper: 1, + timeDilation: 60, + relativeOfsset: 0.5, + g_x: setRepelStrength, + f_x: WaveFunctory.create(scaledWave, [[3, 5], [5, 4], [7, 2]]) + } + ] + }, + { + name: "Jump Roping", + intervals: [ + { + lower: 0.7, + upper: 0.99, + timeDilation: 0.4, + g_x: setLinkDistance, + f_x: PeriodicFunctory.create(scaledSine) + }, + { + lower: 0.4, + upper: 0.55, + timeDilation: 1, + g_x: setCenterForce, + f_x: WaveFunctory.create(scaledWave, [[1, 1], [2, 1], [0.5, 1]]) + }, + { + lower: 0.7, + upper: 0.99, + timeDilation: 0.35, + g_x: setLinkStrength, + f_x: PeriodicFunctory.create(scaledSine) + }, + { + lower: 0.9, + upper: 0.99, + timeDilation: 0.6, + g_x: setRepelStrength, + f_x: WaveFunctory.create(scaledWave, [[1, 1], [2, 1], [0.5, 1]]) + } + ] + }, + { + name: "I like to move it", + centerForce: 0.6, + linkForce: 1, + linkDistance: 0.3, + intervals: [ + { + lower: 0.3, + upper: 1.2, + timeDilation: 1.9, + multiplier: 1.2, + g_x: setRepelStrength, + f_x: WaveFunctory.create(scaledWave, [[1, 1], [3, 1 / 3], [5, 1 / 5]]) + } + ] + }, + { + name: "Boo!", + centerForce: 0.5, + linkForce: 1, + linkDistance: 1, + intervals: [ + { + lower: 0.3, + upper: 1, + timeDilation: 2.8, + multiplier: 5, + g_x: setRepelStrength, + f_x: WaveFunctory.create(scaledWave, [[1, 1], [3, 1 / 3], [5, 1 / 5], [7, 1 / 7], [9, 1 / 9], [11, 1 / 11], [13, 1 / 13]]) + } + ] + }, + { + name: "Panting", + intervals: [ + { + lower: 0.3, + upper: 1, + timeDilation: -20, + g_x: setLinkStrength, + f_x: WaveFunctory.create(scaledWave, [[3, 2], [5, 3], [4.5, -6]]) + }, + { + lower: 0.3, + upper: 1, + timeDilation: 20, + g_x: setRepelStrength, + f_x: WaveFunctory.create(scaledWave, [[3, 2], [5, 3], [4.5, -6]]) + }, + { + lower: 0.1, + upper: 0.25, + timeDilation: -20, + g_x: setCenterForce, + f_x: WaveFunctory.create(scaledWave, [[3, 2], [5, 3], [4.5, -6]]) + }, + { + lower: 0, + upper: 1, + timeDilation: -20, + g_x: setLinkDistance, + f_x: WaveFunctory.create(scaledWave, [[3, 2], [5, 3], [4.5, -6]]) + } + ] + } +]; +var LivingGraphPlugin = class extends import_obsidian.Plugin { + startIntervals() { + let ags = this.activeGraphSetting; + let setAttribute = (value, func) => { + let [low, high] = getScaleConversion(func.name, [0, 1]); + func(value * (high - low) + low, this.graphLeaves); + }; + if (ags.centerForce) + setAttribute(ags.centerForce, setCenterForce); + if (ags.linkForce) + setAttribute(ags.linkForce, setLinkStrength); + if (ags.repelForce) + setAttribute(ags.repelForce, setRepelStrength); + if (ags.linkDistance) + setAttribute(ags.linkDistance, setLinkDistance); + if (this.intervals.first().isActive()) + setTimeout(this.clearIntervals.bind(this), 1500); + else + this.intervals.forEach((i) => i.start(this.graphLeaves)); + } + clearIntervals() { + var _a; + (_a = this.intervals) == null ? void 0 : _a.forEach((i) => i.clear()); + } + refreshLeaves() { + var _a, _b; + this.graphLeaves = [].concat((_a = this.app.workspace.getLeavesOfType("graph")) != null ? _a : []).concat(this.settings.includeLocal ? (_b = this.app.workspace.getLeavesOfType("localgraph")) != null ? _b : [] : []); + } + onload() { + return __async(this, null, function* () { + yield this.loadData(); + this.addSettingTab(new LivingGraphSettingTab(this.app, this)); + this.registerEvent(this.app.workspace.on("layout-change", this.refreshLeaves.bind(this))); + this.app.workspace.onLayoutReady(this.refreshLeaves.bind(this)); + this.refreshLeaves(); + this.addCommand({ + id: "toggle", + name: "Living Graph - Toggle", + callback: this.startIntervals.bind(this) + }); + this.updateIntervals(); + }); + } + onunload() { + return __async(this, null, function* () { + this.clearIntervals(); + }); + } + loadData() { + var __superGet = (key) => super[key]; + return __async(this, null, function* () { + this.settings = Object.assign({}, DEFAULT_SETTINGS, yield __superGet("loadData").call(this)); + }); + } + saveData() { + var __superGet = (key) => super[key]; + return __async(this, null, function* () { + yield __superGet("saveData").call(this, this.settings); + }); + } + updateIntervals(which) { + which != null ? which : which = new Set(this.settings.activeComposites); + this.clearIntervals(); + this.refreshLeaves(); + this.intervals = intervals.filter((c) => { + let use = which.has(c.name); + if (use) + this.activeGraphSetting = c; + return use; + }).map((c) => c.intervals.map((i) => new Interval(i, this))).flat(); + } +}; +var DEFAULT_SETTINGS = { + activeComposites: [intervals[0].name], + includeLocal: true +}; +var LivingGraphSettingTab = class extends import_obsidian.PluginSettingTab { + constructor(app, plugin) { + super(app, plugin); + this.plugin = plugin; + } + display() { + const { containerEl } = this; + containerEl.empty(); + containerEl.createEl("h2", { text: "Living Graph" }); + let saveAndRestart = (() => { + var _a; + let wasActive = (_a = this.plugin.intervals) == null ? void 0 : _a.first().isActive(); + this.plugin.updateIntervals(); + if (wasActive) + this.plugin.startIntervals(); + this.plugin.saveData(); + }).bind(this); + new import_obsidian.Setting(containerEl).setName("Presets").setDesc("Activate a living graph preset").addDropdown((cb) => { + intervals.map((i) => i.name).forEach((name) => cb.addOption(name, name)); + cb.onChange((name) => __async(this, null, function* () { + this.plugin.settings.activeComposites = [name]; + saveAndRestart(); + })); + cb.setValue(this.plugin.settings.activeComposites[0]); + }); + new import_obsidian.Setting(containerEl).setName("Include Local Graphs").addToggle((cb) => { + cb.onChange((value) => __async(this, null, function* () { + this.plugin.settings.includeLocal = value; + saveAndRestart(); + })); + cb.setValue(this.plugin.settings.includeLocal); + }); + } +}; + +/* nosourcemap */ \ No newline at end of file diff --git a/.obsidian/plugins/obsidian-living-graph/manifest.json b/.obsidian/plugins/obsidian-living-graph/manifest.json new file mode 100644 index 0000000..500b28a --- /dev/null +++ b/.obsidian/plugins/obsidian-living-graph/manifest.json @@ -0,0 +1,9 @@ +{ + "id": "obsidian-living-graph", + "name": "Living Graph", + "version": "1.0.3", + "minAppVersion": "0.13.19", + "description": "A for-fun graph plugin", + "author": "Garrett", + "isDesktopOnly": false +} \ No newline at end of file diff --git a/.obsidian/workspace.json b/.obsidian/workspace.json index 63c3cc1..af3d63d 100644 --- a/.obsidian/workspace.json +++ b/.obsidian/workspace.json @@ -4,17 +4,17 @@ "type": "split", "children": [ { - "id": "2bdea1e21f1dbc3d", + "id": "ac04fb4554df7ee7", "type": "tabs", "children": [ { - "id": "977b375358a91d37", + "id": "322b44aa8d3d6bfd", "type": "leaf", "state": { - "type": "empty", + "type": "graph", "state": {}, - "icon": "lucide-file", - "title": "New tab" + "icon": "lucide-git-fork", + "title": "Graph view" } } ] @@ -48,7 +48,7 @@ "state": { "type": "search", "state": { - "query": "tag:#ent-prof-card tag:#card", + "query": "", "matchingCase": false, "explainSearch": true, "collapseAll": false, @@ -70,7 +70,7 @@ } } ], - "currentTab": 1 + "currentTab": 2 } ], "direction": "horizontal", @@ -90,7 +90,7 @@ "state": { "type": "backlink", "state": { - "file": "pages/Fever.md", + "file": "pages/Hemophilia.md", "collapseAll": false, "extraContext": false, "sortOrder": "alphabetical", @@ -100,7 +100,7 @@ "unlinkedCollapsed": true }, "icon": "links-coming-in", - "title": "Backlinks for Fever" + "title": "Backlinks for Hemophilia" } }, { @@ -109,12 +109,11 @@ "state": { "type": "outgoing-link", "state": { - "file": "pages/Fever.md", "linksCollapsed": false, "unlinkedCollapsed": true }, "icon": "links-going-out", - "title": "Outgoing links from Fever" + "title": "Outgoing links" } }, { @@ -135,18 +134,17 @@ "type": "leaf", "state": { "type": "outline", - "state": { - "file": "pages/Fever.md" - }, + "state": {}, "icon": "lucide-list", - "title": "Outline of Fever" + "title": "Outline" } } - ] + ], + "currentTab": 3 } ], "direction": "horizontal", - "width": 300, + "width": 705.5, "collapsed": true }, "left-ribbon": { @@ -156,11 +154,29 @@ "canvas:Create new canvas": false, "daily-notes:Open today's daily note": false, "templates:Insert template": false, - "command-palette:Open command palette": false + "command-palette:Open command palette": false, + "infranodus-graph-view:InfraNodus Graph View": false } }, - "active": "977b375358a91d37", + "active": "322b44aa8d3d6bfd", "lastOpenFiles": [ + "Untitled.md", + "pages/SLE.md", + "pages/Hemophilia.md", + "Hemoptysis.md", + "pages/Clubbing.md", + "logseq/bak/pages/Clubbing/2024-12-10T16_03_25.730Z.Desktop.md", + "Scabies.md", + "Lung Abscess.md", + "pages/Pleural Effusion.md", + "pages/Nephrotic Syndrome.md", + "MCNS.md", + "Serum Sickness.md", + "pages/Haemoconcentration.md", + "pages/Lymphoma.md", + "pages/Surgery.md", + "pages/Medicine.md", + "logseq/bak/pages/Conjunctivitis/2024-12-07T11_10_46.312Z.Desktop.md", "logseq/bak/pages/Thyroidectomy/2024-12-09T11_06_23.322Z.Desktop.md", "logseq/bak/pages/Hoarseness of Voice/2024-12-09T11_06_23.321Z.Desktop.md", "logseq/bak/pages/Brachial Cyst/2024-12-09T11_06_23.303Z.Desktop.md", @@ -169,20 +185,6 @@ "pages/Wax.md", "journals/2024_12_09.md", "pages/Perichondritis.md", - "pages/Otomycosis.md", - "pages/Achalasia Cardia.md", - "pages/Acute Anterior Uveitis.md", - "logseq/bak/pages/Glaucoma/2024-12-07T11_10_46.318Z.Desktop.md", - "pages/Chalazion.md", - "pages/Conjunctivitis.md", - "pages/Allergic Conjunctivitis.md", - "pages/Acute Dacrocystitis.md", - "pages/Accomodation.md", - "pages/Fever.md", - "DCR.md", - "pages/eye-prof-written.md", - "pages/Cataract.md", - "pages/Closed Angle Glaucoma.md", - "pages/Smoking History.md" + "pages/Otomycosis.md" ] } \ No newline at end of file diff --git a/Hemoptysis.md b/Hemoptysis.md new file mode 100644 index 0000000..e69de29 diff --git a/Lung Abscess.md b/Lung Abscess.md new file mode 100644 index 0000000..e69de29 diff --git a/MCNS.md b/MCNS.md new file mode 100644 index 0000000..e69de29 diff --git a/Scabies.md b/Scabies.md new file mode 100644 index 0000000..e69de29 diff --git a/Serum Sickness.md b/Serum Sickness.md new file mode 100644 index 0000000..e69de29 diff --git a/Untitled.md b/Untitled.md new file mode 100644 index 0000000..e69de29 diff --git a/journals/2024_12_10.md b/journals/2024_12_10.md index 2e1262c..ea02b49 100644 --- a/journals/2024_12_10.md +++ b/journals/2024_12_10.md @@ -1,5 +1,5 @@ -- Gyne - abortion -- obs - normal labor +- DONE Gyne - abortion, done only habitual abortion definition +- DONE obs - added set 1, done 10 cards - pedi - 5 cards -- eye - 10 cards -- ent - 70 cards \ No newline at end of file +- DONE eye - 10 cards +- ent - 70 cards . doing \ No newline at end of file diff --git a/logseq/.recycle/pages_Cholesteatoma.md b/logseq/.recycle/pages_Cholesteatoma.md new file mode 100644 index 0000000..e69de29 diff --git a/logseq/bak/pages/Absolute Bone Conduction Test/2024-12-10T15_30_39.473Z.Desktop.md b/logseq/bak/pages/Absolute Bone Conduction Test/2024-12-10T15_30_39.473Z.Desktop.md new file mode 100644 index 0000000..9410028 --- /dev/null +++ b/logseq/bak/pages/Absolute Bone Conduction Test/2024-12-10T15_30_39.473Z.Desktop.md @@ -0,0 +1,3 @@ +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6758027c-89e4-4a7e-845d-641b9d65bb18 \ No newline at end of file diff --git a/logseq/bak/pages/Accomodation/2024-12-10T15_30_39.478Z.Desktop.md b/logseq/bak/pages/Accomodation/2024-12-10T15_30_39.478Z.Desktop.md new file mode 100644 index 0000000..87f21ec --- /dev/null +++ b/logseq/bak/pages/Accomodation/2024-12-10T15_30_39.478Z.Desktop.md @@ -0,0 +1,3 @@ +# Mechanism of Accomodation #eye-prof-written +Changes or events occur during accommodation +- SN: #eye-prof-written \ No newline at end of file diff --git a/logseq/bak/pages/Achalasia Cardia/2024-12-10T15_30_39.475Z.Desktop.md b/logseq/bak/pages/Achalasia Cardia/2024-12-10T15_30_39.475Z.Desktop.md new file mode 100644 index 0000000..6aa03fd --- /dev/null +++ b/logseq/bak/pages/Achalasia Cardia/2024-12-10T15_30_39.475Z.Desktop.md @@ -0,0 +1,78 @@ +- alias:: + ICD-11_Code:: + tags:: #Disease +- ## Etiology #ent-prof-card #unanswered #card + background-color:: blue + deck:: #ENT + id:: 36de9f45-68c5-4331-8e37-c3daf391bb23 + - ### Causative Agents + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features #ent-prof-card #unanswered #card + background-color:: blue + deck:: #ENT + id:: 52c64503-bf27-4d6a-8474-e752eb17a295 + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria +- ## Diagnosis + background-color:: blue + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-card #unanswered #card + background-color:: blue + deck:: #ENT + id:: 2d2ff087-298c-43ec-a324-fce7ddfa9dfa + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675813a2-a798-47ba-bba1-392a69a7cf38 \ No newline at end of file diff --git a/logseq/bak/pages/Acute Dacrocystitis/2024-12-10T15_30_39.497Z.Desktop.md b/logseq/bak/pages/Acute Dacrocystitis/2024-12-10T15_30_39.497Z.Desktop.md new file mode 100644 index 0000000..b2faf51 --- /dev/null +++ b/logseq/bak/pages/Acute Dacrocystitis/2024-12-10T15_30_39.497Z.Desktop.md @@ -0,0 +1,104 @@ +- alias:: + ICD-11_Code:: + tags:: #Disease +- ## Etiology + background-color:: blue + - ### Causative Agents + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features #eye-prof-written + background-color:: blue + - ### Signs and Symptoms + - #### Symptoms #eye-prof-written #card + deck:: [[Eye]] + id:: a8ddd379-c7eb-43bf-b5c6-55cb70de2c56 + - Watering + logseq.order-list-type:: number + - Pain + logseq.order-list-type:: number + - #### Signs #eye-prof-written #card + deck:: [[Eye]] + id:: 455c396b-e575-43bc-97c9-9a788db9e227 + - Red tender tense swelling in medial canthus + logseq.order-list-type:: number + - Abscess in several cases + logseq.order-list-type:: number + - ### Stages or Classification + - ### Diagnostic Criteria +- ## Diagnosis + background-color:: blue + - ### Clinical Diagnosis + - #### Classical Presentation #classical-presentation + probability:: 85-95% + - Painful Swelling and redness over the lacrimal sac area(medial canthus), with history [[Epiphora]], occasional discharge for last 2 years + - **Pain** and **erythema** over the lacrimal sac region + - **Swelling** and **tenderness** in the lacrimal sac area + - **Purulent discharge** with pressure over the sac (regurgitation test) + - **Systemic symptoms** like **fever** and **malaise** + - Acute onset of symptoms (usually within **hours to days**) + - #### Probable Diagnosis + - ### Differential Diagnosis + - [[Chronic Dacryocystitis]] + check-for:: intermittent mucopurulent discharge without acute pain or systemic symptoms, history of long-term obstruction + - [[Acute Sinusitis]] + check-for:: nasal symptoms (congestion, discharge), pain in the maxillary or ethmoid sinuses, and possible post-nasal drip + - ### Confirmation of Diagnosis + probability:: +0% (85-95%) + - [[Sac Patency Test]] is difficult as it is painful +- ## Management and Treatment + background-color:: blue + - ### Medical Treatment + recurrence:: 30-50% or even higher (if persistent nasolacrimal obstruction) + - Broad Spectrum Antibiotics + - Warm compression + - ### Surgical Options + recurrence:: 5-10% + - [[DCR]] + - ### Lifestyle and Dietary Recommendations + - ### Follow-up +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications #eye-prof-written #card + deck:: [[Eye]] + id:: e901594a-f442-44c1-8dcb-52494a6b4f39 + - [[Chronic Dacryocystitis]] + logseq.order-list-type:: number + - [[Lacrimal Abscess]] + logseq.order-list-type:: number + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue +- SN: #eye-prof-written diff --git a/logseq/bak/pages/Acute Epiglottitis/2024-12-10T15_30_39.503Z.Desktop.md b/logseq/bak/pages/Acute Epiglottitis/2024-12-10T15_30_39.503Z.Desktop.md new file mode 100644 index 0000000..4bff9a1 --- /dev/null +++ b/logseq/bak/pages/Acute Epiglottitis/2024-12-10T15_30_39.503Z.Desktop.md @@ -0,0 +1,82 @@ +- alias:: + ICD-11_Code:: + tags:: #Disease +- ## Etiology #ent-prof-card #unanswered #card + background-color:: blue + deck:: #ENT + id:: 679efe77-ff1d-4c8d-888c-abb551b9ada2 + - ### Causative Agents + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features #ent-prof-card #unanswered #card + background-color:: blue + deck:: #ENT + id:: 594754be-5664-46ab-8213-ccbed28261b5 + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria +- ## Diagnosis + background-color:: blue + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - [[Acute Laryngotracheobronchitis]] + - Differences #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756b395-74e9-4b44-83bd-651dc5aeded1 + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-card #unanswered #card + background-color:: blue + deck:: #ENT + id:: 4ef3c41d-da98-42b2-ae51-71ddb4f116d4 + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580fed-6ad9-45f9-9c83-6b554715552c \ No newline at end of file diff --git a/logseq/bak/pages/Acute Mastoiditis/2024-12-10T15_30_39.523Z.Desktop.md b/logseq/bak/pages/Acute Mastoiditis/2024-12-10T15_30_39.523Z.Desktop.md new file mode 100644 index 0000000..586adc9 --- /dev/null +++ b/logseq/bak/pages/Acute Mastoiditis/2024-12-10T15_30_39.523Z.Desktop.md @@ -0,0 +1,80 @@ +- alias:: + ICD-11_Code:: + tags:: #Disease +- ## Etiology + background-color:: blue + - ### Causative Agents + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features #ent-prof-written #unanswered #card + background-color:: blue + deck:: #ENT + id:: ccd50f0e-f676-42f1-b879-d7518c4828c3 + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria +- ## Diagnosis + background-color:: blue + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - [[Furunculosis]] + - Differences #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756bf74-1837-4386-b65d-01fd1761851d + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-written #unanswered #card + background-color:: blue + deck:: #ENT + id:: e90e31bf-d0f0-4ba7-ba3a-9c39398d3eb5 + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6757ffdb-17b0-4334-81bf-65dedfdc9354 \ No newline at end of file diff --git a/logseq/bak/pages/Acute Maxillary Sinusitis/2024-12-10T15_30_39.474Z.Desktop.md b/logseq/bak/pages/Acute Maxillary Sinusitis/2024-12-10T15_30_39.474Z.Desktop.md new file mode 100644 index 0000000..77607b7 --- /dev/null +++ b/logseq/bak/pages/Acute Maxillary Sinusitis/2024-12-10T15_30_39.474Z.Desktop.md @@ -0,0 +1,80 @@ +- alias:: + ICD-11_Code:: + tags:: #Disease +- ## Etiology #ent-prof-card #unanswered #card + background-color:: blue + deck:: #ENT + id:: 3fae41d5-d42b-4c21-9e86-58cedddcc339 + - ### Causative Agents + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features #ent-prof-card #ent-prof-written #unanswered #card + background-color:: blue + id:: 00ed145a-4123-46b2-8747-008133352fc0 + deck:: #ENT + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria +- ## Diagnosis + background-color:: blue + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-card #unanswered #card + background-color:: blue + deck:: #ENT + id:: e0e6c817-331f-4915-8c21-e69e459165b0 + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Complications #ent-prof-card #ent-prof-written #unanswered #card + id:: 481a1175-c18c-4f1f-9336-7f2707e71ffd + deck:: #ENT + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580b82-e50f-4cde-a16e-f7d4b1436be9 \ No newline at end of file diff --git a/logseq/bak/pages/Acute Retropharyngeal Abscess/2024-12-10T15_30_39.520Z.Desktop.md b/logseq/bak/pages/Acute Retropharyngeal Abscess/2024-12-10T15_30_39.520Z.Desktop.md new file mode 100644 index 0000000..92f05f5 --- /dev/null +++ b/logseq/bak/pages/Acute Retropharyngeal Abscess/2024-12-10T15_30_39.520Z.Desktop.md @@ -0,0 +1,91 @@ +- alias:: + ICD-11_Code:: + tags:: #Disease +- #definition {{c1 }} #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675810f9-674c-4fbc-b426-cfaf80f94596 +- ## Etiology + background-color:: blue + - ### Causative Agents #ent-prof-written #unanswered #card + deck:: #ENT + id:: 25b9a42f-a66c-4373-9430-b840179b9c7e + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features #ent-prof-card #ent-prof-written #unanswered #card + background-color:: blue + id:: 27392bbe-50d1-4650-837d-dccf4f455d4f + deck:: #ENT + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria +- ## Diagnosis + background-color:: blue + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Investigation #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756b61f-4520-49bf-a222-e8244026dcf1 + - ### Typical Radiological Features #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67581125-937a-4643-916e-2a9d4f1d223a + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - [[Chronic Retropharyngeal Abscess]] + - Differences #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756ae63-85c1-4975-92c6-81bccebb2bfb + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-card #ent-prof-written #unanswered #card + background-color:: blue + id:: 32ecf5df-62d9-4669-bf18-94d0b5189c9d + deck:: #ENT + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6758116b-0463-45d8-b849-9d0a266d1fe1 \ No newline at end of file diff --git a/logseq/bak/pages/Adenoidectomy/2024-12-10T15_30_39.507Z.Desktop.md b/logseq/bak/pages/Adenoidectomy/2024-12-10T15_30_39.507Z.Desktop.md new file mode 100644 index 0000000..61c679c --- /dev/null +++ b/logseq/bak/pages/Adenoidectomy/2024-12-10T15_30_39.507Z.Desktop.md @@ -0,0 +1,8 @@ +# Indications #ent-prof-card #unanswered #card + +deck:: #ENT +id:: 6756b20d-4737-4be6-a805-51d67da83b14 +- # Postoperative Complications of Adenoidectomy #ent-prof-card #unanswered #card + id:: 6756b219-4c90-4cd6-9ad0-94a78e34ae37 + deck:: #ENT +- SN: Important complications of adenoid operation \ No newline at end of file diff --git a/logseq/bak/pages/Allergic Rhinitis/2024-12-10T15_30_39.488Z.Desktop.md b/logseq/bak/pages/Allergic Rhinitis/2024-12-10T15_30_39.488Z.Desktop.md new file mode 100644 index 0000000..896076a --- /dev/null +++ b/logseq/bak/pages/Allergic Rhinitis/2024-12-10T15_30_39.488Z.Desktop.md @@ -0,0 +1,79 @@ +alias:: Nasal Allergy +ICD-11_Code:: +tags:: #Disease + +- ## Etiology + background-color:: blue + - ### Causative Agents + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features #ent-prof-card #ent-prof-written #unanswered #card + background-color:: blue + id:: b1a89f71-c40c-4f6d-b9b5-94bd9c0b80de + deck:: #ENT + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria +- ## Diagnosis + background-color:: blue + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-card #unanswered #card + background-color:: blue + deck:: #ENT + id:: 72e3ee78-26ee-49d6-ab82-23fbaefdcc05 + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications #ent-prof-written #unanswered #card + deck:: #ENT + id:: 7d0d3a9a-d02d-4cf1-bd50-c786494f96a6 + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580ab5-3112-4ea5-a899-574a3677ebe8 \ No newline at end of file diff --git a/logseq/bak/pages/Antenatal Care/2024-12-10T17_34_38.441Z.Desktop.md b/logseq/bak/pages/Antenatal Care/2024-12-10T17_34_38.441Z.Desktop.md new file mode 100644 index 0000000..41f7e20 --- /dev/null +++ b/logseq/bak/pages/Antenatal Care/2024-12-10T17_34_38.441Z.Desktop.md @@ -0,0 +1,52 @@ +- #definition ((6718c32e-2f09-4a4c-b3cc-e230529f73d7)) #obspw +- # Aims #obspw #obspc + - ((6718c381-a0b8-42a3-9a16-2264370f77ba)) +- # Objectives #obspw #obspc + - ((6718c3a9-9064-49a4-828b-1f9d44e0a619)) +- # Advantages #obspw +- # Values #obspw + - ((6718c46e-c6e0-47e2-a895-75bf57c0f610)) +- # WHO recommendation for antenatal visits #obspw +- # WHO antenatal visits #obspw + - Second Trimester, around 16 weeks + logseq.order-list-type:: number + - Between 24 and 28 weeks + logseq.order-list-type:: number + - 32 weeks + logseq.order-list-type:: number + - 36 weeks + logseq.order-list-type:: number +- # Information #obspw + - Complaints + - History of Present Illness + - Obstetric History + - Gravida and Parity + - Menstrual History + - Period of Gestation calculation by LMP and calculation of EDD + - Past History + - Family History + - Personal History +- # Investigation #obspw + - Routine + - Blood + - Hemoglobin + - Hematocrit + - ABO blood grouping + - Rh blood typing + - Hemoglobinopathies + - Blood Glucose + - VDRL + - Urine + - Protein + - Sugar + - Pus cells + - Pap smear + - Special + - Serology : Rubella, Hepatitis B, HIV + - Genetic screen : Maternal serum alpha-fetoprotein + - Ultrasound examination + - Hemoglobin + - Urine Protein + - Random Blood Sugar +- # Investigations in Booking Visit #obspw +- # Dietary Advice to Pregnant mother #obspw \ No newline at end of file diff --git a/logseq/bak/pages/Antepartum Hemorrhage/2024-12-10T17_34_38.494Z.Desktop.md b/logseq/bak/pages/Antepartum Hemorrhage/2024-12-10T17_34_38.494Z.Desktop.md new file mode 100644 index 0000000..75147f0 --- /dev/null +++ b/logseq/bak/pages/Antepartum Hemorrhage/2024-12-10T17_34_38.494Z.Desktop.md @@ -0,0 +1,23 @@ +alias:: APH +source:: Chapter ((671a2f62-866e-4f30-a251-05c2686ade76)) of [[Dutta Obs]] + +- #definition ((6719b1c0-b5eb-4f5e-b70e-13bc5a2d9efc)) #obspw #confusion might be 20th week +- # Etiology #obspw + alias:: Classification of Antepartum hemorrhage + - ((6719b208-4fdb-4f2d-8820-cc6beb8e32ed)) +- # Diagnosis #obspw + similar-to:: ((6718edc1-f69a-40e0-9826-ec8d0995a444)) + - Nature of Bleeding + - Painful/Painless + - Causeless/Association with Pre-eclampsia, Trauma + - Character of Blood + - Bright Red/Dark Colored + - General Condition and Anemia + - Proportionate/Disproportionate to the visible blood loss + - Abdominal Examination + - Height of Uterus : Proportionate/Disproportionate to gestational age + - Feel of Uterus : Soft, Relaxed / Tense, Tender and Rigid + - Malpresentation + - FHS : Present/Absent + - Placentography (USG) : Placenta in lower segment/ upper segment + - Vaginal Examination : Placenta is felt/ not felt on the lower segment \ No newline at end of file diff --git a/logseq/bak/pages/Antral Washout/2024-12-10T15_30_39.479Z.Desktop.md b/logseq/bak/pages/Antral Washout/2024-12-10T15_30_39.479Z.Desktop.md new file mode 100644 index 0000000..ba93c2a --- /dev/null +++ b/logseq/bak/pages/Antral Washout/2024-12-10T15_30_39.479Z.Desktop.md @@ -0,0 +1,14 @@ +tags:: #[[Surgical Procedure]] + +- # Indications #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756c44b-7db9-4b7f-ae8b-176edf836f3a +- # Procedure #ent-prof-card #ent-prof-written #unanswered #card + id:: 6756cf36-daf0-4b1b-b27a-38bdfc1b2cbd + deck:: #ENT +- # Complications #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756cf36-4a24-4d8f-b0ac-af31f3f3910a +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580d4c-b2a6-4647-beb0-c1eef96a0e33 \ No newline at end of file diff --git a/logseq/bak/pages/Aphakia/2024-12-10T15_30_39.496Z.Desktop.md b/logseq/bak/pages/Aphakia/2024-12-10T15_30_39.496Z.Desktop.md new file mode 100644 index 0000000..d2ca143 --- /dev/null +++ b/logseq/bak/pages/Aphakia/2024-12-10T15_30_39.496Z.Desktop.md @@ -0,0 +1,10 @@ +- #definition {{c1 Literally aphakia means absence of normal crystalline lens from eyeball. + Optically aphakia means absence of crystalline lens from its normal position in the pupillary area}} #eye-prof-written #eye-prof-card #card + deck:: #Eye + id:: 675020e1-3f82-4221-8e24-a23c0882d8d0 +- SN: #eye-prof-written +- Methods of Treatment #eye-prof-written +- # Pseudophakia + - #definition {{c1 In cataract surgery, human biological lens is removed and replaced by the artifical lens (IOL) by surgical procedure. This condition is known as pseudophakia.}} #eye-prof-card #card + deck:: #Eye + id:: 6755e1c9-22e9-4582-86bc-4872cfadc659 \ No newline at end of file diff --git a/logseq/bak/pages/Apyrexial Laryngeal Stridor/2024-12-10T15_30_39.494Z.Desktop.md b/logseq/bak/pages/Apyrexial Laryngeal Stridor/2024-12-10T15_30_39.494Z.Desktop.md new file mode 100644 index 0000000..9a7b019 --- /dev/null +++ b/logseq/bak/pages/Apyrexial Laryngeal Stridor/2024-12-10T15_30_39.494Z.Desktop.md @@ -0,0 +1,6 @@ +# Causes #ent-prof-written #unanswered #card +deck:: #ENT +id:: 6758148e-0885-4892-8610-ef6d4e505cc2 +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67581496-e5de-445e-afb0-d985e3cfd6ac \ No newline at end of file diff --git a/logseq/bak/pages/Atrophic Rhinitis/2024-12-10T15_30_39.470Z.Desktop.md b/logseq/bak/pages/Atrophic Rhinitis/2024-12-10T15_30_39.470Z.Desktop.md new file mode 100644 index 0000000..8e24a55 --- /dev/null +++ b/logseq/bak/pages/Atrophic Rhinitis/2024-12-10T15_30_39.470Z.Desktop.md @@ -0,0 +1,81 @@ +- alias:: + ICD-11_Code:: + tags:: #Disease +- #definition {{c1 }} #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675809f3-6032-49dc-a61b-75b648bb5f64 +- ## Etiology + background-color:: blue + - ### Causative Agents + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features #ent-prof-card #ent-prof-written #unanswered #card + background-color:: blue + id:: 076f87a1-3352-4223-ab92-057fa79dcb5c + deck:: #ENT + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria +- ## Diagnosis + background-color:: blue + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-card #ent-prof-written #unanswered #card + background-color:: blue + id:: 6c359ab4-206d-4b36-ac9e-9ccef443bae6 + deck:: #ENT + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications #ent-prof-card #unanswered #card + deck:: #ENT + id:: cdac1bc9-1e05-45ba-8e84-2c8168f2a52c + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580a39-cf56-4b0f-aed8-c22d29d68144 \ No newline at end of file diff --git a/logseq/bak/pages/Atropine 1% Sulphate/2024-12-10T15_30_39.502Z.Desktop.md b/logseq/bak/pages/Atropine 1% Sulphate/2024-12-10T15_30_39.502Z.Desktop.md new file mode 100644 index 0000000..1b873c7 --- /dev/null +++ b/logseq/bak/pages/Atropine 1% Sulphate/2024-12-10T15_30_39.502Z.Desktop.md @@ -0,0 +1,9 @@ +alias:: Atropine eye drop + +- SN: #eye-prof-written +- ((6733ccee-50d1-41fe-9e24-601c73096b43)) +- # Indication #eye-prof-written + - [[Neovascular Glaucoma]] + >*Atropine is contraindicated for [[Glaucoma]] but indicated for [[Neovascular Glaucoma]] * +- # Contraindication #eye-prof-written + - [[Galucoma]] \ No newline at end of file diff --git a/logseq/bak/pages/Branchial Cyst/2024-12-10T15_30_39.478Z.Desktop.md b/logseq/bak/pages/Branchial Cyst/2024-12-10T15_30_39.478Z.Desktop.md new file mode 100644 index 0000000..0397cc1 --- /dev/null +++ b/logseq/bak/pages/Branchial Cyst/2024-12-10T15_30_39.478Z.Desktop.md @@ -0,0 +1,77 @@ +- alias:: + ICD-11_Code:: + tags:: #Disease +- #definition {{c1 }} #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675816b7-9859-4bc6-bc3d-d746c1d1ad9d +- ## Etiology + background-color:: blue + - ### Causative Agents + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features + background-color:: blue + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria +- ## Diagnosis + background-color:: blue + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-written #unanswered #card + background-color:: blue + deck:: #ENT + id:: b0461cb4-85cd-4d1f-b38c-e0b364f85390 + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675816cb-502e-4950-a501-eba182f53e6b \ No newline at end of file diff --git a/logseq/bak/pages/Breast Feeding/2024-12-10T17_34_46.861Z.Desktop.md b/logseq/bak/pages/Breast Feeding/2024-12-10T17_34_46.861Z.Desktop.md new file mode 100644 index 0000000..db3e4a9 --- /dev/null +++ b/logseq/bak/pages/Breast Feeding/2024-12-10T17_34_46.861Z.Desktop.md @@ -0,0 +1,43 @@ +# Exclusive Breast Feeding +alias:: EBF +tags:: #Paediatrics + - #definition Exclusive Breast Feeding means giving the baby only breast milk (not even a drop of water or other foods) from birth till 6 months (180 days) of age. (newer definitions allow consumption of medicine) #pedi-prof-written +- # Benefits of Breast Feeding #pedi-prof-written + - ## Benefit to the New Born #obspc #pedi-prof-written + - Complete food, Species specific + - Easily digested & well absorbed + - Protects against infection + - Promotes emotional bonding + - Better brain growth & intelligence + - Protects from allergy + - Lower incidence of childhood cancer + - ## Benefits to mother + - Helps in involution of uterus + - Delays pregnancy + - Lowers risk of breast & ovarian cancer + - Decreases mother's work load + - ## Benefits to family & Society + - Saves money + - Promotes family planning + - Decreases need for hospitalization + - Contributes to child survival +- # Positioning & Attachment #pedi-prof-written + - Proper Positioning means #obspc #pedi-prof-written + - The body is fully supported + logseq.order-list-type:: number + - Body close to the mother + logseq.order-list-type:: number + - Straight head & body + logseq.order-list-type:: number + - Facing breast, nose opposite to the nipple + logseq.order-list-type:: number + - Good attachment #obspc + - The baby's chin is touching the breast + logseq.order-list-type:: number + - The baby's mouth is openly widely + logseq.order-list-type:: number + - The baby's lower lop is turned outwards + logseq.order-list-type:: number + - More areola is seen above than below + logseq.order-list-type:: number +- \ No newline at end of file diff --git a/logseq/bak/pages/Caesarean Section/2024-12-10T17_34_46.308Z.Desktop.md b/logseq/bak/pages/Caesarean Section/2024-12-10T17_34_46.308Z.Desktop.md new file mode 100644 index 0000000..a2a582e --- /dev/null +++ b/logseq/bak/pages/Caesarean Section/2024-12-10T17_34_46.308Z.Desktop.md @@ -0,0 +1,10 @@ +alias:: CS + +- ## Absoulute Indication #obspc + - Absolutely Contracted Uterus + - [[Central Placenta Praevia]] + - Absolute Cephalopelvic Disproportion + - Obstructed Labor + - Transverse Lie + - Advanced carcinoma cervix + - [[Vesicovaginal Fistula Repair]] \ No newline at end of file diff --git a/logseq/bak/pages/Carcinoma Larynx/2024-12-10T15_30_39.515Z.Desktop.md b/logseq/bak/pages/Carcinoma Larynx/2024-12-10T15_30_39.515Z.Desktop.md new file mode 100644 index 0000000..97e1743 --- /dev/null +++ b/logseq/bak/pages/Carcinoma Larynx/2024-12-10T15_30_39.515Z.Desktop.md @@ -0,0 +1,83 @@ +- alias:: + ICD-11_Code:: + tags:: #Disease +- ## Etiology + background-color:: blue + - ### Causative Agents + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features (Glottis Stage-I) #ent-prof-card #ent-prof-written #unanswered #card + background-color:: blue + id:: e7ef8278-394b-4031-81a4-7ae527bf7f6f + deck:: #ENT + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria +- ## Diagnosis + background-color:: blue + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Investigation #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756ba70-7690-4493-9769-4bb8d8576e1b + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment(Glottis Stage-1) #ent-prof-card #ent-prof-written #unanswered #card + background-color:: blue + id:: f47ebcf7-3ddd-490a-ba70-306d4b3239be + deck:: #ENT + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up +- ##### Release a case of airway obstruction due to Carcinoma Larynx #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756baf9-e01b-4bb0-8058-c9b6f7e146f1 + - [[Tracheostomy]] +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6758153c-60f5-4a53-ad56-171ae794ed64 \ No newline at end of file diff --git a/logseq/bak/pages/Central Placenta Praevia/2024-12-10T15_30_39.476Z.Desktop.md b/logseq/bak/pages/Central Placenta Praevia/2024-12-10T15_30_39.476Z.Desktop.md new file mode 100644 index 0000000..d9be0a4 --- /dev/null +++ b/logseq/bak/pages/Central Placenta Praevia/2024-12-10T15_30_39.476Z.Desktop.md @@ -0,0 +1,11 @@ +id:: 671a12f1-f1de-46e7-9a10-3d678a1544fe +alias:: Type-IV Placenta Previa, Total Placenta Previa +tags:: #SN , + +- #definition The placenta completely covers the internal os even after it is fully dilated #obspw +- SN: #obs-prof-written +- Complications #obspw #unanswered +- Management #obspw #unanswered + - Obstetric Management #obspw + question:: important steps to be taken at the time of delivery + - Mode of Delivery is [[Caesarean Section]] #obspw \ No newline at end of file diff --git a/logseq/bak/pages/Chalazion/2024-12-10T15_30_39.494Z.Desktop.md b/logseq/bak/pages/Chalazion/2024-12-10T15_30_39.494Z.Desktop.md new file mode 100644 index 0000000..e79ab61 --- /dev/null +++ b/logseq/bak/pages/Chalazion/2024-12-10T15_30_39.494Z.Desktop.md @@ -0,0 +1,93 @@ +alias:: +ICD-11_Code:: +tags:: #Disease + +- #definition {{c1 It is a chronic granulomatous non-infections lesion in [[Meibomian Gland]] due to occlusion of its duct.}} #eye-prof-written #eye-prof-card #card + deck:: #Eye + id:: 67542e6e-8422-4c0a-9aaf-8d258b53e746 +- ## Etiology + background-color:: blue + - ### Causative Agents + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features + background-color:: blue + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria +- ## Diagnosis + background-color:: blue + - ### Clinical Diagnosis + - #### Classical Presentation + - Cardinal Features #eye-prof-card #card + deck:: #Eye + id:: 6755ecef-3719-432c-9179-1e5f38e3c300 + - Non-Tender,painless + logseq.order-list-type:: number + - Firm ,Tense + logseq.order-list-type:: number + - Nodular swelling of eyelid away from margin + logseq.order-list-type:: number + - No signs of inflammation + logseq.order-list-type:: number + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment #eye-prof-written + background-color:: blue + - ### Medical Management + id:: 4b839cd7-0d9e-432d-a908-0e842ff94c1b + - Initially {{c1 Antibiotic}} & {{c1 Hot Compression}} #eye-prof-card #card + deck:: #Eye + id:: 6755e6f6-49cd-45a8-a276-c802dc9732ba + - ### Surgical Treatment + id:: 991b1321-eec2-4363-b81c-cd94158ea089 + - {{c1 Incision}} and {{c1 Curettage}} ( {{c2 vertical}} incision to the lid margin) #eye-prof-card #card + id:: 6755e72e-388d-4f4e-af82-6779b34321e0 + deck:: #Eye + - ### Lifestyle and Dietary Recommendations + - ### Follow-up +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - #### Without Treatment #eye-prof-written + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue +- SN: #eye-prof-written diff --git a/logseq/bak/pages/Chronic Retropharyngeal Abscess/2024-12-10T15_30_39.495Z.Desktop.md b/logseq/bak/pages/Chronic Retropharyngeal Abscess/2024-12-10T15_30_39.495Z.Desktop.md new file mode 100644 index 0000000..54aaf53 --- /dev/null +++ b/logseq/bak/pages/Chronic Retropharyngeal Abscess/2024-12-10T15_30_39.495Z.Desktop.md @@ -0,0 +1,79 @@ +- alias:: + ICD-11_Code:: + tags:: #Disease +- ## Etiology + background-color:: blue + - ### Causative Agents + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features #ent-prof-card #unanswered #card + background-color:: blue + deck:: #ENT + id:: 25d8cef9-d646-4c62-a329-59dc6819cf92 + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria +- ## Diagnosis + background-color:: blue + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Investigation #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756b622-96b5-44c0-8b11-0d31e5b0a86e + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-card #ent-prof-written #unanswered #card + background-color:: blue + id:: b74bd004-ee30-4dd4-abc5-fa18e986569f + deck:: #ENT + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6758118c-3559-4253-97b5-4b3a4592b1f5 \ No newline at end of file diff --git a/logseq/bak/pages/Chronic Suppurative Otitis Media/2024-12-10T15_30_39.525Z.Desktop.md b/logseq/bak/pages/Chronic Suppurative Otitis Media/2024-12-10T15_30_39.525Z.Desktop.md new file mode 100644 index 0000000..3a0cf6a --- /dev/null +++ b/logseq/bak/pages/Chronic Suppurative Otitis Media/2024-12-10T15_30_39.525Z.Desktop.md @@ -0,0 +1,97 @@ +alias:: CSOM +ICD-11_Code:: +tags:: #Disease + +- ## Etiology + background-color:: blue + - ### Causative Agents + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features + background-color:: blue + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification #ent-prof-written #unanswered #card + deck:: #ENT + id:: e02ad0f3-b7ca-4c01-b24b-d23f02d1d618 + - [[Tubotympanic Chronic Suppurative Otitis Media]] + - [[Anticoantral Chronic Suppurative Otitis Media]] + - Differences between [[Tubotympanic variety CSOM]] and [[Anticoantral variety CSOM]] #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756c6d1-5755-4374-91b1-8f5ec4f8f6ef + - ### Diagnostic Criteria +- ### Differences between CSOM safe variety from unsafe variety #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6757fca8-097d-4e46-a639-851515f4c2f8 +- ## Diagnosis + background-color:: blue + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Investigation + - deck:: #ENT + id:: 6756bff6-4066-4836-ad06-539a7077b1ca + |Test|Interpretation| + |[[Rinne's Test]]|{{c1 }}| + |[[Weber Test]]|{{c2 }}| + #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756bff6-4066-4836-ad06-539a7077b1ca + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- # Management of a safe variety of CSOM in dry Stage #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6757fb4f-2585-4c30-90bc-5e207aac3091 +- ## Management and Treatment + background-color:: blue + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications #ent-prof-card #ent-prof-written #unanswered #card + id:: c93f1a22-c346-4a1e-9be1-67b2db2bca1c + deck:: #ENT + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6757fb69-04f9-42d1-b8e8-d8fb771044e9 \ No newline at end of file diff --git a/logseq/bak/pages/Clubbing/2024-12-10T16_03_25.730Z.Desktop.md b/logseq/bak/pages/Clubbing/2024-12-10T16_03_25.730Z.Desktop.md new file mode 100644 index 0000000..9e9d615 --- /dev/null +++ b/logseq/bak/pages/Clubbing/2024-12-10T16_03_25.730Z.Desktop.md @@ -0,0 +1,81 @@ +[h]()- #definition It is the bulbous enlargement of the terminal phalanges due to proliferation of connective tissue. +- Grades of Clubbing + id:: 66ee8e35-aeb3-482f-aeb0-6e9e676f646b + - |Grade||Features| + |--|--|--| + |Grade 1|Fluctuation|Normal Appearance and Angle Nail bed Fluctuation| + |Grade 2|Obliteration|Obliteration of Lovibond angle| + |Grade 3|Drumstick|Increased Curvature of Nails, Parrot Beak or Drumstick Appearance| + |Grade 4| [[HPOA]] |Swelling in all Directions [[Hypertrophic Osteoarthropathy]] | +- Pathophysiology + - Neurogenic + - Hypoxia + - lower oxygenation of tissue causes VEGF which increases neovasculature + - Platelet derived growth factor + - Megakaryocytes in normal physiology enter the pulmonary capillaries and split into smaller platelets + - If they skip pulmonary capillaries due to Pathology of Lung, it gets clogged in the systemic capillaries, which then causes release of PDGF and VEGF + - Mutation + - Mutation of HPGD Gene (Autosomal Dominant) + - Dysfunction of 15 PGDH enzyme + - Failure to metabolize PGE2 + - Increased blood flow, and connective tissue proliferation +- Etiology + - Respiratory + - Bronchial Carcinoma (more commonly large cell than small cell) + - Chronic suppurative lung disease + - Bronchiectasis + - Lung Abscess + - Chronic empyema + - Pulmonary Fibrosis + - Idiopathic pulmonary fibrosis + - Cystic fibrosis + - Fibrosing Alveolitis + - Asbestosis + - Sarcoidosis + - Cardiac + - Fallot Tetralogy + - Eisenmenger Syndrome + - Subactute Bacterial Endocarditis + - Left Atrial Myxoma + - GI + - [[IBD]] + - Cirrhosis + - Coliac Disease + - GI Lymphoma + - PBC + - Idiopathic + - Familial usually before puberty + - Rare + - Thyroid Acropachy + - Pregnancy + - Unilateral clubbing + - Bronchial arteovenous aneurysm + - Axillary artery aneurysm +- ## Approach + - ### History + - #### Onset + - Recent : Acute process + - Long-Standing + - #### Associated Symptoms + - Respiratory : [[Cough]], [[Hemoptysis]], [[Dyspnea]] + - Cardiovascular: [[Cyanosis]], [[Chest Pain]], [[Palpitations]] + - Gastrointestinal: [[Diarrhoea]] , [[Weight Loss]], [[Jaundice]] + - #### History of Past Illness + - [[Chronic Lung Disease]] : [[COPD]], [[Interstitial Lung Disease]] + - Heart Disease : [[Congenital Heart Diseases]], [[Endocarditis]] + - Liver or GI Disease : [[Cirrhosis]], [[Inflammatory Bowel Disease]] + - #### Family History + - Hereditary Clubbing can occur in rare cases + - #### Personal History + - [[Smoking History]] is strong link to lung cancer and other [[Chronic Lung Disease]] + - ### Physical Examination + - #### Inspection of fingers and toes + - **Shape**: Look for "drumstick" appearance of the fingertips. + - **Nail changes**: Curved or "floating" nails. + - **Schamroth's sign**: Loss of the normal diamond-shaped window formed when dorsal surfaces of the opposite fingers are placed together. + - Perform ((66ee8e35-aeb3-482f-aeb0-6e9e676f646b)) + - #### Systemic Examination + - **Respiratory**: Look for signs of chronic lung disease, auscultate for abnormal breath sounds. + - **Cardiovascular**: Check for signs of heart failure or cyanosis. + - **Abdominal**: Look for hepatomegaly, ascites (indicating liver disease). + - **Skin**: Check for signs of systemic diseases (e.g., vasculitis, erythema nodosum). \ No newline at end of file diff --git a/logseq/bak/pages/Cochlear Implant/2024-12-10T15_30_39.496Z.Desktop.md b/logseq/bak/pages/Cochlear Implant/2024-12-10T15_30_39.496Z.Desktop.md new file mode 100644 index 0000000..156d858 --- /dev/null +++ b/logseq/bak/pages/Cochlear Implant/2024-12-10T15_30_39.496Z.Desktop.md @@ -0,0 +1,3 @@ +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580122-f481-4e5c-af10-a58169662bac \ No newline at end of file diff --git a/logseq/bak/pages/Deviated Nasal Septum/2024-12-10T15_30_39.489Z.Desktop.md b/logseq/bak/pages/Deviated Nasal Septum/2024-12-10T15_30_39.489Z.Desktop.md new file mode 100644 index 0000000..38e3e36 --- /dev/null +++ b/logseq/bak/pages/Deviated Nasal Septum/2024-12-10T15_30_39.489Z.Desktop.md @@ -0,0 +1,78 @@ +- alias:: + ICD-11_Code:: + tags:: #Disease +- ## Etiology #ent-prof-card #unanswered #card + background-color:: blue + deck:: #ENT + id:: a12b2c41-66a3-47f3-955c-f74a8fd201f4 + - ### Causative Agents + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features #ent-prof-card #ent-prof-written #unanswered #card + background-color:: blue + id:: 54938744-188d-4ab1-aa09-32bef16d24a4 + deck:: #ENT + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria +- ## Diagnosis + background-color:: blue + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-card #unanswered #card + background-color:: blue + deck:: #ENT + id:: 79b6dbbe-38f6-4e65-98ab-4b95f3dade21 + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6758081e-3bcc-4f03-8216-c0e7fccb3ecd \ No newline at end of file diff --git a/logseq/bak/pages/Enlarged Adenoid/2024-12-10T15_30_39.102Z.Desktop.md b/logseq/bak/pages/Enlarged Adenoid/2024-12-10T15_30_39.102Z.Desktop.md new file mode 100644 index 0000000..82a0ef1 --- /dev/null +++ b/logseq/bak/pages/Enlarged Adenoid/2024-12-10T15_30_39.102Z.Desktop.md @@ -0,0 +1,83 @@ +alias:: Adenoid + +- #definition {{c1 }} #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580de0-f75a-494a-9860-2edd42814113 +- alias:: + ICD-11_Code:: + tags:: #Disease +- ## Etiology + background-color:: blue + - ### Causative Agents + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features #ent-prof-written #unanswered #card + background-color:: blue + deck:: #ENT + id:: ebea0a07-c8e9-495a-bcf6-ed94e5f1e3a8 + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria +- # Clinical Features of Adenoid Facies #ent-prof-card #ent-prof-written #unanswered #card + id:: 6756cf30-0e89-4438-8dbb-5f4e1ed28c63 + deck:: #ENT +- ## Diagnosis + background-color:: blue + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Investigations #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580e87-164e-4437-9d0d-cc738924bf3c + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- # Correction/Treatment #ent-prof-card #ent-prof-written #unanswered #card + id:: 6756cf30-222b-4dce-8e35-4a8fc615ffe1 + deck:: #ENT +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - ((6756b219-4c90-4cd6-9ad0-94a78e34ae37)) + - #### Without Treatment + - ##### Consequences (in child) #ent-prof-card #unanswered #card + id:: 6756adaf-ec4b-4d1a-bee3-fc2360b0cd27 + deck:: #ENT + deck:: #ENT + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580ebb-8cdb-4b69-b32d-1cc4df492e16 \ No newline at end of file diff --git a/logseq/bak/pages/Fallopian Tube/2024-12-10T17_34_38.489Z.Desktop.md b/logseq/bak/pages/Fallopian Tube/2024-12-10T17_34_38.489Z.Desktop.md new file mode 100644 index 0000000..a1b94b1 --- /dev/null +++ b/logseq/bak/pages/Fallopian Tube/2024-12-10T17_34_38.489Z.Desktop.md @@ -0,0 +1,23 @@ +alias:: Uterine Tube, Oviduct +tags:: #obspw +length:: 10 cm long + +- Type of Organ : muscular tubular organ +- # Parts + - Infundibulum + alias:: fimbriated end + - numerous projections at the abdominal end called fimriae + - longest fimbria is called : ovarian fimbriae + - Ampulla + length:: 5 cm + - most dilated part + - site for fertilization + - Isthmus + length:: 3 cm + - Intramural part + - within the musculature of the uterus +- Two opening + - Abdominal Ostium + lies:: laterally + - Uterine Ostium + lies:: medially \ No newline at end of file diff --git a/logseq/bak/pages/Foreign Body in Ear/2024-12-10T15_30_39.514Z.Desktop.md b/logseq/bak/pages/Foreign Body in Ear/2024-12-10T15_30_39.514Z.Desktop.md new file mode 100644 index 0000000..5834468 --- /dev/null +++ b/logseq/bak/pages/Foreign Body in Ear/2024-12-10T15_30_39.514Z.Desktop.md @@ -0,0 +1,53 @@ +# Types #ent-prof-card #ent-prof-written #card #[[External Ear]] +id:: 6756a934-1410-48f2-b1a9-99cdf6a75c0c +deck:: #ENT + - Nonliving + logseq.order-list-type:: number + - Children inserted + logseq.order-list-type:: number + - piece of paper or sponge + logseq.order-list-type:: number + - grain seeds (rice, wheat, maize) + logseq.order-list-type:: number + - slate pencil + logseq.order-list-type:: number + - piece of chalk or metallic ball bearings + logseq.order-list-type:: number + - Adults inserted + logseq.order-list-type:: number + - broken end of matchstick + logseq.order-list-type:: number + - overlooked cotton swab + logseq.order-list-type:: number + - Living + logseq.order-list-type:: number + - Flycing or crawling insects like + logseq.order-list-type:: number + - mosquitoes + logseq.order-list-type:: number + - beetles + logseq.order-list-type:: number + - cockroach + logseq.order-list-type:: number + - ant + logseq.order-list-type:: number + - maggots from flies + logseq.order-list-type:: number +- # Management of a case of Living Body in ear #ent-prof-card #ent-prof-written #card #[[External Ear]] + id:: 6756cf39-f53f-48c4-b651-e41c2953306b + deck:: #ENT + - No attempt should be made to catch them alive + background-color:: pink + - Insect killed by + - oil (household remedy) + - spirit + - chloroform water + - Removed by + - Forceps removal + - Syrining + - Suction + - Microscopic removal with special instruments + - Postaural approach +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6757f761-f508-45ac-86a6-33c2821188c7 \ No newline at end of file diff --git a/logseq/bak/pages/Foreign Body in Esophagus/2024-12-10T15_30_39.109Z.Desktop.md b/logseq/bak/pages/Foreign Body in Esophagus/2024-12-10T15_30_39.109Z.Desktop.md new file mode 100644 index 0000000..644e9c3 --- /dev/null +++ b/logseq/bak/pages/Foreign Body in Esophagus/2024-12-10T15_30_39.109Z.Desktop.md @@ -0,0 +1,85 @@ +- alias:: + ICD-11_Code:: + tags:: #Disease +- ## Etiology + background-color:: blue + - ## Common Foreign Bodies that may introduced in the Oesophagus #ent-prof-card #ent-prof-written #unanswered #card + id:: 6756b3d0-6307-466a-a856-af9b4a6ef67c + deck:: #ENT + - In oldage + - ## Where are the esophageal Foreign Body found commonly #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67581348-bcd7-4fa6-bb26-526d2e32d786 + - ### Causative Agents + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features #ent-prof-card #unanswered #card + background-color:: blue + deck:: #ENT + id:: fcaf4274-5a62-4051-bb53-6838993f76b1 + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria +- ## Diagnosis + background-color:: blue + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-card #ent-prof-written #unanswered #card + background-color:: blue + id:: 6dfa3abe-e61f-4f44-bf88-55cc2d38780e + deck:: #ENT + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications #ent-prof-written #unanswered #card + deck:: #ENT + id:: b42c502a-a704-4ce8-a75c-694ca18e15b0 + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6758138c-9ac2-4045-89ea-9389dde02a04 \ No newline at end of file diff --git a/logseq/bak/pages/Foreign Body in Nose/2024-12-10T15_30_39.113Z.Desktop.md b/logseq/bak/pages/Foreign Body in Nose/2024-12-10T15_30_39.113Z.Desktop.md new file mode 100644 index 0000000..531ef3b --- /dev/null +++ b/logseq/bak/pages/Foreign Body in Nose/2024-12-10T15_30_39.113Z.Desktop.md @@ -0,0 +1,79 @@ +- alias:: + ICD-11_Code:: + tags:: #Disease +- ## Etiology + background-color:: blue + - ### Causative Agents + - ### Names of Foreign Bodies in Nose #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756c608-aef3-4c0d-a3a3-ecc8abd74751 + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features #ent-prof-card #unanswered #card + background-color:: blue + deck:: #ENT + id:: 2825038c-36a6-4d14-bc37-11cff7ba062a + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria +- ## Diagnosis + background-color:: blue + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-card #unanswered #card + background-color:: blue + deck:: #ENT + id:: 75f55c1e-b022-41f2-864f-518b3d6e6db5 + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580948-5e8e-43cf-b726-b358427d9d85 \ No newline at end of file diff --git a/logseq/bak/pages/Functional Endoscopic Sinus Surgery/2024-12-10T15_30_39.493Z.Desktop.md b/logseq/bak/pages/Functional Endoscopic Sinus Surgery/2024-12-10T15_30_39.493Z.Desktop.md new file mode 100644 index 0000000..cfa2ace --- /dev/null +++ b/logseq/bak/pages/Functional Endoscopic Sinus Surgery/2024-12-10T15_30_39.493Z.Desktop.md @@ -0,0 +1,15 @@ +alias:: FESS +tags:: #[[Surgical Procedure]] + +- #definition {{c1 }} #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580cd6-321f-49d8-8ff0-ab27e721a78c +- # Indications #ent-prof-card #ent-prof-written #unanswered #card + id:: 6756bc61-818f-48fa-bfcc-07b3c2f7d429 + deck:: #ENT +- # Complications #ent-prof-card #ent-prof-written #unanswered #card + id:: 6756cf38-c69d-4a54-ac79-21ddb2e7b4bf + deck:: #ENT +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580d41-b5bd-436b-b1b2-a8d630eacf9a \ No newline at end of file diff --git a/logseq/bak/pages/Grand Multipara/2024-12-10T17_34_38.435Z.Desktop.md b/logseq/bak/pages/Grand Multipara/2024-12-10T17_34_38.435Z.Desktop.md new file mode 100644 index 0000000..0d5471a --- /dev/null +++ b/logseq/bak/pages/Grand Multipara/2024-12-10T17_34_38.435Z.Desktop.md @@ -0,0 +1,26 @@ +- #definition ((6718cab3-f79c-4b0c-8a70-8ab207166200)) #obspw +- # Complications #obspw + - Abortion + logseq.order-list-type:: number + - Inherent Obstetric hazards such as + logseq.order-list-type:: number + - malpresentation + logseq.order-list-type:: number + - multiple pregnancy + logseq.order-list-type:: number + - placenta previa + logseq.order-list-type:: number + - medical disorders such as + logseq.order-list-type:: number + - anemia(both iron deficiency and megaloblastic) + logseq.order-list-type:: number + - hypertension with or without superimposed pre-eclampsia + logseq.order-list-type:: number + - cardiac disability + logseq.order-list-type:: number + - exaggerated manifestations of hemorrhoids and varicose veins + logseq.order-list-type:: number + - hiatus hernia + logseq.order-list-type:: number + - Prematurity + logseq.order-list-type:: number \ No newline at end of file diff --git a/logseq/bak/pages/High Risk Pregnancy/2024-12-10T17_34_38.442Z.Desktop.md b/logseq/bak/pages/High Risk Pregnancy/2024-12-10T17_34_38.442Z.Desktop.md new file mode 100644 index 0000000..f31bc8d --- /dev/null +++ b/logseq/bak/pages/High Risk Pregnancy/2024-12-10T17_34_38.442Z.Desktop.md @@ -0,0 +1,7 @@ +- #definition ((6718c95f-0b6b-4f7f-914f-1ed96c4f6459)) #obspw +- # Causes #obspw + - ((6718c9cf-b713-4414-9a0f-8758a665108d)) +- # High Risk Factors of Pregnacy #obspc + - ((671a3612-cba8-48dd-84ee-005be6ca7df2)) +- # Danger Signs of Pregnancy #obspw +- \ No newline at end of file diff --git a/logseq/bak/pages/IUFGR/2024-12-10T17_34_46.320Z.Desktop.md b/logseq/bak/pages/IUFGR/2024-12-10T17_34_46.320Z.Desktop.md new file mode 100644 index 0000000..c549b5e --- /dev/null +++ b/logseq/bak/pages/IUFGR/2024-12-10T17_34_46.320Z.Desktop.md @@ -0,0 +1,46 @@ +alias:: Intra-Uterine Fetal Growth Retardation + +- #definition IUFGR is said to be present in those babies whose birth wegiht is below the 10th percentile of the average for the gestational age #obspc +- # Difference between symmetrical & asymmetrical IUFGR #obspc + - |Symmetric IUFGR|Asymmetrical IUFGR| + |--|--| + |Uniformly small|Head larger than abdomen| + |Ponderal index (Birth weight/Crown-heel length) - normal|Low| + |HC : AC and[:br]FL : AC ratios - normal|Elevated| + |Etiology : Genetic disease or infection - (Intrinsic to fetus)|Chronic placental insufficiency - (Extrinsic to fetus)| + |Total cell number - less[:br]Cell size - normal|Normal[:br]Smaller| + |Neonatal course - complicated with poor prognosis|Usually uncomplicated having good prognosis| +- # Complications #obspc + - Fetal + - Antenatal + - Chronic fetal distress, fetal death + - Intranatal + - Hypoxia + - Acidosis + - Postnatal + - Immediate + - Asphyxia, Bronchopulmonary Dysplasia and RDS + - Hypoglycemia due to shortage of glycogen reserve in the liver + - Meconium aspiration syndrome + - Microcoagulation leading to DIC + - Hypothermia + - Pulmonary hemorrhage + - Polycythemia, anemia, thrombocytopenia + - Hyper viscosity-thrombosis + - Necrotizing enterocolitis due to reduced intestinal blood flow + - Intraventricular hemorrhage (IVH) + - Electrolyte abnormalities + - Hypocalcemia + - Hyperphosphatemia + - Hypokalemia + - Multiorgan failure + - Increased perinatal morbidity and mortality + - Late + - Retarded neurological and intellectual development infancy + - Increased risk of metabolic syndrome in adult life + - Obesity + - Hypertension + - Diabetes + - Coronary Heart Disease + - LBW infants have an altered orexigenic mechanism that causes increased appetite and reduced satiety + - Reduced number of nephrons - causes renal vascular hypertension \ No newline at end of file diff --git a/logseq/bak/pages/Impedance Audiogram/2024-12-10T15_30_39.474Z.Desktop.md b/logseq/bak/pages/Impedance Audiogram/2024-12-10T15_30_39.474Z.Desktop.md new file mode 100644 index 0000000..0cce5e4 --- /dev/null +++ b/logseq/bak/pages/Impedance Audiogram/2024-12-10T15_30_39.474Z.Desktop.md @@ -0,0 +1,3 @@ +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580575-9992-4646-9d82-3e223fe3f083 \ No newline at end of file diff --git a/logseq/bak/pages/Jones II test/2024-12-10T15_30_39.486Z.Desktop.md b/logseq/bak/pages/Jones II test/2024-12-10T15_30_39.486Z.Desktop.md new file mode 100644 index 0000000..761dc78 --- /dev/null +++ b/logseq/bak/pages/Jones II test/2024-12-10T15_30_39.486Z.Desktop.md @@ -0,0 +1 @@ +- SN: #eye-prof-written \ No newline at end of file diff --git a/logseq/bak/pages/Juvenile Nasopharyngeal Angiofibroma/2024-12-10T15_30_39.518Z.Desktop.md b/logseq/bak/pages/Juvenile Nasopharyngeal Angiofibroma/2024-12-10T15_30_39.518Z.Desktop.md new file mode 100644 index 0000000..2c9febc --- /dev/null +++ b/logseq/bak/pages/Juvenile Nasopharyngeal Angiofibroma/2024-12-10T15_30_39.518Z.Desktop.md @@ -0,0 +1,8 @@ +- Benign Tumor of nasal mucosa (benign, yet destructive) +- the tumor (oma) consists of blood vessels and fibrous tissue +- male adolescent +- profuse nose bleed(epitaxis) +- bipsy may be contraindicated +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580efb-a12a-4496-907a-890dbbe8effa \ No newline at end of file diff --git a/logseq/bak/pages/LASIK/2024-12-10T15_30_39.476Z.Desktop.md b/logseq/bak/pages/LASIK/2024-12-10T15_30_39.476Z.Desktop.md new file mode 100644 index 0000000..1d676f6 --- /dev/null +++ b/logseq/bak/pages/LASIK/2024-12-10T15_30_39.476Z.Desktop.md @@ -0,0 +1,2 @@ +# Criteria for suitable case of LASIK patient #eye-prof-written +- SN: LASIK #eye-prof-written \ No newline at end of file diff --git a/logseq/bak/pages/Labor Pain/2024-12-10T17_34_38.493Z.Desktop.md b/logseq/bak/pages/Labor Pain/2024-12-10T17_34_38.493Z.Desktop.md new file mode 100644 index 0000000..4ea0903 --- /dev/null +++ b/logseq/bak/pages/Labor Pain/2024-12-10T17_34_38.493Z.Desktop.md @@ -0,0 +1,39 @@ +# True Labor Pain +id:: 67134327-4e96-4637-a126-a918578bba77 + - #definition ((6713bf44-e7b6-4b14-90d2-83b3d81ee3d0)) #obs-prof-written + - ## Confirmation #obs-prof-written #unanswered + id:: 67225f9e-fa22-4363-92aa-bd374e2084fe +- # False Labor Pain + id:: 6713433b-2673-45bb-bb8f-3b5b868e6757 + - #definition ((6713bf5b-4eb1-4a17-8e45-033848ac8fde)) + - ## Causes #obs-prof-written #unanswered + - ## Classical Presentation #classical-presentation #obspc + - Near Term/Term lower abdominal Pain without ((671347fa-4c45-4263-aa88-3ec7cb590a45)), Uterine contraction absent & os closed + - # Management #obspc + - Reassurance & mental support + logseq.order-list-type:: number + - Clarify the nature & characteristics of actual labour pain + logseq.order-list-type:: number + - If the patient is near term & if possible, patient should be hospitalized till term & delivery + logseq.order-list-type:: number +- Near Term/Term lower abdominal Pain without show, Uterine contraction absent & os closed +- Reassurance & mental support + logseq.order-list-type:: number +- Clarify the nature & characteristics of actual labour pain + logseq.order-list-type:: number +- If the patient is near term & if possible, patient should be hospitalized till term & delivery + logseq.order-list-type:: number +- ### Difference between ((67134327-4e96-4637-a126-a918578bba77)) and ((6713433b-2673-45bb-bb8f-3b5b868e6757)) #obspw + - | Traits | True Labor Pain | False Labor Pain | + | ------------------- | ------------------------------------------------------------------------------------------------------------------------------------- | ---------------------------------------------- | + | Site | Back & Front of the abdomen | Lower abdomen & groin | + | Radiation | ((6713c205-60a8-433e-b1ef-268ccf5cbea5)) | Localized | + | Character | Colicky | Dull | + | Duration | Intermittent | Persistent/continuous | + | Intensity | Severe | Less severe | + | Progression | Increasing intensity & duration | Continuous and non-progressive | + | Relieving factor | Nothing | Sedative, analgesic & enema | + | Associated features | - Progressive effacement & dilation of the cervix[:br]- ((671347fa-4c45-4263-aa88-3ec7cb590a45)) [:br]- Formation of bag of forewater | May be assocaited with hardening of the uterus | +- ### Show + id:: 671347fa-4c45-4263-aa88-3ec7cb590a45 + - #definition ((6713bf80-6436-49c4-a37e-93d37edb7996)) \ No newline at end of file diff --git a/logseq/bak/pages/Labor/2024-12-10T17_34_38.490Z.Desktop.md b/logseq/bak/pages/Labor/2024-12-10T17_34_38.490Z.Desktop.md new file mode 100644 index 0000000..489466e --- /dev/null +++ b/logseq/bak/pages/Labor/2024-12-10T17_34_38.490Z.Desktop.md @@ -0,0 +1,39 @@ +alias:: Labour +contrast:: [[Braxton Hicks contraction]] , not regular and without cervical change + +- #definition ((6713bc8d-10b6-4544-9313-75cc8efac4ea)) #obspw #obs-prof-card #card + deck:: #Obstetrics +- [[Normal Labor]] & ((67225810-2ee9-4dee-8e5d-714fd84d2b1a)) +- [[Fetal Orientation]] +- # Presentation #classical-presentation #obs-prof-written #unanswered + alias:: Signs and Symptoms of Onset of Labor + - [[Term]] + - [[Labor Pain]] +- # Confirmation/Diagnosis #obs-prof-written #unanswered + similar-to:: ((67225f9e-fa22-4363-92aa-bd374e2084fe)) +- # Maternal Changes + collapsed:: true + - ## Cervical dilation + - #definition opening/diameter of cervix during labor + - Full Dilation of Cervix + id:: 6711ec53-8dd0-47dc-811d-012d2c2ec744 + - #definition 10 cm cervical dilation + - ## Cervical effacement + note:: `although this correlates with the cervical dilation, it is not the same, as that is the gap in between the cervix, while this is the thickness of the cervix itself` + - #definition Thickness of the cervix, expressed as a percentage + - 2 cm is 0% effacement; 1 cm is 50% + - 100% effacement + id:: 6711eafd-a950-4149-8d0b-d4c8828ef836 + - the cervix is simply a thin membrane + - Effacement coincides with increasing levels of prostaglandins and oxytocin + - Cervical ripening agents + - [[Misoprostol]] + - [[Laminaria]] +- # Lower Segement of Uterus #obspw + alias:: LS + - #definition #obs-prof-written ((6713c79b-ba93-455e-af98-77ccb7eb6139)) + - SN : #obs-prof-written #unanswered +- # Engagement + - #definition #obspw + - ## Causes of non-engaged head in a primae #obspw + - Complications if labor occurs in primae #obspw \ No newline at end of file diff --git a/logseq/bak/pages/Littles Area/2024-12-10T15_30_39.481Z.Desktop.md b/logseq/bak/pages/Littles Area/2024-12-10T15_30_39.481Z.Desktop.md new file mode 100644 index 0000000..21bcb14 --- /dev/null +++ b/logseq/bak/pages/Littles Area/2024-12-10T15_30_39.481Z.Desktop.md @@ -0,0 +1,12 @@ +- #definition {{c1 }} #ent-prof-card #ent-prof-written #unanswered #card + id:: 6756bcc7-fbf8-411d-b48f-312a50249833 + deck:: #ENT +- # Formation #ent-prof-card #ent-prof-written #unanswered #card + id:: 6756cf35-c282-4bea-a8d4-b1ba0552c3e1 + deck:: #ENT +- # Clinical Importance #ent-prof-card #ent-prof-written #unanswered #card + id:: 6756cf35-249b-42d1-853d-a57a518fa977 + deck:: #ENT +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580700-cfda-4772-a1cf-33c6109c5cd9 \ No newline at end of file diff --git a/logseq/bak/pages/Ludwig's Angina/2024-12-10T15_30_39.501Z.Desktop.md b/logseq/bak/pages/Ludwig's Angina/2024-12-10T15_30_39.501Z.Desktop.md new file mode 100644 index 0000000..b9661f5 --- /dev/null +++ b/logseq/bak/pages/Ludwig's Angina/2024-12-10T15_30_39.501Z.Desktop.md @@ -0,0 +1,77 @@ +- alias:: + ICD-11_Code:: + tags:: #Disease +- #definition {{c1 }} #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756b8b1-7ab0-4520-b4a3-4cda026d234c +- ## Etiology + background-color:: blue + - ### Causative Agents + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features + background-color:: blue + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria +- ## Diagnosis + background-color:: blue + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-card #unanswered #card + background-color:: blue + deck:: #ENT + id:: bde4b4a6-a339-4cd2-8e9a-5718408a868d + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6758158a-e90c-4bef-bd9c-7ecac5e0e50f \ No newline at end of file diff --git a/logseq/bak/pages/Mastoid Abscess/2024-12-10T15_30_39.509Z.Desktop.md b/logseq/bak/pages/Mastoid Abscess/2024-12-10T15_30_39.509Z.Desktop.md new file mode 100644 index 0000000..ced32e1 --- /dev/null +++ b/logseq/bak/pages/Mastoid Abscess/2024-12-10T15_30_39.509Z.Desktop.md @@ -0,0 +1,76 @@ +- alias:: + ICD-11_Code:: + tags:: #Disease +- ## Etiology + background-color:: blue + - ### Causative Agents + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features + background-color:: blue + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria +- ## Diagnosis + background-color:: blue + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - [[Furunculosis]] + - Differentiate #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6757f854-6d93-4975-9e3c-2d16ad361ffb + - ### Confirmation of Diagnosis +- ## Management and Treatment + background-color:: blue + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6757f861-7242-4f50-9e37-e8f431f7acb9 \ No newline at end of file diff --git a/logseq/bak/pages/Mastoidectomy/2024-12-10T15_30_39.504Z.Desktop.md b/logseq/bak/pages/Mastoidectomy/2024-12-10T15_30_39.504Z.Desktop.md new file mode 100644 index 0000000..8c1e52b --- /dev/null +++ b/logseq/bak/pages/Mastoidectomy/2024-12-10T15_30_39.504Z.Desktop.md @@ -0,0 +1,19 @@ +- #definition {{c1 }} #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675805a6-3211-4260-9ca9-54cda3217df9 +- # Types #ent-prof-card #ent-prof-written #unanswered #card + id:: 6756c778-bb1a-42e6-bb4c-72b8d6d8cece + deck:: #ENT +- # Aims #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675805ed-471e-4652-9259-b4964ea64a14 +- # Indications of Different Types of Mastoidectomy #ent-prof-card #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6758061e-8971-4017-b83c-9a3e05e54183 +- # Complication #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675805be-d972-4904-9e77-546bf17e5707 +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580655-70fe-4807-b22f-f0deeb621cb5 +- \ No newline at end of file diff --git a/logseq/bak/pages/Meniere's Disease/2024-12-10T15_30_39.491Z.Desktop.md b/logseq/bak/pages/Meniere's Disease/2024-12-10T15_30_39.491Z.Desktop.md new file mode 100644 index 0000000..7c43a6f --- /dev/null +++ b/logseq/bak/pages/Meniere's Disease/2024-12-10T15_30_39.491Z.Desktop.md @@ -0,0 +1,79 @@ +- alias:: + ICD-11_Code:: + tags:: #Disease +- #definition {{c1 }} #ent-prof-card #ent-prof-written #unanswered #card + id:: 6756c23f-2e59-47e9-b177-c10af5c95e12 + deck:: #ENT +- ## Etiology + background-color:: blue + - ### Causative Agents + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features + background-color:: blue + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria +- ## Diagnosis #ent-prof-card #unanswered #card + background-color:: blue + deck:: #ENT + id:: cacace2a-0212-4b4f-8198-80c2164bb44f + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-card #ent-prof-written #unanswered #card + background-color:: blue + id:: 3abf9902-4436-4be6-ad4c-1ad09cab3a65 + deck:: #ENT + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675800ff-fe62-48ff-98ef-df6ef1e4aa43 \ No newline at end of file diff --git a/logseq/bak/pages/Multiple Papilloma of Larynx/2024-12-10T15_30_39.506Z.Desktop.md b/logseq/bak/pages/Multiple Papilloma of Larynx/2024-12-10T15_30_39.506Z.Desktop.md new file mode 100644 index 0000000..424a03b --- /dev/null +++ b/logseq/bak/pages/Multiple Papilloma of Larynx/2024-12-10T15_30_39.506Z.Desktop.md @@ -0,0 +1,76 @@ +- alias:: + ICD-11_Code:: + tags:: #Disease +- ## Etiology + background-color:: blue + - ### Causative Agents + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features #ent-prof-written #unanswered #card + background-color:: blue + deck:: #ENT + id:: 59f69b52-7bf6-43ba-b5b6-1d93d37f677b + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria +- ## Diagnosis + background-color:: blue + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-card #ent-prof-written #unanswered #card + background-color:: blue + id:: 042c3d7d-5137-411a-9c18-72e8dc5973c7 + deck:: #ENT + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue +- SN: Inverted Papilloma #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6758152f-13ba-497e-a307-a1b2a2605320 \ No newline at end of file diff --git a/logseq/bak/pages/Myringoplasty/2024-12-10T15_30_39.510Z.Desktop.md b/logseq/bak/pages/Myringoplasty/2024-12-10T15_30_39.510Z.Desktop.md new file mode 100644 index 0000000..4a61603 --- /dev/null +++ b/logseq/bak/pages/Myringoplasty/2024-12-10T15_30_39.510Z.Desktop.md @@ -0,0 +1,3 @@ +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580581-9ea8-462a-9f67-1e27ec9ca67a \ No newline at end of file diff --git a/logseq/bak/pages/Myringotomy/2024-12-10T15_30_39.493Z.Desktop.md b/logseq/bak/pages/Myringotomy/2024-12-10T15_30_39.493Z.Desktop.md new file mode 100644 index 0000000..665abe3 --- /dev/null +++ b/logseq/bak/pages/Myringotomy/2024-12-10T15_30_39.493Z.Desktop.md @@ -0,0 +1,3 @@ +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580589-6a65-4393-9e78-e600770e0bc3 \ No newline at end of file diff --git a/logseq/bak/pages/Otitis Media with Effusion/2024-12-10T15_30_39.480Z.Desktop.md b/logseq/bak/pages/Otitis Media with Effusion/2024-12-10T15_30_39.480Z.Desktop.md new file mode 100644 index 0000000..154bd29 --- /dev/null +++ b/logseq/bak/pages/Otitis Media with Effusion/2024-12-10T15_30_39.480Z.Desktop.md @@ -0,0 +1,84 @@ +alias:: OME, Glue Ear +ICD-11_Code:: +tags:: #Disease + +- #definition {{c1 }} #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6757ff02-d29d-46fa-a9c6-b8f1f6544728 +- ## Etiology + background-color:: blue + - ### Causative Agents #ent-prof-written #unanswered #card + deck:: #ENT + id:: cf712701-e431-456e-b423-a4a876655d95 + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease #ent-prof-card #unanswered #card + deck:: #ENT + id:: e5e8984f-91b9-4523-b5d1-00400bfb2a81 + - ### Affected Systems/Organs +- ## Clinical Features #ent-prof-written #unanswered #card + background-color:: blue + deck:: #ENT + id:: 01f76540-cb7c-4ef8-a154-d49c03cf558b + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria +- ## Diagnosis + background-color:: blue + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-written #unanswered #card + background-color:: blue + deck:: #ENT + id:: 721febf5-0538-48d5-ab55-5a624f78a3b9 + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6757ff5f-3b11-438c-a3eb-314789142181 \ No newline at end of file diff --git a/logseq/bak/pages/Otomycosis/2024-12-10T15_30_39.513Z.Desktop.md b/logseq/bak/pages/Otomycosis/2024-12-10T15_30_39.513Z.Desktop.md new file mode 100644 index 0000000..82ded31 --- /dev/null +++ b/logseq/bak/pages/Otomycosis/2024-12-10T15_30_39.513Z.Desktop.md @@ -0,0 +1,114 @@ +- #definition It is a fungal infection of external auditory canal #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6733ccee-4455-4ccc-aecc-9123043c28a7 +- alias:: AA03 + ICD-11_Code:: [[AA03]] + tags:: #Disease +- ## Etiology #ent-prof-written #unanswered #card + background-color:: blue + deck:: #ENT + id:: 6733ccee-75c3-49a6-8adf-01d9db0dbc53 + - ### Causative Agents + - _[[Aspergillus niger]]_ (black fungal ball) + - _[[Aspergillus fumigatus]]_ (green) + - _[[Candida albicans]]_ (whitish) + - ### Risk Factors + - Hot and humid climate + - More in summer, DM, topical use of antibiotics + - Secondary to bacterial infection diffuse otitis externa and suppurative otitis media + - At that time antibiotic should not be given because antibiotic solution support the growth of fungus +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features #ent-prof-card #ent-prof-written #unanswered #card + background-color:: blue + id:: 6733ccee-2abe-4542-a82e-a7e5755b34d6 + deck:: #ENT + - ### Signs and Symptoms + - #### Symptoms + - Intense Itching + - Discomfort + - Pain + - #### Signs + - Watery Discharge with a musty odour + - Ear blockage + - fungal mass may appear white, brown or black and has been likened to a wet piece of filter paper + - ### Stages or Classification + - ### Diagnostic Criteria +- ## Diagnosis + background-color:: blue + - ### Clinical Diagnosis : S/S + - ### Investigations + - Otoscope Findings + - Fungal ball or otomycotic plug - wet filter paper/ newspaper + - A. niger appears black headed filamentous growth + - A. fumigatus as pale blue or green + - Candida as white or creamy deposit + - Meatal skin appear, *sodden, red* and *oedematous* + - Wet film preparation + - Hyphae are found in aspergillus + - Small ovoid budding is found in candida + - Aural swab for C/S + - ### Imaging Studies + - ### Differential Diagnosis +- ## Management and Treatment #ent-prof-card #ent-prof-written #card #[[External Ear]] + background-color:: blue + id:: 6733ccee-2f53-4849-b192-14e354d05c13 + deck:: #ENT + - ### Surgical Options + - For blockage: + id:: 6733ccee-7980-4895-ad56-952edb6147b4 + Thorough Ear toilet to remove all discharge and epithelial debris which are conductive to the growth of fungus by syringing, suction or mopping + - ### Medical Treatment + id:: 6756cf36-e0de-4456-8c77-c1efbe134db8 + - Antifungal + - They are + - Nystatin against Candida + - Other borad-spectrum antifungal agents : Cotrimazole and Povidone Iodine + - Two percent salicylic acid in alcohol is also effective + - Antifungal treatment should be continued for a week even after apparent cure to avoid recurrences + - Antibiotic/steroid preparation for secondary bacterial infections + - ### Lifestyle and Dietary Recommendations + - Ear must be kept dry +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Complications + background-color:: blue + - ### Possible Complications + - ### Long-term Effects +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6757f8d6-dc67-41ec-b250-9de12becf15c \ No newline at end of file diff --git a/logseq/bak/pages/Pathology/2024-12-10T17_34_38.443Z.Desktop.md b/logseq/bak/pages/Pathology/2024-12-10T17_34_38.443Z.Desktop.md new file mode 100644 index 0000000..a6bfdd5 --- /dev/null +++ b/logseq/bak/pages/Pathology/2024-12-10T17_34_38.443Z.Desktop.md @@ -0,0 +1,6 @@ +- [[Female Reproductive System]] + - Pathological Conditions of the [[Fallopian Tube]] #obspw + - [[Salphingitis]] + - [[Ectopic Pregnancy]] +- [[Neoplasm]] +- \ No newline at end of file diff --git a/logseq/bak/pages/Perinatal Mortality/2024-12-10T17_34_46.863Z.Desktop.md b/logseq/bak/pages/Perinatal Mortality/2024-12-10T17_34_46.863Z.Desktop.md new file mode 100644 index 0000000..d4cb0c7 --- /dev/null +++ b/logseq/bak/pages/Perinatal Mortality/2024-12-10T17_34_46.863Z.Desktop.md @@ -0,0 +1,27 @@ +- #definition Perinatal mortality is defined as deaths among fetuses weighing 100 g or more at brith (28 weeks gestation) who die before or during delivery or within the first 7 days of delivery #obspc +- The perinatal mortality rate is expressed in terms of such deaths per 1000 total births +- # Causes + - Chronic hypoxia(30%) + - Pregnancy complications(30%) + - Congenital malformations(15%) + - Infection (5%) and + - Unexplained (20%) +- # Prevention + - Pre-Pregnancy health care and counselling + logseq.order-list-type:: number + - Genetic counselling in high-risk cases and prenatal diagnosis to detect genetic, chromosomal or structural abnormalities are essential + logseq.order-list-type:: number + - Regular antenatal care, with advice regarding health, diet and rest + logseq.order-list-type:: number + - Detection and management of medical disorders in pregnancy: anemia, diabetes, infections and preeclampsia-eclampsia. Immunization against tetanus should be done as routine + logseq.order-list-type:: number + - Screening of high-risk patients those of poor socioeconomic status or high parity, extremes of age, and twins, etc. and their mandatory hospital delivery + logseq.order-list-type:: number + - Careful monitoring in labor to detect hypoxia eraly and avoidance of traumatic vaginal delivery + logseq.order-list-type:: number + - Skilled birth attendant - To minimize sepsis, at least three cleans are to be maintained + logseq.order-list-type:: number + - Provision of referral neonatal service specially to look after the preterm babies + logseq.order-list-type:: number + - Health care education of the mother about the care of the newborn. Early and exclusive breastfeeding, prevention of hypothermia + logseq.order-list-type:: number \ No newline at end of file diff --git a/logseq/bak/pages/Peurperial Pyrexia/2024-12-10T17_34_46.862Z.Desktop.md b/logseq/bak/pages/Peurperial Pyrexia/2024-12-10T17_34_46.862Z.Desktop.md new file mode 100644 index 0000000..c20a3b2 --- /dev/null +++ b/logseq/bak/pages/Peurperial Pyrexia/2024-12-10T17_34_46.862Z.Desktop.md @@ -0,0 +1,20 @@ +- #definition A rise of temperature reaching 100.4 ºF (38 ºC) #pyrexia or more (measured orally) on two separate occasions at 24 hours apart (excluding first 24 hours) within first 10 days following delivery is called puerperal pyrexia. #obspc +- # Causes #obspc #reminder (might have to classify on days basis) + - Puerperal sepsis + - Urinary tract infections: Cystitis, Pyelonephritis + - Mastitis, Breast abscess + - Wound infections: CS or Episiotomy + - Pulmonary infections: Atelectasis, Pneumonia + - Septic pelvic thrombophlebitis + - A recrudescence of malaria or pulmonary tuberculosis + - Others: Pharyngitis, Gastroenteritis +- # Complications #obspc + - Breast engorgement + logseq.order-list-type:: number + - Cracked and retracted nipple leading to difficulty in breastfeeding + logseq.order-list-type:: number + - Mastitis and Breast abscess + logseq.order-list-type:: number + - Lactation failure + logseq.order-list-type:: number +- \ No newline at end of file diff --git a/logseq/bak/pages/Phylectenular Conjunctivitis/2024-12-10T15_30_39.507Z.Desktop.md b/logseq/bak/pages/Phylectenular Conjunctivitis/2024-12-10T15_30_39.507Z.Desktop.md new file mode 100644 index 0000000..761dc78 --- /dev/null +++ b/logseq/bak/pages/Phylectenular Conjunctivitis/2024-12-10T15_30_39.507Z.Desktop.md @@ -0,0 +1 @@ +- SN: #eye-prof-written \ No newline at end of file diff --git a/logseq/bak/pages/Plummer Vinson Syndrome/2024-12-10T15_30_39.505Z.Desktop.md b/logseq/bak/pages/Plummer Vinson Syndrome/2024-12-10T15_30_39.505Z.Desktop.md new file mode 100644 index 0000000..10ac01e --- /dev/null +++ b/logseq/bak/pages/Plummer Vinson Syndrome/2024-12-10T15_30_39.505Z.Desktop.md @@ -0,0 +1,3 @@ +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67581274-8b47-479f-93b0-5edf85d77c61 \ No newline at end of file diff --git a/logseq/bak/pages/Pre-auricular Sinus/2024-12-10T15_30_39.482Z.Desktop.md b/logseq/bak/pages/Pre-auricular Sinus/2024-12-10T15_30_39.482Z.Desktop.md new file mode 100644 index 0000000..a0d5809 --- /dev/null +++ b/logseq/bak/pages/Pre-auricular Sinus/2024-12-10T15_30_39.482Z.Desktop.md @@ -0,0 +1,72 @@ +- alias:: + ICD-11_Code:: + tags:: #Disease +- ## Etiology + background-color:: blue + - ### Causative Agents + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features + background-color:: blue + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria +- ## Diagnosis + background-color:: blue + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment + background-color:: blue + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580553-dc10-46d6-b1f3-37887c42e645 \ No newline at end of file diff --git a/logseq/bak/pages/Pterygium/2024-12-10T15_30_39.522Z.Desktop.md b/logseq/bak/pages/Pterygium/2024-12-10T15_30_39.522Z.Desktop.md new file mode 100644 index 0000000..d249cb0 --- /dev/null +++ b/logseq/bak/pages/Pterygium/2024-12-10T15_30_39.522Z.Desktop.md @@ -0,0 +1,91 @@ +id:: 67503fc7-1712-4c11-a1f2-e7bcf9942f04 +alias:: +icd-11-code:: + +- #definition {{c1 Triangular, fibrovascular, subepithelial ingrowth of degenerative bulbar conjunctival tissue extending from the conjunctiva on to the cornea encroaching the limbus}} #eye-prof-card, #eye-prof-written #card + id:: 6754219b-65c2-49eb-bf00-c1e9287c63d8 + deck:: #Eye +- ## Etiology + background-color:: blue + - ### Causative Agents + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features + background-color:: blue + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria +- ## Diagnosis + background-color:: blue + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment #eye-prof-written + background-color:: blue + - ### Medical Treatment (Symptomatic Relief) + recurrence:: + - Low Potent steroid drop + - Artificial Tear + - Advice the patient to stay away from aggravating factors (Heat, Dust) + - Follow up + - ### Surgical Options #eye-prof-written + - Small : {{c1 Excision of Pterygium with conjunctival autograft}} from {{c2 same}} #card + id:: 675351eb-458f-441e-b5d0-62fb96e65bda + deck:: #Eye + - Large : {{c1 Excision of Pterygium with amniotic membrane graft}} #card + deck:: #Eye + id:: 67535203-19de-45d7-8d92-4fc6b6c5a0fc + - Recurrent : {{c1 Excision of Pterygium with Mitomycin C and conjunctival autograft}} #card + deck:: #Eye + id:: 6753521e-81a7-47d8-8133-0bcb1765cb04 + - Adjunctive Radiotherapy with ß-radiation + - Excision of Pterygium with bear sclera + - ### Lifestyle and Dietary Recommendations + - ### Follow-up +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - #### Without Treatment #eye-prof-written + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + collapsed:: true + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue +- SN: #eye-prof-written \ No newline at end of file diff --git a/logseq/bak/pages/Pure Tone Audiometry/2024-12-10T15_30_39.508Z.Desktop.md b/logseq/bak/pages/Pure Tone Audiometry/2024-12-10T15_30_39.508Z.Desktop.md new file mode 100644 index 0000000..5b650c2 --- /dev/null +++ b/logseq/bak/pages/Pure Tone Audiometry/2024-12-10T15_30_39.508Z.Desktop.md @@ -0,0 +1,5 @@ +alias:: PTA + +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580298-d5e4-4c7a-b8cf-ecce2a3bf3cc \ No newline at end of file diff --git a/logseq/bak/pages/Quinsy/2024-12-10T15_30_39.502Z.Desktop.md b/logseq/bak/pages/Quinsy/2024-12-10T15_30_39.502Z.Desktop.md new file mode 100644 index 0000000..604d0c1 --- /dev/null +++ b/logseq/bak/pages/Quinsy/2024-12-10T15_30_39.502Z.Desktop.md @@ -0,0 +1,82 @@ +alias:: peritonsillar abscess +ICD-11_Code:: +tags:: #Disease + +- #definition {{c1 }} #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756b260-7501-42a1-9738-3d39be0fe940 +- ## Etiology + background-color:: blue + - ### Causative Agents + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features + background-color:: blue + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria +- ## Diagnosis #ent-prof-written #card + deck:: #ENT + id:: 5c209012-cdf7-4712-aa47-73e29d7cc99e + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Cardinal Features #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756b2ed-83ee-4754-a88d-f345b31725c0 + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-card #unanswered #ent-prof-written #card + background-color:: blue + deck:: #ENT + id:: 482c2fd5-0fa6-4908-a26b-7c5429aa5d14 + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue +- SN: #ent-prof-written #card + deck:: #ENT + id:: 6756d165-7510-43dd-9c23-5bf2e574f25a diff --git a/logseq/bak/pages/Ranula/2024-12-10T15_30_39.492Z.Desktop.md b/logseq/bak/pages/Ranula/2024-12-10T15_30_39.492Z.Desktop.md new file mode 100644 index 0000000..1ad2f3f --- /dev/null +++ b/logseq/bak/pages/Ranula/2024-12-10T15_30_39.492Z.Desktop.md @@ -0,0 +1,3 @@ +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675816e2-5b7d-481f-83a9-8e20a55a39b3 \ No newline at end of file diff --git a/logseq/bak/pages/Referred Otalgia/2024-12-10T15_30_39.492Z.Desktop.md b/logseq/bak/pages/Referred Otalgia/2024-12-10T15_30_39.492Z.Desktop.md new file mode 100644 index 0000000..049b733 --- /dev/null +++ b/logseq/bak/pages/Referred Otalgia/2024-12-10T15_30_39.492Z.Desktop.md @@ -0,0 +1,9 @@ +- #definition {{c1 }} #ent-prof-card #ent-prof-written #unanswered #card + id:: 6756cdfe-6998-4b9b-b70f-d6fc70262a07 + deck:: #ENT +- # Causes #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756cf34-9c7c-44ec-99e7-9e06e1a0eb22 +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675804e8-a0f0-4856-b49a-972069eed24c \ No newline at end of file diff --git a/logseq/bak/pages/Retropharyngeal abscess/2024-12-10T15_30_39.527Z.Desktop.md b/logseq/bak/pages/Retropharyngeal abscess/2024-12-10T15_30_39.527Z.Desktop.md new file mode 100644 index 0000000..fb49f83 --- /dev/null +++ b/logseq/bak/pages/Retropharyngeal abscess/2024-12-10T15_30_39.527Z.Desktop.md @@ -0,0 +1,79 @@ +- alias:: + ICD-11_Code:: + tags:: #Disease +- #definition {{c1 }} #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675810b0-fc80-45f7-806c-f4764d7c82be +- ## Etiology + background-color:: blue + - ### Causative Agents + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features + background-color:: blue + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification #ent-prof-written #unanswered #card + deck:: #ENT + id:: 7f32f9e9-ccda-4242-aad5-0eedb0b3cb43 + - [[Acute Retropharyngeal Abscess]] + - [[Chronic Retropharyngeal Abscess]] + - ### Diagnostic Criteria +- ## Diagnosis + background-color:: blue + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment + background-color:: blue + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67581171-79d1-475c-a2f2-827bd0568291 \ No newline at end of file diff --git a/logseq/bak/pages/Rhinoplasty/2024-12-10T15_30_39.472Z.Desktop.md b/logseq/bak/pages/Rhinoplasty/2024-12-10T15_30_39.472Z.Desktop.md new file mode 100644 index 0000000..16847b3 --- /dev/null +++ b/logseq/bak/pages/Rhinoplasty/2024-12-10T15_30_39.472Z.Desktop.md @@ -0,0 +1,3 @@ +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580d39-411f-4213-b2c9-25d117ce3e16 \ No newline at end of file diff --git a/logseq/bak/pages/Rhinosporidiosis/2024-12-10T15_30_39.500Z.Desktop.md b/logseq/bak/pages/Rhinosporidiosis/2024-12-10T15_30_39.500Z.Desktop.md new file mode 100644 index 0000000..0feec16 --- /dev/null +++ b/logseq/bak/pages/Rhinosporidiosis/2024-12-10T15_30_39.500Z.Desktop.md @@ -0,0 +1,81 @@ +- alias:: + ICD-11_Code:: + tags:: #Disease +- #definition {{c1 }} #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580c17-1935-4c28-9aa1-56dad69bc9d2 +- ## Etiology #ent-prof-card #unanswered #card + background-color:: blue + deck:: #ENT + id:: 120242e6-8089-4346-a09b-24c41a65d894 + - ### Causative Agents + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features #ent-prof-card #ent-prof-written #unanswered #card + background-color:: blue + id:: d15cc573-58c4-4954-9664-4ee4841c91f8 + deck:: #ENT + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria +- ## Diagnosis + background-color:: blue + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-card #ent-prof-written #unanswered #card + background-color:: blue + id:: 95047ab4-df72-4522-9526-e1fe19c4e9b6 + deck:: #ENT + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580c43-adc9-4abd-985f-da2724930a4d \ No newline at end of file diff --git a/logseq/bak/pages/Rinne's Test/2024-12-10T15_30_39.103Z.Desktop.md b/logseq/bak/pages/Rinne's Test/2024-12-10T15_30_39.103Z.Desktop.md new file mode 100644 index 0000000..9b47dc9 --- /dev/null +++ b/logseq/bak/pages/Rinne's Test/2024-12-10T15_30_39.103Z.Desktop.md @@ -0,0 +1,9 @@ +# Procedure #ent-prof-written #unanswered #card +deck:: #ENT +id:: 67580220-8cf9-417b-8718-a11493550724 +- # Interference #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580224-8c14-432f-8875-7683d9f1cefd +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6758023b-32da-4a25-9014-9ddc0f1f112c \ No newline at end of file diff --git a/pages/Cholesteatoma.md b/logseq/bak/pages/Septal Abscess/2024-12-10T15_30_39.528Z.Desktop.md similarity index 65% rename from pages/Cholesteatoma.md rename to logseq/bak/pages/Septal Abscess/2024-12-10T15_30_39.528Z.Desktop.md index 7a8c929..71183e6 100644 --- a/pages/Cholesteatoma.md +++ b/logseq/bak/pages/Septal Abscess/2024-12-10T15_30_39.528Z.Desktop.md @@ -2,10 +2,12 @@ ICD-11_Code:: tags:: #Disease - #definition {{c1 }} #ent-prof-card #ent-prof-written #unanswered #card - id:: 6756c713-60be-453c-8b30-ab4c6d5335e0 + id:: 6756c537-1205-46d8-91a0-cc1915f6ae4e deck:: #ENT -- ## Etiology +- ## Etiology #ent-prof-card #unanswered #card background-color:: blue + deck:: #ENT + id:: 6756cf32-bc6a-478e-b20d-f7f4b03ce19c - ### Causative Agents - ### Risk Factors - ## Epidemiology @@ -16,24 +18,16 @@ - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease #ent-prof-card #unanswered #card - deck:: #ENT - id:: b4a881f1-bb60-4a39-8c4d-af04161a135e + - ### Mechanism of Disease - ### Affected Systems/Organs - - Intracranial Complications - - Mechanism #ent-prof-card #unanswered #card - deck:: #ENT - id:: 6756ce3a-2ab7-4c2c-8a0a-1cc353422dd0 - ## Clinical Features #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT - id:: 6756cf34-077e-4771-9169-584c3f362368 + id:: 9cf87f7c-b5ea-4dd9-a176-292616919594 - ### Signs and Symptoms - #### Symptoms - #### Signs - - ### Stages or Classification #ent-prof-written #unanswered #card - deck:: #ENT - id:: 74adc7e7-90e1-4f58-a18e-ac41a147949d + - ### Stages or Classification - ### Diagnostic Criteria - ## Diagnosis background-color:: blue @@ -44,10 +38,10 @@ - ### Imaging Studies - ### Differential Diagnosis - ### Confirmation of Diagnosis -- ## Management and Treatment #ent-prof-card #unanswered #card +- ## Management and Treatment #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue + id:: da63716d-c270-4810-9403-4f1b6f1c1073 deck:: #ENT - id:: 2e0078c6-cf6c-4b3d-8223-0ca14f393bf2 - ### Medical Treatment - ### Surgical Options - ### Lifestyle and Dietary Recommendations @@ -57,12 +51,10 @@ - ### Expected Course - #### With Treatment - #### Without Treatment - - ##### Possible Complications #ent-prof-card #unanswered #card - id:: b23de92e-4657-4264-824c-24fa3cad1f05 - deck:: #ENT - - ##### Extracranial Complications #ent-prof-written #unanswered #card + - ##### Possible Complications #ent-prof-written #unanswered #card deck:: #ENT - id:: 26f0e9a1-f225-4e31-8f8c-6797e5c5d606 + id:: 35f613dd-1108-499c-af39-932f6168400f + - ##### Long-Term Effects - ### Survival Rates - #### With Treatment - #### Without Treatment @@ -85,4 +77,7 @@ - ## Key Literature background-color:: blue - ## Guidelines and Protocols - background-color:: blue \ No newline at end of file + background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580834-84ac-437b-9a11-14d51d49267e \ No newline at end of file diff --git a/logseq/bak/pages/Septal Hematoma/2024-12-10T15_30_39.530Z.Desktop.md b/logseq/bak/pages/Septal Hematoma/2024-12-10T15_30_39.530Z.Desktop.md new file mode 100644 index 0000000..e804713 --- /dev/null +++ b/logseq/bak/pages/Septal Hematoma/2024-12-10T15_30_39.530Z.Desktop.md @@ -0,0 +1,79 @@ +- alias:: + ICD-11_Code:: + tags:: #Disease +- #definition +- ## Etiology + background-color:: blue + - ### Causative Agents #ent-prof-card #unanswered #card + deck:: #ENT + id:: 64266b0a-1aaa-42f1-8753-bdefd8d0e31a + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features #ent-prof-card #unanswered #card + background-color:: blue + deck:: #ENT + id:: 932292be-6531-4121-a91b-8f88bd317a67 + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria +- ## Diagnosis + background-color:: blue + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment #ent-prof-card #ent-prof-written #unanswered #card + background-color:: blue + id:: a9a2e6bf-5e0f-4758-9453-efb3537e2918 + deck:: #ENT + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6758093e-1bc3-48e4-9ca4-62f6d2ae503e \ No newline at end of file diff --git a/logseq/bak/pages/Septoplasty/2024-12-10T15_30_39.104Z.Desktop.md b/logseq/bak/pages/Septoplasty/2024-12-10T15_30_39.104Z.Desktop.md new file mode 100644 index 0000000..09229e2 --- /dev/null +++ b/logseq/bak/pages/Septoplasty/2024-12-10T15_30_39.104Z.Desktop.md @@ -0,0 +1,18 @@ +- #definition {{c1 }} #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6756c4d5-1198-40ad-af3d-44cc31ef44e2 +- # Indication #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580c95-feea-449d-add1-eb64e925ab6e +- # Advantages #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580c9e-7fa0-4976-bfc3-1488c542ef85 +- # Disadvantages #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580ca6-1545-42eb-a5a9-9e8840307b86 +- # Complications #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580c64-3671-45dc-921b-d12f0a939656 +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580d2a-5aa6-4808-950e-684bf8b0e35f \ No newline at end of file diff --git a/logseq/bak/pages/Stages of Labor/2024-12-10T17_34_38.477Z.Desktop.md b/logseq/bak/pages/Stages of Labor/2024-12-10T17_34_38.477Z.Desktop.md new file mode 100644 index 0000000..2b1ced1 --- /dev/null +++ b/logseq/bak/pages/Stages of Labor/2024-12-10T17_34_38.477Z.Desktop.md @@ -0,0 +1,166 @@ +tags:: #obspw #obspc + +- Names of Stages with Duration #obs-prof-card #card + deck:: #Obstetrics + - |Stage of Labor|Duration Primi|Duration Multigravida| + |--|--|--| + |Stage 1|12 hours|6 hours| + |Stage 2|2 hours|30 minutes| + |Stage 3|15 minutes|| + |Stage 4|1 hour|| +- # Stage One of Labor + id:: 6711ec95-ab78-44a9-97ff-cb303010369c + duration-primigarvida:: 12 hours + duration-multigravida:: 6 hours + start-event:: onset of true labor pain + end-event:: ((6711ec53-8dd0-47dc-811d-012d2c2ec744)) + - #definition Closed to ((6711ec53-8dd0-47dc-811d-012d2c2ec744)) + - ((6711eafd-a950-4149-8d0b-d4c8828ef836)) and ((6711ec53-8dd0-47dc-811d-012d2c2ec744)) + - ### Latent Stage One of Labor + id:: 67120253-4848-4e62-bb98-e1c7f8f23d75 + - #definition Closed to 3-4 cm dilated + - ### Active Stage One of Labor + - #definition 3-4 cm to full dilation (dilation accelerates) + - Cardinal movements begin to occur + - ## Management #obspw + - ### Principles + collapsed:: true + - ((6713de39-95ed-4e4b-97d4-1e5ca784dce1)) + logseq.order-list-type:: number + - ((6713de1f-8999-42fd-bf0d-035f4ebbb9a7)) + logseq.order-list-type:: number + - ## Priliminaries + collapsed:: true + - ((6713de64-6f54-4aed-b7c9-46c3ff060cb1)) + - ### Actual Management + collapsed:: true + - #### General + - ((6713e12f-04cb-46e8-849d-4dc91520fc9e)) + logseq.order-list-type:: number + - ((6713e141-b38a-4c06-9e04-424e0d14a0f1)) + logseq.order-list-type:: number + - ((6713e14c-0558-41bd-8831-476a4646443c)) + logseq.order-list-type:: number + - Position + - Not necessarily confined to bed + - Take a comfortable position in bed + - ((6713e188-3676-495b-9dc6-7fe0abb61fb4)) + - #### Bowel + - no enema as ((6713e2e8-bb08-4826-97c8-153f39bfdc19)) + - #### Rest and ambulation + - Can walk if membranes are intact + - prevents venacaval compression + - Encourages descent of the head + - Ambulation + - ((6713e3b8-15d7-4c90-9918-7da556ed9934)) + - reduces ((6713e3ca-8a35-4306-a52c-69b9af35bdd5)) + - ((6713e3d9-944e-4c39-a881-b565ab0d2a2b)) + - Will take bed rest, if ((6713e3fd-bcc4-466d-a4cb-28139a94dc48)) + - #### Diet + - Solid food is delayed for risk of aspiration following general anesthesia when needed unexpectedly ((6713e47a-1b9b-4d86-a624-7909f91bd9da)) + - Fluids + - Plain water + - Ice chips + - Fruit Juice + - Intravenous Fluid with Ringer's Solution ((6713e4dd-b61e-46a0-9844-d64482c11adf)) + - #### Bladder care + - Frequent urination advice as there is active fluid intake... ((6713e57d-a213-4da1-915c-c7168aabf1f8)) + - if bed-ridden, bed-pan + - if late-first stage then, urinary catheterization + - #### Relief of pain + - [[Pethidine]], 50-100 mg IM ([[Metoclopramide]] 10 mg IM is for combating vomiting) + - ((6713e6ae-53ff-4394-8f5d-b4b76c3f364b)) + - #### Assessment of progress of labor and partograph recording + - Pulse + every:: 30 minutes + symbol:: dot(.) + - Blood Pressure + every:: 1 hour + symbol:: arrows(↑↓) + - Temperature + every:: 2 hours + - Urine Output + - Volume + - Protien + - Acetone + - Drug + - Abdominal palpation + - Uterine contractions + - number of contrations in 10 minutes duration + - each contractions in seconds + - ((6713e8d5-96d6-40a0-9393-ad5a16136ceb)) + - Pelvic grip + - Station, expressed in fifths + - Shifting of the maximal intensity of the fetal heart beat downward and medially + - #### To note the fetal well being + - Fetal Heart Rate along with its rhythm and intesity should be noted every half hour + - ((6713eb49-9d06-4942-a1ee-a75467adb250)) + - #### Vaginal examination + - Dilation of the cervix (cm vs hrs) + - Position of the head and degree of flexion + - Station of the head + - Color of the liquor + - Degree of molding of the head + - Caput formation +- # Stage Two of Labor + + duration-primigravida:: 2 hours + duration-multiparae:: 30 minutes + start-event:: ((6711ec53-8dd0-47dc-811d-012d2c2ec744)) + end-event:: expulsion of the fetus from the birth canal + - #definition Full dilation to delivery of fetus + - ## Events #obs-prof-written #unanswered + - ## Causes of Delay #obs-prof-written #unanswered + - ## Management #obspw + - ### Principle + collapsed:: true + - ((671499fd-6751-4332-9b99-3ef50bc95c2b)) + logseq.order-list-type:: number + - ((67149a0f-a783-42e2-8a3d-26a9562389be)) + logseq.order-list-type:: number + - General Measures + collapsed:: true + - in bed + - constant supervision and the FHR recorded every 5 minutes + - inhalational analgesics, $$\ce{N2O}$$ and $$\ce{O2}$$ to relive pain during contractions + - Vaginal examination + - confirm onset + logseq.order-list-type:: number + - detect accidental prolapse + logseq.order-list-type:: number + - ((67149b3a-a6bd-4f97-8e41-393564bd0b0f)) + logseq.order-list-type:: number +- # Stage Three of Labor + + duration:: 15 minutes + start-event:: expulsion of the fetus from the birth canal + end-event:: expulsion of the placenta and membranes (afterbirths) + - #definition Delivery of fetus to delivery of placenta + - ### Complications #obspw #obspc + - Postpartum hemorrhage + logseq.order-list-type:: number + - Retention of placenta + logseq.order-list-type:: number + - Shock - hemorrhagic or nonhemorrhagic + logseq.order-list-type:: number + - Pulmonary embolism either by amniotic fluid or by air + logseq.order-list-type:: number + - Uterine inversion + logseq.order-list-type:: number + rare:: rare + - ## Management #obs-prof-written #unanswered +- # Stage Four of Labor + id:: 67120339-884f-4956-b117-a92e2dcdbc38 + duration:: 1 hour + - #definition The hour following delivery + - Things to Observe + - Vitals + - Pulse + - BP + - Anemia + - Abdominal Examination + - Height of Uterus + - Uterine Contraction + - Bladder Examination + - Per-vaginal Examination + - Check for per-vaginal bleeding \ No newline at end of file diff --git a/logseq/bak/pages/Stillbirth/2024-12-10T17_34_46.308Z.Desktop.md b/logseq/bak/pages/Stillbirth/2024-12-10T17_34_46.308Z.Desktop.md new file mode 100644 index 0000000..63516f7 --- /dev/null +++ b/logseq/bak/pages/Stillbirth/2024-12-10T17_34_46.308Z.Desktop.md @@ -0,0 +1,12 @@ +- #definition A stillbirth is the birht of a newborn after 28th completred week (weighing 1000 g or more) when the baby does not breathe or show any sign of life after delivery. #obspc +- # Causes #obspc + - Birth asphyxia and trauma + logseq.order-list-type:: number + - Pregnancy complications ([[Abruptio Placentae]], [[Pre-Eclampsia]], [[Diabetes Mellitus]] ) + logseq.order-list-type:: number + - Fetal Congenital Anomalies + logseq.order-list-type:: number + - Chromosomal Anomalies + logseq.order-list-type:: number + - Infection + logseq.order-list-type:: number \ No newline at end of file diff --git a/logseq/bak/pages/Stridor/2024-12-10T15_30_39.471Z.Desktop.md b/logseq/bak/pages/Stridor/2024-12-10T15_30_39.471Z.Desktop.md new file mode 100644 index 0000000..e3f72ce --- /dev/null +++ b/logseq/bak/pages/Stridor/2024-12-10T15_30_39.471Z.Desktop.md @@ -0,0 +1,19 @@ +tags:: #Signs + +- #definition {{c1 }} #ent-prof-card #ent-prof-written #unanswered #card + id:: 6756b3b2-dc1f-4fe6-8ec0-16f71c98fa2a + deck:: #ENT +- # Causes #ent-prof-card #ent-prof-written #unanswered #card + id:: 6756b3bf-1f1a-4151-a1a2-dee3068c5861 + deck:: #ENT + - In Children +- # Investigation #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6758149f-ebc1-44f7-a02d-70f044729e25 +- # Management #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675814a7-b326-4e67-ac7d-be0491e1cb78 +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6756bba6-f30d-4b1a-9c28-e005696fde64 +- \ No newline at end of file diff --git a/logseq/bak/pages/Thryroglossal Duct/2024-12-10T15_30_39.449Z.Desktop.md b/logseq/bak/pages/Thryroglossal Duct/2024-12-10T15_30_39.449Z.Desktop.md new file mode 100644 index 0000000..9a16dc4 --- /dev/null +++ b/logseq/bak/pages/Thryroglossal Duct/2024-12-10T15_30_39.449Z.Desktop.md @@ -0,0 +1,72 @@ +- alias:: + ICD-11_Code:: + tags:: #Disease +- ## Etiology + background-color:: blue + - ### Causative Agents + - ### Risk Factors +- ## Epidemiology + background-color:: blue + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution +- ## Pathophysiology + background-color:: blue + - ### Mechanism of Disease + - ### Affected Systems/Organs +- ## Clinical Features + background-color:: blue + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria +- ## Diagnosis + background-color:: blue + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis +- ## Management and Treatment + background-color:: blue + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up +- ## Prognosis + background-color:: blue + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations +- ## Prevention + background-color:: blue + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications +- ## Patient Education and Support + background-color:: blue + - ### Educational Resources + - ### Support Groups + - ### Counseling Options +- ## Recent Research and Developments + background-color:: blue + - ### Ongoing Clinical Trials + - ### Recent Advances +- ## Key Literature + background-color:: blue +- ## Guidelines and Protocols + background-color:: blue +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 675816dc-76d2-4cef-a2ca-1e3160849887 \ No newline at end of file diff --git a/logseq/bak/pages/Tongue Ulcer/2024-12-10T15_30_39.525Z.Desktop.md b/logseq/bak/pages/Tongue Ulcer/2024-12-10T15_30_39.525Z.Desktop.md new file mode 100644 index 0000000..be754b4 --- /dev/null +++ b/logseq/bak/pages/Tongue Ulcer/2024-12-10T15_30_39.525Z.Desktop.md @@ -0,0 +1,3 @@ +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67581046-5be0-4710-b623-401ccef414af \ No newline at end of file diff --git a/logseq/bak/pages/Tracheostomy/2024-12-10T15_30_39.482Z.Desktop.md b/logseq/bak/pages/Tracheostomy/2024-12-10T15_30_39.482Z.Desktop.md new file mode 100644 index 0000000..cb06bd8 --- /dev/null +++ b/logseq/bak/pages/Tracheostomy/2024-12-10T15_30_39.482Z.Desktop.md @@ -0,0 +1,28 @@ +tags:: #[[Surgical Procedure]] + +- #definition {{c1 }} #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67581722-3531-4104-91ab-73d32249f47e +- # Aims/Objectives(How Does Tracheostomy Help a Patient) #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6758172e-58d0-45bc-8d78-d13fcc61e306 +- # Indication #ent-prof-card #ent-prof-written #unanswered #card + id:: 6756bb4f-9e5d-4db1-b83a-a512bcc575d2 + deck:: #ENT +- # Steps of Tracheostomy #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756cf31-a107-4987-b45a-1438ce2609fa +- # Types #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756cf31-bd80-4513-9079-4aa7d90d28c7 +- # Complications #ent-prof-card #ent-prof-written #unanswered #card + id:: 6756cf31-13c8-4242-aff7-89c661a83299 + deck:: #ENT + - peroperative + - Postoperative +- # Postoperative Care of a Tracheostomized Patient #ent-prof-card #ent-prof-written #unanswered #card + id:: 6756cf31-300d-4849-9162-7cfa687f441a + deck:: #ENT +- SN: Emergency Tracheostomy/Tracheostomy #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67581832-6df8-4455-9370-c9197f2c9a91 \ No newline at end of file diff --git a/logseq/bak/pages/Twin Pregnancy/2024-12-10T17_34_46.310Z.Desktop.md b/logseq/bak/pages/Twin Pregnancy/2024-12-10T17_34_46.310Z.Desktop.md new file mode 100644 index 0000000..82cc777 --- /dev/null +++ b/logseq/bak/pages/Twin Pregnancy/2024-12-10T17_34_46.310Z.Desktop.md @@ -0,0 +1,35 @@ +- Antenatal Complications of Twin Pregnancy #obspc + - ## Maternal + - During Pregnancy + - Nausea and vomiting + - Anemia + - Preeclampsia (25%) + - Hydramnios (10%) + - Antepartum hemorrhage + - Malpresentation + - Preterm Labor(50%) + - Mechanical distress increased compared to a singleton pregnancy + - Palpitation + - Dyspnea + - Varicosities and hemorrhoids + - During Labor + - Early rupture of the membranes and cord prolapse + - Prolonged labor + - Increased operative interference + - Bleeding (intrapartum) + - Postpartum hemorrhage is the real danger + - During Peurperium + - There is increased incidence of + - Subinvolution - because of bigger size of the uterus + - Infection because of increased operative interference, preexisting anemia and blood loss during delivery + - Lactation failure - this is minimized by reassurance and giving her additional support + - ## Fetal + - Miscarriage rate is increased especially with monozygotic twins + - Premature rate (80%) + - Discordant twin growth (25%) + - Intrauterine death of one fetus + - Appearing twin + - Fetal anomalies are increased by 2-4% + - Asphyxia and childbirth are more common +- Delivery of Second baby of twin pregnancy + - \ No newline at end of file diff --git a/logseq/bak/pages/Tympanoplasty/2024-12-10T15_30_39.506Z.Desktop.md b/logseq/bak/pages/Tympanoplasty/2024-12-10T15_30_39.506Z.Desktop.md new file mode 100644 index 0000000..d25893e --- /dev/null +++ b/logseq/bak/pages/Tympanoplasty/2024-12-10T15_30_39.506Z.Desktop.md @@ -0,0 +1,3 @@ +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580594-4015-4ff4-a19b-d09f07eec7b6 \ No newline at end of file diff --git a/logseq/bak/pages/Uterus/2024-12-10T17_34_38.488Z.Desktop.md b/logseq/bak/pages/Uterus/2024-12-10T17_34_38.488Z.Desktop.md new file mode 100644 index 0000000..1b20355 --- /dev/null +++ b/logseq/bak/pages/Uterus/2024-12-10T17_34_38.488Z.Desktop.md @@ -0,0 +1,31 @@ +# Measurements + - length : 7.5 cm + - fundus & body : 5 cm + - cervix : 2.5 cm + - length of uterine cavity : 6 cm + - maximum breadth at fundus : 5 cm + - thickness : 2.5 cm + - weight : 30-40 gm +- # Parts #obspw + - Fundus of the uterus + - Isthmus of the uterus + - Cornu of uterus + - Body of the uterus + - Uterine Cavity + - continuous to uterine tube + - communicated below with the cervix + - Surface + - Anterior Surface + - Posterior Surface + - Two lateral borders + - Cervix of the Uterus + - Internal Os + - External Os + - Layers + - Endometrium + - Myometrium + - Perimetrius +- # Support #obspw + - |Primary|Secondary| + |--|--| + |Ligaments[:br]- transverse cervical ligaments[:br]- Round ligaments of uterus[:br]- Uterosacral ligaments[:br]- Pubocervical ligamentts[:br]Muscular[:br]- Pelvic diaphragm[:br]- Perineal Body[:br]- Urogenital Diaphragm[:br]Visceral[:br]- Urinary Bladder[:br]- Rectum|Broad Ligaments[:br]Uterocesical fold of peritoneum[:br]Rectovaginal folds of peritoneum| \ No newline at end of file diff --git a/logseq/bak/pages/Waldeyer's Ring/2024-12-10T15_30_39.504Z.Desktop.md b/logseq/bak/pages/Waldeyer's Ring/2024-12-10T15_30_39.504Z.Desktop.md new file mode 100644 index 0000000..7b2b6b7 --- /dev/null +++ b/logseq/bak/pages/Waldeyer's Ring/2024-12-10T15_30_39.504Z.Desktop.md @@ -0,0 +1,15 @@ +- #definition {{c1 }} #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580d87-ed89-4539-82ed-0b47c85244d5 +- # Drawing and Labelling Waldeyer's Ring #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580d9f-480e-4481-acdc-2ed55842109c +- # Constituents #ent-prof-card #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6756ad91-2397-4f01-93af-db93973ee577 +- # Clinical Importance #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756cf30-0c4d-4a7d-b90c-8ed2e058783f +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580db4-8ec4-4061-a7fc-d56c2d831c7a \ No newline at end of file diff --git a/logseq/bak/pages/White Patches on the tonsil/2024-12-10T15_30_39.096Z.Desktop.md b/logseq/bak/pages/White Patches on the tonsil/2024-12-10T15_30_39.096Z.Desktop.md new file mode 100644 index 0000000..de39cc3 --- /dev/null +++ b/logseq/bak/pages/White Patches on the tonsil/2024-12-10T15_30_39.096Z.Desktop.md @@ -0,0 +1,8 @@ +tags:: #Signs + +- # Differential Diagnosis #ent-prof-card #unanswered #ent-prof-written #card + deck:: #ENT + id:: 6756b1ae-51e0-4ba9-9220-dc162ef3b54e +- SN: #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580f8a-746d-4c4f-9cfb-9db49c65b8a1 \ No newline at end of file diff --git a/logseq/bak/pages/mydriasis/2024-12-10T15_30_39.486Z.Desktop.md b/logseq/bak/pages/mydriasis/2024-12-10T15_30_39.486Z.Desktop.md new file mode 100644 index 0000000..e5718e6 --- /dev/null +++ b/logseq/bak/pages/mydriasis/2024-12-10T15_30_39.486Z.Desktop.md @@ -0,0 +1,5 @@ +contrast:: [[Cycloplegia]] + +- # Causes #eye-prof-written +- # Differentiation from [[Cycloplegia]] +- SN: #eye-prof-written \ No newline at end of file diff --git a/logseq/bak/pages/oligohydramnios/2024-12-10T17_34_46.307Z.Desktop.md b/logseq/bak/pages/oligohydramnios/2024-12-10T17_34_46.307Z.Desktop.md new file mode 100644 index 0000000..8750513 --- /dev/null +++ b/logseq/bak/pages/oligohydramnios/2024-12-10T17_34_46.307Z.Desktop.md @@ -0,0 +1,12 @@ +- #definition Where the liquor amnii is deficient in amount to the extent of less than 200 mL at term. Sonographically, it is defined when the maximum vertical pocket of liquir is less than >2cm or when amniotic fluid index(AFI) is less than 5 cm (less than 5 percentile) #obspc +- # Maternal Causes of Oligohydramnios #obspc + - Hypertensive Disorders + - Uteroplacental insufficiency + - Dehydration + - Idiopathic +- # Diagnosis of Oligohydramnios #obspc + - Uterine size is much smaller than the period of amenorrhea + - Less fetal movements + - The uterus is "full of fetus" because of scanty liquor + - Malpresentation (breech) is common + - Evidences of intrauterine growth retardation of the fetus \ No newline at end of file diff --git a/pages/Abruptio Placentae.md b/pages/Abruptio Placentae.md index e74e427..23e6ef1 100644 --- a/pages/Abruptio Placentae.md +++ b/pages/Abruptio Placentae.md @@ -31,7 +31,7 @@ - Fetal Heart Sound absent in concealed type - ### Stages or Classification - ### Diagnostic Criteria -- ## Diagnosis #obspw #unanswered +- ## Diagnosis #obs-prof-written #unanswered background-color:: blue - ### Clinical Diagnosis #obGyn-prof-OSPE - Lower abdominal pain @@ -45,7 +45,7 @@ - ### Imaging Studies - [[Abdominal Ultrasonography]] : Placenta in upper segment - ### Differential Diagnosis -- ## Management and Treatment #obspw #unanswered #obGyn-prof-OSPE +- ## Management and Treatment #obs-prof-written #unanswered #obGyn-prof-OSPE background-color:: blue - Bishop's scoring - If cervix favourable @@ -64,7 +64,7 @@ - #### With Treatment - #### Without Treatment - ### Quality of Life Considerations -- ## Complications #obspw #unanswered +- ## Complications #obs-prof-written #unanswered background-color:: blue - ### Possible Complications #obGyn-prof-OSPE - Acute Renal Failure diff --git a/pages/Absolute Bone Conduction Test.md b/pages/Absolute Bone Conduction Test.md index 9410028..2786e22 100644 --- a/pages/Absolute Bone Conduction Test.md +++ b/pages/Absolute Bone Conduction Test.md @@ -1,3 +1,3 @@ -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 6758027c-89e4-4a7e-845d-641b9d65bb18 \ No newline at end of file + id:: 6758027c-89e4-4a7e-845d-641b9d65bb18 diff --git a/pages/Accidental Hemorrhage.md b/pages/Accidental Hemorrhage.md index 38f8d42..a5339d0 100644 --- a/pages/Accidental Hemorrhage.md +++ b/pages/Accidental Hemorrhage.md @@ -1 +1 @@ -# Steps of Management of Accidental Haemorrhage at 36 weeks of pregnancy #obspw #unanswered #confusion (same as [[APH]] ? ) \ No newline at end of file +# Steps of Management of Accidental Haemorrhage at 36 weeks of pregnancy #obs-prof-written #unanswered #confusion (same as [[APH]] ? ) diff --git a/pages/Accomodation.md b/pages/Accomodation.md index 87f21ec..baa8a85 100644 --- a/pages/Accomodation.md +++ b/pages/Accomodation.md @@ -1,3 +1,5 @@ # Mechanism of Accomodation #eye-prof-written + Changes or events occur during accommodation -- SN: #eye-prof-written \ No newline at end of file + +- #SN Short Note #eye-prof-written diff --git a/pages/Achalasia Cardia.md b/pages/Achalasia Cardia.md index 6aa03fd..844d875 100644 --- a/pages/Achalasia Cardia.md +++ b/pages/Achalasia Cardia.md @@ -5,74 +5,74 @@ background-color:: blue deck:: #ENT id:: 36de9f45-68c5-4331-8e37-c3daf391bb23 - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: 52c64503-bf27-4d6a-8474-e752eb17a295 - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis - ## Management and Treatment #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: 2d2ff087-298c-43ec-a324-fce7ddfa9dfa - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 675813a2-a798-47ba-bba1-392a69a7cf38 \ No newline at end of file + id:: 675813a2-a798-47ba-bba1-392a69a7cf38 diff --git a/pages/Acute Dacrocystitis.md b/pages/Acute Dacrocystitis.md index b2faf51..a015cd8 100644 --- a/pages/Acute Dacrocystitis.md +++ b/pages/Acute Dacrocystitis.md @@ -101,4 +101,4 @@ background-color:: blue - ## Guidelines and Protocols background-color:: blue -- SN: #eye-prof-written +- #SN Short Note #eye-prof-written diff --git a/pages/Acute Epiglottitis.md b/pages/Acute Epiglottitis.md index 4bff9a1..81abcc4 100644 --- a/pages/Acute Epiglottitis.md +++ b/pages/Acute Epiglottitis.md @@ -5,78 +5,78 @@ background-color:: blue deck:: #ENT id:: 679efe77-ff1d-4c8d-888c-abb551b9ada2 - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: 594754be-5664-46ab-8213-ccbed28261b5 - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - [[Acute Laryngotracheobronchitis]] - - Differences #ent-prof-card #unanswered #card - deck:: #ENT - id:: 6756b395-74e9-4b44-83bd-651dc5aeded1 - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - [[Acute Laryngotracheobronchitis]] + - Differences #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756b395-74e9-4b44-83bd-651dc5aeded1 + - ### Confirmation of Diagnosis - ## Management and Treatment #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: 4ef3c41d-da98-42b2-ae51-71ddb4f116d4 - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 67580fed-6ad9-45f9-9c83-6b554715552c \ No newline at end of file + id:: 67580fed-6ad9-45f9-9c83-6b554715552c diff --git a/pages/Acute Mastoiditis.md b/pages/Acute Mastoiditis.md index 586adc9..f271aa9 100644 --- a/pages/Acute Mastoiditis.md +++ b/pages/Acute Mastoiditis.md @@ -3,78 +3,78 @@ tags:: #Disease - ## Etiology background-color:: blue - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features #ent-prof-written #unanswered #card background-color:: blue deck:: #ENT id:: ccd50f0e-f676-42f1-b879-d7518c4828c3 - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - [[Furunculosis]] - - Differences #ent-prof-card #unanswered #card - deck:: #ENT - id:: 6756bf74-1837-4386-b65d-01fd1761851d - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - [[Furunculosis]] + - Differences #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756bf74-1837-4386-b65d-01fd1761851d + - ### Confirmation of Diagnosis - ## Management and Treatment #ent-prof-written #unanswered #card background-color:: blue deck:: #ENT id:: e90e31bf-d0f0-4ba7-ba3a-9c39398d3eb5 - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 6757ffdb-17b0-4334-81bf-65dedfdc9354 \ No newline at end of file + id:: 6757ffdb-17b0-4334-81bf-65dedfdc9354 diff --git a/pages/Acute Maxillary Sinusitis.md b/pages/Acute Maxillary Sinusitis.md index 77607b7..900fecf 100644 --- a/pages/Acute Maxillary Sinusitis.md +++ b/pages/Acute Maxillary Sinusitis.md @@ -5,76 +5,76 @@ background-color:: blue deck:: #ENT id:: 3fae41d5-d42b-4c21-9e86-58cedddcc339 - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue id:: 00ed145a-4123-46b2-8747-008133352fc0 deck:: #ENT - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis - ## Management and Treatment #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: e0e6c817-331f-4915-8c21-e69e459165b0 - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Complications #ent-prof-card #ent-prof-written #unanswered #card - id:: 481a1175-c18c-4f1f-9336-7f2707e71ffd - deck:: #ENT - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Complications #ent-prof-card #ent-prof-written #unanswered #card + id:: 481a1175-c18c-4f1f-9336-7f2707e71ffd + deck:: #ENT + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 67580b82-e50f-4cde-a16e-f7d4b1436be9 \ No newline at end of file + id:: 67580b82-e50f-4cde-a16e-f7d4b1436be9 diff --git a/pages/Acute Retropharyngeal Abscess.md b/pages/Acute Retropharyngeal Abscess.md index 92f05f5..fbf685a 100644 --- a/pages/Acute Retropharyngeal Abscess.md +++ b/pages/Acute Retropharyngeal Abscess.md @@ -6,86 +6,86 @@ id:: 675810f9-674c-4fbc-b426-cfaf80f94596 - ## Etiology background-color:: blue - - ### Causative Agents #ent-prof-written #unanswered #card - deck:: #ENT - id:: 25b9a42f-a66c-4373-9430-b840179b9c7e - - ### Risk Factors + - ### Causative Agents #ent-prof-written #unanswered #card + deck:: #ENT + id:: 25b9a42f-a66c-4373-9430-b840179b9c7e + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue id:: 27392bbe-50d1-4650-837d-dccf4f455d4f deck:: #ENT - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Investigation #ent-prof-card #unanswered #card - deck:: #ENT - id:: 6756b61f-4520-49bf-a222-e8244026dcf1 - - ### Typical Radiological Features #ent-prof-written #unanswered #card - deck:: #ENT - id:: 67581125-937a-4643-916e-2a9d4f1d223a - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - [[Chronic Retropharyngeal Abscess]] - - Differences #ent-prof-card #unanswered #card - deck:: #ENT - id:: 6756ae63-85c1-4975-92c6-81bccebb2bfb - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Investigation #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756b61f-4520-49bf-a222-e8244026dcf1 + - ### Typical Radiological Features #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67581125-937a-4643-916e-2a9d4f1d223a + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - [[Chronic Retropharyngeal Abscess]] + - Differences #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756ae63-85c1-4975-92c6-81bccebb2bfb + - ### Confirmation of Diagnosis - ## Management and Treatment #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue id:: 32ecf5df-62d9-4669-bf18-94d0b5189c9d deck:: #ENT - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 6758116b-0463-45d8-b849-9d0a266d1fe1 \ No newline at end of file + id:: 6758116b-0463-45d8-b849-9d0a266d1fe1 diff --git a/pages/Acute Suppurative Otitis Media.md b/pages/Acute Suppurative Otitis Media.md index 3cb9aba..b88b763 100644 --- a/pages/Acute Suppurative Otitis Media.md +++ b/pages/Acute Suppurative Otitis Media.md @@ -2,12 +2,20 @@ alias:: ASOM ICD-11_Code:: tags:: #Disease -- ## Etiology #ent-prof-card #unanswered #card +- ## Etiology #ent-prof-card #[[Middle Ear]] #card background-color:: blue - deck:: #ENT id:: 6756cf32-3a7b-41ed-8fea-a0f681ae9e7d + deck:: #ENT - ### Causative Agents + - *S. beta haemolyticus* + - *S. pneumonia* + - *S. aureus* + - *H. influenza* - ### Risk Factors + - Age: Infants & Child + - Poor Socio-economic status + - Recurrent attacks of common cold + - Infections of tonsils and adenoid - ## Epidemiology background-color:: blue - ### Incidence @@ -23,20 +31,30 @@ tags:: #Disease deck:: #ENT id:: 6757fa48-ff98-449d-a3ed-3ba27e8a7f71 - ### Affected Systems/Organs -- ## Clinical Features #ent-prof-card #ent-prof-written #unanswered #card +- ## Clinical Features #ent-prof-card #ent-prof-written #[[Middle Ear]] #card background-color:: blue id:: a75925d6-4e7c-4bb5-b330-4c6e4c33c818 deck:: #ENT - ### Signs and Symptoms - #### Symptoms - - #### Signs + - Severe Earache + - Conductive Deafness + - Otorrhea + - Fever - ### Stages or Classification - - ### Diagnostic Criteria + - Total occlusion + - Presuppuration + - Suppuration + - Resolution + - Complications - ## Diagnosis background-color:: blue - ### Clinical Diagnosis - #### Classical Presentation - #### Probable Diagnosis + - ### Auroscopic Examination + - [[Tympanic Membrane]] congested + - Handle of Malleus Prominent - ### Laboratory Tests - ### Imaging Studies - ### Differential Diagnosis @@ -57,12 +75,14 @@ tags:: #Disease - ### Expected Course - #### With Treatment - #### Without Treatment - - ##### Complications #ent-prof-card #unanswered #card - deck:: #ENT + - ##### Complications/Sequel #ent-prof-card #[[Middle Ear]] #card id:: 06d1b4e7-12da-40c3-9f32-d0f47a801483 - - ##### Sequel #ent-prof-card #unanswered #card deck:: #ENT - id:: 6756cf32-6112-4fa1-81f0-3f85ea01f0ab + - [[Acute Mastoiditis]] with abscess + - Facial paralysis + - Intracranial Complication + - Labyrinthitis + - [[CSOM]] - ### Survival Rates - #### With Treatment - #### Without Treatment diff --git a/pages/Adenoidectomy.md b/pages/Adenoidectomy.md index 61c679c..2c1a959 100644 --- a/pages/Adenoidectomy.md +++ b/pages/Adenoidectomy.md @@ -2,7 +2,8 @@ deck:: #ENT id:: 6756b20d-4737-4be6-a805-51d67da83b14 + - # Postoperative Complications of Adenoidectomy #ent-prof-card #unanswered #card id:: 6756b219-4c90-4cd6-9ad0-94a78e34ae37 deck:: #ENT -- SN: Important complications of adenoid operation \ No newline at end of file +- #SN Short Note Important complications of adenoid operation diff --git a/pages/Allergic Rhinitis.md b/pages/Allergic Rhinitis.md index 896076a..b0cb741 100644 --- a/pages/Allergic Rhinitis.md +++ b/pages/Allergic Rhinitis.md @@ -4,76 +4,76 @@ tags:: #Disease - ## Etiology background-color:: blue - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue id:: b1a89f71-c40c-4f6d-b9b5-94bd9c0b80de deck:: #ENT - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis - ## Management and Treatment #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: 72e3ee78-26ee-49d6-ab82-23fbaefdcc05 - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications #ent-prof-written #unanswered #card - deck:: #ENT - id:: 7d0d3a9a-d02d-4cf1-bd50-c786494f96a6 - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications #ent-prof-written #unanswered #card + deck:: #ENT + id:: 7d0d3a9a-d02d-4cf1-bd50-c786494f96a6 + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 67580ab5-3112-4ea5-a899-574a3677ebe8 \ No newline at end of file + id:: 67580ab5-3112-4ea5-a899-574a3677ebe8 diff --git a/pages/Antenatal Care.md b/pages/Antenatal Care.md index 41f7e20..3acf757 100644 --- a/pages/Antenatal Care.md +++ b/pages/Antenatal Care.md @@ -1,13 +1,17 @@ -- #definition ((6718c32e-2f09-4a4c-b3cc-e230529f73d7)) #obspw -- # Aims #obspw #obspc +- #definition ((6718c32e-2f09-4a4c-b3cc-e230529f73d7)) #obs-prof-written +- # Aims #obs-prof-written #obs-prof-card #card + deck:: #Obstetrics + id:: 67587bae-6aa5-4e6e-89fe-897f0d5474a0 - ((6718c381-a0b8-42a3-9a16-2264370f77ba)) -- # Objectives #obspw #obspc +- # Objectives #obs-prof-written #obs-prof-card #card + deck:: #Obstetrics + id:: 6733ccec-92e5-495e-8806-320d5e73b0d8 - ((6718c3a9-9064-49a4-828b-1f9d44e0a619)) -- # Advantages #obspw -- # Values #obspw +- # Advantages #obs-prof-written +- # Values #obs-prof-written - ((6718c46e-c6e0-47e2-a895-75bf57c0f610)) -- # WHO recommendation for antenatal visits #obspw -- # WHO antenatal visits #obspw +- # WHO recommendation for antenatal visits #obs-prof-written +- # WHO antenatal visits #obs-prof-written - Second Trimester, around 16 weeks logseq.order-list-type:: number - Between 24 and 28 weeks @@ -16,7 +20,7 @@ logseq.order-list-type:: number - 36 weeks logseq.order-list-type:: number -- # Information #obspw +- # Information #obs-prof-written - Complaints - History of Present Illness - Obstetric History @@ -26,7 +30,7 @@ - Past History - Family History - Personal History -- # Investigation #obspw +- # Investigation #obs-prof-written - Routine - Blood - Hemoglobin @@ -48,5 +52,5 @@ - Hemoglobin - Urine Protein - Random Blood Sugar -- # Investigations in Booking Visit #obspw -- # Dietary Advice to Pregnant mother #obspw \ No newline at end of file +- # Investigations in Booking Visit #obs-prof-written +- # Dietary Advice to Pregnant mother #obs-prof-written \ No newline at end of file diff --git a/pages/Antepartum Hemorrhage.md b/pages/Antepartum Hemorrhage.md index 75147f0..a7d2d97 100644 --- a/pages/Antepartum Hemorrhage.md +++ b/pages/Antepartum Hemorrhage.md @@ -1,23 +1,23 @@ -alias:: APH +alias:: APH source:: Chapter ((671a2f62-866e-4f30-a251-05c2686ade76)) of [[Dutta Obs]] -- #definition ((6719b1c0-b5eb-4f5e-b70e-13bc5a2d9efc)) #obspw #confusion might be 20th week -- # Etiology #obspw +- #definition ((6719b1c0-b5eb-4f5e-b70e-13bc5a2d9efc)) #obs-prof-written #confusion might be 20th week +- # Etiology #obs-prof-written alias:: Classification of Antepartum hemorrhage - - ((6719b208-4fdb-4f2d-8820-cc6beb8e32ed)) -- # Diagnosis #obspw + - ((6719b208-4fdb-4f2d-8820-cc6beb8e32ed)) +- # Diagnosis #obs-prof-written similar-to:: ((6718edc1-f69a-40e0-9826-ec8d0995a444)) - - Nature of Bleeding - - Painful/Painless - - Causeless/Association with Pre-eclampsia, Trauma - - Character of Blood - - Bright Red/Dark Colored - - General Condition and Anemia - - Proportionate/Disproportionate to the visible blood loss - - Abdominal Examination - - Height of Uterus : Proportionate/Disproportionate to gestational age - - Feel of Uterus : Soft, Relaxed / Tense, Tender and Rigid - - Malpresentation - - FHS : Present/Absent - - Placentography (USG) : Placenta in lower segment/ upper segment - - Vaginal Examination : Placenta is felt/ not felt on the lower segment \ No newline at end of file + - Nature of Bleeding + - Painful/Painless + - Causeless/Association with Pre-eclampsia, Trauma + - Character of Blood + - Bright Red/Dark Colored + - General Condition and Anemia + - Proportionate/Disproportionate to the visible blood loss + - Abdominal Examination + - Height of Uterus : Proportionate/Disproportionate to gestational age + - Feel of Uterus : Soft, Relaxed / Tense, Tender and Rigid + - Malpresentation + - FHS : Present/Absent + - Placentography (USG) : Placenta in lower segment/ upper segment + - Vaginal Examination : Placenta is felt/ not felt on the lower segment diff --git a/pages/Anticoantral Chronic Suppurative Otitis Media.md b/pages/Anticoantral Chronic Suppurative Otitis Media.md index ad01fcd..30d3852 100644 --- a/pages/Anticoantral Chronic Suppurative Otitis Media.md +++ b/pages/Anticoantral Chronic Suppurative Otitis Media.md @@ -1,7 +1,9 @@ -alias:: Anticoantral variety CSOM, Unsafe variety of CSOM +alias:: Anticoantral variety CSOM, Unsafe variety of CSOM, Cholesteoma ICD-11_Code:: tags:: #Disease +- #definition [[cholesteomata]]{{c1 Cholesteotoma is a sac/a pocket in the middle ear cleft lined by a keratinized squamous epithelium and contains desquamated sheets of keratin }} #ent-prof-card #ent-prof-written #unanswered #card + deck:: #ENT - ## Etiology background-color:: blue - ### Causative Agents @@ -14,16 +16,18 @@ tags:: #Disease - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease + - ### Mechanism of Disease #ent-prof-card #unanswered #card + deck:: #ENT - ### Affected Systems/Organs -- ## Clinical Features #ent-prof-written #unanswered #card +- ## Clinical Features #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue - deck:: #ENT id:: f8d47a95-8dcc-438b-b36a-e4d1e6108f8c + deck:: #ENT - ### Signs and Symptoms - #### Symptoms - #### Signs - - ### Stages or Classification + - ### Stages or Classification #ent-prof-written #unanswered #card + deck:: #ENT - ### Diagnostic Criteria - # Characteristics of Discharge #ent-prof-written #unanswered #card deck:: #ENT @@ -37,26 +41,46 @@ tags:: #Disease - ### Imaging Studies - ### Differential Diagnosis - ### Confirmation of Diagnosis -- ## Management and Treatment +- ## Management and Treatment #ent-prof-card #unanswered #card background-color:: blue - ### Medical Treatment + - Antibiotic ear drops: Gentamicin + - Systemic Antibiotics: Amoxicillin + - Nasal decongestants + - Antihistamine + - Analgesic - ### Surgical Options + - Modified Radical mastoidectomy with exploration + - Middle ear reconstruction by myringoplasty and ossiculoplasty - ### Lifestyle and Dietary Recommendations + - Keep water out of the ear + - Maintain aural hygine - ### Follow-up + - 14 days later + - - ## Prognosis background-color:: blue - ### Expected Course - #### With Treatment - #### Without Treatment - - ##### Possible Complications #ent-prof-written #unanswered #card - deck:: #ENT + - ##### Possible Complications #ent-prof-card #ent-prof-written #unanswered #card id:: c482bb3c-04fd-4000-9f1a-337441876d57 - - ##### Intracranial Complications #ent-prof-written #unanswered #card deck:: #ENT - id:: 686fe1fe-fdcf-416c-8dc1-6dc2ec404981 + - ##### Intracranial Complications + - Extradural abscess + - Subdural abscess + - Meningitis, Encephalitis + - Brain abscess + - Lateral sinus thromboplebitis + - Otitic Hydrocephalus + - ##### Extracranial Complications + - Mastoiditis + - Petrositis + - Facial Paralysis + - Labyrinthitis - ##### Management of any one intracranial complications of CSOM #ent-prof-written #unanswered #card - deck:: #ENT id:: 6757fe99-6247-41fd-aeaa-1a73068239ed + deck:: #ENT - ### Survival Rates - #### With Treatment - #### Without Treatment @@ -78,5 +102,5 @@ tags:: #Disease - ### Recent Advances - ## Key Literature background-color:: blue -- ## Guidelines and Protocols +- ## Guidelines and Protocol background-color:: blue \ No newline at end of file diff --git a/pages/Antral Washout.md b/pages/Antral Washout.md index ba93c2a..8e8eec9 100644 --- a/pages/Antral Washout.md +++ b/pages/Antral Washout.md @@ -9,6 +9,6 @@ tags:: #[[Surgical Procedure]] - # Complications #ent-prof-card #unanswered #card deck:: #ENT id:: 6756cf36-4a24-4d8f-b0ac-af31f3f3910a -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 67580d4c-b2a6-4647-beb0-c1eef96a0e33 \ No newline at end of file + id:: 67580d4c-b2a6-4647-beb0-c1eef96a0e33 diff --git a/pages/Aphakia.md b/pages/Aphakia.md index d2ca143..f7aa8c6 100644 --- a/pages/Aphakia.md +++ b/pages/Aphakia.md @@ -1,10 +1,10 @@ -- #definition {{c1 Literally aphakia means absence of normal crystalline lens from eyeball. +- #definition {{c1 Literally aphakia means absence of normal crystalline lens from eyeball. Optically aphakia means absence of crystalline lens from its normal position in the pupillary area}} #eye-prof-written #eye-prof-card #card deck:: #Eye id:: 675020e1-3f82-4221-8e24-a23c0882d8d0 -- SN: #eye-prof-written +- #SN Short Note #eye-prof-written - Methods of Treatment #eye-prof-written - # Pseudophakia - - #definition {{c1 In cataract surgery, human biological lens is removed and replaced by the artifical lens (IOL) by surgical procedure. This condition is known as pseudophakia.}} #eye-prof-card #card - deck:: #Eye - id:: 6755e1c9-22e9-4582-86bc-4872cfadc659 \ No newline at end of file + - #definition {{c1 In cataract surgery, human biological lens is removed and replaced by the artifical lens (IOL) by surgical procedure. This condition is known as pseudophakia.}} #eye-prof-card #card + deck:: #Eye + id:: 6755e1c9-22e9-4582-86bc-4872cfadc659 diff --git a/pages/Apyrexial Laryngeal Stridor.md b/pages/Apyrexial Laryngeal Stridor.md index 9a7b019..23b9b40 100644 --- a/pages/Apyrexial Laryngeal Stridor.md +++ b/pages/Apyrexial Laryngeal Stridor.md @@ -1,6 +1,8 @@ # Causes #ent-prof-written #unanswered #card + deck:: #ENT id:: 6758148e-0885-4892-8610-ef6d4e505cc2 -- SN: #ent-prof-written #unanswered #card + +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 67581496-e5de-445e-afb0-d985e3cfd6ac \ No newline at end of file + id:: 67581496-e5de-445e-afb0-d985e3cfd6ac diff --git a/pages/Atrophic Rhinitis.md b/pages/Atrophic Rhinitis.md index 8e24a55..4ecb169 100644 --- a/pages/Atrophic Rhinitis.md +++ b/pages/Atrophic Rhinitis.md @@ -6,76 +6,76 @@ id:: 675809f3-6032-49dc-a61b-75b648bb5f64 - ## Etiology background-color:: blue - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue id:: 076f87a1-3352-4223-ab92-057fa79dcb5c deck:: #ENT - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis - ## Management and Treatment #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue id:: 6c359ab4-206d-4b36-ac9e-9ccef443bae6 deck:: #ENT - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications #ent-prof-card #unanswered #card - deck:: #ENT - id:: cdac1bc9-1e05-45ba-8e84-2c8168f2a52c - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications #ent-prof-card #unanswered #card + deck:: #ENT + id:: cdac1bc9-1e05-45ba-8e84-2c8168f2a52c + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 67580a39-cf56-4b0f-aed8-c22d29d68144 \ No newline at end of file + id:: 67580a39-cf56-4b0f-aed8-c22d29d68144 diff --git a/pages/Atropine 1% Sulphate.md b/pages/Atropine 1% Sulphate.md index 1b873c7..522456e 100644 --- a/pages/Atropine 1% Sulphate.md +++ b/pages/Atropine 1% Sulphate.md @@ -1,9 +1,9 @@ alias:: Atropine eye drop -- SN: #eye-prof-written +- #SN Short Note #eye-prof-written - ((6733ccee-50d1-41fe-9e24-601c73096b43)) - # Indication #eye-prof-written - - [[Neovascular Glaucoma]] - >*Atropine is contraindicated for [[Glaucoma]] but indicated for [[Neovascular Glaucoma]] * + - [[Neovascular Glaucoma]] + > _Atropine is contraindicated for [[Glaucoma]] but indicated for [[Neovascular Glaucoma]] _ - # Contraindication #eye-prof-written - - [[Galucoma]] \ No newline at end of file + - [[Galucoma]] diff --git a/pages/Branchial Cyst.md b/pages/Branchial Cyst.md index 0397cc1..8c79b66 100644 --- a/pages/Branchial Cyst.md +++ b/pages/Branchial Cyst.md @@ -6,72 +6,72 @@ id:: 675816b7-9859-4bc6-bc3d-d746c1d1ad9d - ## Etiology background-color:: blue - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features background-color:: blue - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis - ## Management and Treatment #ent-prof-written #unanswered #card background-color:: blue deck:: #ENT id:: b0461cb4-85cd-4d1f-b38c-e0b364f85390 - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 675816cb-502e-4950-a501-eba182f53e6b \ No newline at end of file + id:: 675816cb-502e-4950-a501-eba182f53e6b diff --git a/pages/Breast Feeding.md b/pages/Breast Feeding.md index db3e4a9..e9c2413 100644 --- a/pages/Breast Feeding.md +++ b/pages/Breast Feeding.md @@ -1,9 +1,14 @@ # Exclusive Breast Feeding + alias:: EBF tags:: #Paediatrics - - #definition Exclusive Breast Feeding means giving the baby only breast milk (not even a drop of water or other foods) from birth till 6 months (180 days) of age. (newer definitions allow consumption of medicine) #pedi-prof-written + - #definition Exclusive Breast Feeding means giving the baby only breast milk (not even a drop of water or other foods) from birth till 6 months (180 days) of age. (newer definitions allow consumption of medicine) #pedi-prof-written #obs-prof-card #card + deck:: #Obstetrics + id:: 67587cd3-809e-4887-b692-340d02cdcb87 - # Benefits of Breast Feeding #pedi-prof-written - - ## Benefit to the New Born #obspc #pedi-prof-written + - ## Benefit to the New Born #pedi-prof-written #obs-prof-card #card + deck:: #Obstetrics + id:: 6733ccec-b532-47d5-a51c-1657898381da - Complete food, Species specific - Easily digested & well absorbed - Protects against infection @@ -21,8 +26,10 @@ tags:: #Paediatrics - Promotes family planning - Decreases need for hospitalization - Contributes to child survival -- # Positioning & Attachment #pedi-prof-written - - Proper Positioning means #obspc #pedi-prof-written +- # Positioning & Attachment #pedi-prof-written + - Proper Positioning means #pedi-prof-written #obs-prof-card #card + deck:: #Obstetrics + id:: 67587bb7-72aa-4e5b-8f38-745b60be57de - The body is fully supported logseq.order-list-type:: number - Body close to the mother @@ -31,12 +38,14 @@ tags:: #Paediatrics logseq.order-list-type:: number - Facing breast, nose opposite to the nipple logseq.order-list-type:: number - - Good attachment #obspc + - Good attachment #obs-prof-card #card + deck:: #Obstetrics + id:: 6733ccec-c3ce-4583-8ca2-56251e7a0fb3 - The baby's chin is touching the breast logseq.order-list-type:: number - The baby's mouth is openly widely logseq.order-list-type:: number - - The baby's lower lop is turned outwards + - The baby's lower lip is turned outwards logseq.order-list-type:: number - More areola is seen above than below logseq.order-list-type:: number diff --git a/pages/Caesarean Section.md b/pages/Caesarean Section.md index a2a582e..c93dd72 100644 --- a/pages/Caesarean Section.md +++ b/pages/Caesarean Section.md @@ -1,10 +1,10 @@ alias:: CS -- ## Absoulute Indication #obspc - - Absolutely Contracted Uterus - - [[Central Placenta Praevia]] - - Absolute Cephalopelvic Disproportion - - Obstructed Labor - - Transverse Lie - - Advanced carcinoma cervix - - [[Vesicovaginal Fistula Repair]] \ No newline at end of file +- ## Absoulute Indication #obs-prof-card + - Absolutely Contracted Uterus + - [[Central Placenta Praevia]] + - Absolute Cephalopelvic Disproportion + - Obstructed Labor + - Transverse Lie + - Advanced carcinoma cervix + - [[Vesicovaginal Fistula Repair]] diff --git a/pages/Carcinoma Larynx.md b/pages/Carcinoma Larynx.md index 97e1743..2e84115 100644 --- a/pages/Carcinoma Larynx.md +++ b/pages/Carcinoma Larynx.md @@ -3,81 +3,81 @@ tags:: #Disease - ## Etiology background-color:: blue - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features (Glottis Stage-I) #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue id:: e7ef8278-394b-4031-81a4-7ae527bf7f6f deck:: #ENT - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Investigation #ent-prof-card #unanswered #card - deck:: #ENT - id:: 6756ba70-7690-4493-9769-4bb8d8576e1b - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Investigation #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756ba70-7690-4493-9769-4bb8d8576e1b + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis - ## Management and Treatment(Glottis Stage-1) #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue id:: f47ebcf7-3ddd-490a-ba70-306d4b3239be deck:: #ENT - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ##### Release a case of airway obstruction due to Carcinoma Larynx #ent-prof-card #unanswered #card deck:: #ENT id:: 6756baf9-e01b-4bb0-8058-c9b6f7e146f1 - - [[Tracheostomy]] + - [[Tracheostomy]] - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 6758153c-60f5-4a53-ad56-171ae794ed64 \ No newline at end of file + id:: 6758153c-60f5-4a53-ad56-171ae794ed64 diff --git a/pages/Central Placenta Praevia.md b/pages/Central Placenta Praevia.md index d9be0a4..8f77705 100644 --- a/pages/Central Placenta Praevia.md +++ b/pages/Central Placenta Praevia.md @@ -2,10 +2,10 @@ id:: 671a12f1-f1de-46e7-9a10-3d678a1544fe alias:: Type-IV Placenta Previa, Total Placenta Previa tags:: #SN , -- #definition The placenta completely covers the internal os even after it is fully dilated #obspw -- SN: #obs-prof-written -- Complications #obspw #unanswered -- Management #obspw #unanswered - - Obstetric Management #obspw - question:: important steps to be taken at the time of delivery - - Mode of Delivery is [[Caesarean Section]] #obspw \ No newline at end of file +- #definition The placenta completely covers the internal os even after it is fully dilated #obs-prof-written +- #SN Short Note #obs-prof-written +- Complications #obs-prof-written #unanswered +- Management #obs-prof-written #unanswered + - Obstetric Management #obs-prof-written + question:: important steps to be taken at the time of delivery + - Mode of Delivery is [[Caesarean Section]] #obs-prof-written diff --git a/pages/Chalazion.md b/pages/Chalazion.md index e79ab61..ba51677 100644 --- a/pages/Chalazion.md +++ b/pages/Chalazion.md @@ -90,4 +90,4 @@ tags:: #Disease background-color:: blue - ## Guidelines and Protocols background-color:: blue -- SN: #eye-prof-written +- #SN Short Note #eye-prof-written diff --git a/pages/Chronic Retropharyngeal Abscess.md b/pages/Chronic Retropharyngeal Abscess.md index 54aaf53..b285464 100644 --- a/pages/Chronic Retropharyngeal Abscess.md +++ b/pages/Chronic Retropharyngeal Abscess.md @@ -3,77 +3,77 @@ tags:: #Disease - ## Etiology background-color:: blue - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: 25d8cef9-d646-4c62-a329-59dc6819cf92 - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Investigation #ent-prof-card #unanswered #card - deck:: #ENT - id:: 6756b622-96b5-44c0-8b11-0d31e5b0a86e - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Investigation #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756b622-96b5-44c0-8b11-0d31e5b0a86e + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis - ## Management and Treatment #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue id:: b74bd004-ee30-4dd4-abc5-fa18e986569f deck:: #ENT - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 6758118c-3559-4253-97b5-4b3a4592b1f5 \ No newline at end of file + id:: 6758118c-3559-4253-97b5-4b3a4592b1f5 diff --git a/pages/Chronic Suppurative Otitis Media.md b/pages/Chronic Suppurative Otitis Media.md index 3a0cf6a..a510a48 100644 --- a/pages/Chronic Suppurative Otitis Media.md +++ b/pages/Chronic Suppurative Otitis Media.md @@ -4,94 +4,94 @@ tags:: #Disease - ## Etiology background-color:: blue - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features background-color:: blue - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification #ent-prof-written #unanswered #card - deck:: #ENT - id:: e02ad0f3-b7ca-4c01-b24b-d23f02d1d618 - - [[Tubotympanic Chronic Suppurative Otitis Media]] - - [[Anticoantral Chronic Suppurative Otitis Media]] - - Differences between [[Tubotympanic variety CSOM]] and [[Anticoantral variety CSOM]] #ent-prof-card #unanswered #card - deck:: #ENT - id:: 6756c6d1-5755-4374-91b1-8f5ec4f8f6ef - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification #ent-prof-written #unanswered #card + deck:: #ENT + id:: e02ad0f3-b7ca-4c01-b24b-d23f02d1d618 + - [[Tubotympanic Chronic Suppurative Otitis Media]] + - [[Anticoantral Chronic Suppurative Otitis Media]] + - Differences between [[Tubotympanic variety CSOM]] and [[Anticoantral variety CSOM]] #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756c6d1-5755-4374-91b1-8f5ec4f8f6ef + - ### Diagnostic Criteria - ### Differences between CSOM safe variety from unsafe variety #ent-prof-written #unanswered #card deck:: #ENT id:: 6757fca8-097d-4e46-a639-851515f4c2f8 - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Investigation - - deck:: #ENT - id:: 6756bff6-4066-4836-ad06-539a7077b1ca - |Test|Interpretation| - |[[Rinne's Test]]|{{c1 }}| - |[[Weber Test]]|{{c2 }}| - #ent-prof-card #unanswered #card - deck:: #ENT - id:: 6756bff6-4066-4836-ad06-539a7077b1ca - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Investigation + - deck:: #ENT + id:: 6756bff6-4066-4836-ad06-539a7077b1ca + |Test|Interpretation| + |[[Rinne's Test]]|{{c1 }}| + |[[Weber Test]]|{{c2 }}| + #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756bff6-4066-4836-ad06-539a7077b1ca + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis - # Management of a safe variety of CSOM in dry Stage #ent-prof-written #unanswered #card deck:: #ENT id:: 6757fb4f-2585-4c30-90bc-5e207aac3091 - ## Management and Treatment background-color:: blue - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications #ent-prof-card #ent-prof-written #unanswered #card - id:: c93f1a22-c346-4a1e-9be1-67b2db2bca1c - deck:: #ENT - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications #ent-prof-card #ent-prof-written #unanswered #card + id:: c93f1a22-c346-4a1e-9be1-67b2db2bca1c + deck:: #ENT + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 6757fb69-04f9-42d1-b8e8-d8fb771044e9 \ No newline at end of file + id:: 6757fb69-04f9-42d1-b8e8-d8fb771044e9 diff --git a/pages/Cochlear Implant.md b/pages/Cochlear Implant.md index 156d858..c60a196 100644 --- a/pages/Cochlear Implant.md +++ b/pages/Cochlear Implant.md @@ -1,3 +1,3 @@ -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 67580122-f481-4e5c-af10-a58169662bac \ No newline at end of file + id:: 67580122-f481-4e5c-af10-a58169662bac diff --git a/pages/Deviated Nasal Septum.md b/pages/Deviated Nasal Septum.md index 38e3e36..30942a8 100644 --- a/pages/Deviated Nasal Septum.md +++ b/pages/Deviated Nasal Septum.md @@ -5,74 +5,74 @@ background-color:: blue deck:: #ENT id:: a12b2c41-66a3-47f3-955c-f74a8fd201f4 - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue id:: 54938744-188d-4ab1-aa09-32bef16d24a4 deck:: #ENT - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis - ## Management and Treatment #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: 79b6dbbe-38f6-4e65-98ab-4b95f3dade21 - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 6758081e-3bcc-4f03-8216-c0e7fccb3ecd \ No newline at end of file + id:: 6758081e-3bcc-4f03-8216-c0e7fccb3ecd diff --git a/pages/Eclampsia.md b/pages/Eclampsia.md index c3f9548..2c02500 100644 --- a/pages/Eclampsia.md +++ b/pages/Eclampsia.md @@ -3,7 +3,7 @@ source:: ((671a2fe1-638a-434d-895f-ddf00e3932c9)) [[Dutta Obs]] ICD-11_Code:: tags:: #Disease -- #definition [[Pre-Eclampsia]] when complicated with grand mal seizures (generalized tonic-clonic convulsions) and/or coma is called eclampsia #obspc +- #definition [[Pre-Eclampsia]] when complicated with grand mal seizures (generalized tonic-clonic convulsions) and/or coma is called eclampsia #obs-prof-card - ## Etiology background-color:: blue - ### Causative Agents @@ -23,7 +23,7 @@ tags:: #Disease - ### Signs and Symptoms - #### Symptoms - #### Signs - - ### Stages or Classification #obspc + - ### Stages or Classification #obs-prof-card collapsed:: true - # Premonitory Stage duration:: 30 seconds diff --git a/pages/Enlarged Adenoid.md b/pages/Enlarged Adenoid.md index 82a0ef1..03c43c9 100644 --- a/pages/Enlarged Adenoid.md +++ b/pages/Enlarged Adenoid.md @@ -8,76 +8,76 @@ alias:: Adenoid tags:: #Disease - ## Etiology background-color:: blue - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features #ent-prof-written #unanswered #card background-color:: blue deck:: #ENT id:: ebea0a07-c8e9-495a-bcf6-ed94e5f1e3a8 - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - # Clinical Features of Adenoid Facies #ent-prof-card #ent-prof-written #unanswered #card id:: 6756cf30-0e89-4438-8dbb-5f4e1ed28c63 deck:: #ENT - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Investigations #ent-prof-written #unanswered #card - deck:: #ENT - id:: 67580e87-164e-4437-9d0d-cc738924bf3c - - ### Differential Diagnosis - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Investigations #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67580e87-164e-4437-9d0d-cc738924bf3c + - ### Differential Diagnosis + - ### Confirmation of Diagnosis - # Correction/Treatment #ent-prof-card #ent-prof-written #unanswered #card id:: 6756cf30-222b-4dce-8e35-4a8fc615ffe1 deck:: #ENT - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - ((6756b219-4c90-4cd6-9ad0-94a78e34ae37)) - - #### Without Treatment - - ##### Consequences (in child) #ent-prof-card #unanswered #card - id:: 6756adaf-ec4b-4d1a-bee3-fc2360b0cd27 - deck:: #ENT - deck:: #ENT - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - ((6756b219-4c90-4cd6-9ad0-94a78e34ae37)) + - #### Without Treatment + - ##### Consequences (in child) #ent-prof-card #unanswered #card + id:: 6756adaf-ec4b-4d1a-bee3-fc2360b0cd27 + deck:: #ENT + deck:: #ENT + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 67580ebb-8cdb-4b69-b32d-1cc4df492e16 \ No newline at end of file + id:: 67580ebb-8cdb-4b69-b32d-1cc4df492e16 diff --git a/pages/Fallopian Tube.md b/pages/Fallopian Tube.md index a1b94b1..5249645 100644 --- a/pages/Fallopian Tube.md +++ b/pages/Fallopian Tube.md @@ -1,23 +1,23 @@ alias:: Uterine Tube, Oviduct -tags:: #obspw +tags:: #obs-prof-written length:: 10 cm long - Type of Organ : muscular tubular organ - # Parts - - Infundibulum - alias:: fimbriated end - - numerous projections at the abdominal end called fimriae - - longest fimbria is called : ovarian fimbriae - - Ampulla - length:: 5 cm - - most dilated part - - site for fertilization - - Isthmus - length:: 3 cm - - Intramural part - - within the musculature of the uterus + - Infundibulum + alias:: fimbriated end + - numerous projections at the abdominal end called fimriae + - longest fimbria is called : ovarian fimbriae + - Ampulla + length:: 5 cm + - most dilated part + - site for fertilization + - Isthmus + length:: 3 cm + - Intramural part + - within the musculature of the uterus - Two opening - - Abdominal Ostium - lies:: laterally - - Uterine Ostium - lies:: medially \ No newline at end of file + - Abdominal Ostium + lies:: laterally + - Uterine Ostium + lies:: medially diff --git a/pages/Foreign Body in Ear.md b/pages/Foreign Body in Ear.md index 5834468..26eaa62 100644 --- a/pages/Foreign Body in Ear.md +++ b/pages/Foreign Body in Ear.md @@ -1,53 +1,39 @@ -# Types #ent-prof-card #ent-prof-written #card #[[External Ear]] +# Types #ent-prof-card #ent-prof-written #card #[[External Ear]] + id:: 6756a934-1410-48f2-b1a9-99cdf6a75c0c -deck:: #ENT - - Nonliving - logseq.order-list-type:: number - - Children inserted - logseq.order-list-type:: number - - piece of paper or sponge - logseq.order-list-type:: number - - grain seeds (rice, wheat, maize) - logseq.order-list-type:: number - - slate pencil - logseq.order-list-type:: number - - piece of chalk or metallic ball bearings - logseq.order-list-type:: number - - Adults inserted - logseq.order-list-type:: number - - broken end of matchstick - logseq.order-list-type:: number - - overlooked cotton swab - logseq.order-list-type:: number - - Living - logseq.order-list-type:: number - - Flycing or crawling insects like - logseq.order-list-type:: number - - mosquitoes - logseq.order-list-type:: number - - beetles - logseq.order-list-type:: number - - cockroach - logseq.order-list-type:: number - - ant - logseq.order-list-type:: number - - maggots from flies - logseq.order-list-type:: number -- # Management of a case of Living Body in ear #ent-prof-card #ent-prof-written #card #[[External Ear]] +deck:: #ENT - Nonliving +logseq.order-list-type:: number - Children inserted +logseq.order-list-type:: number - piece of paper or sponge +logseq.order-list-type:: number - grain seeds (rice, wheat, maize) +logseq.order-list-type:: number - slate pencil +logseq.order-list-type:: number - piece of chalk or metallic ball bearings +logseq.order-list-type:: number - Adults inserted +logseq.order-list-type:: number - broken end of matchstick +logseq.order-list-type:: number - overlooked cotton swab +logseq.order-list-type:: number - Living +logseq.order-list-type:: number - Flycing or crawling insects like +logseq.order-list-type:: number - mosquitoes +logseq.order-list-type:: number - beetles +logseq.order-list-type:: number - cockroach +logseq.order-list-type:: number - ant +logseq.order-list-type:: number - maggots from flies +logseq.order-list-type:: number + +- # Management of a case of Living Body in ear #ent-prof-card #ent-prof-written #card #[[External Ear]] id:: 6756cf39-f53f-48c4-b651-e41c2953306b deck:: #ENT - - No attempt should be made to catch them alive - background-color:: pink - - Insect killed by - - oil (household remedy) - - spirit - - chloroform water - - Removed by - - Forceps removal - - Syrining - - Suction - - Microscopic removal with special instruments - - Postaural approach -- SN: #ent-prof-written #unanswered #card + - No attempt should be made to catch them alive + background-color:: pink + - Insect killed by + - oil (household remedy) + - spirit + - chloroform water + - Removed by + - Forceps removal + - Syrining + - Suction + - Microscopic removal with special instruments + - Postaural approach +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 6757f761-f508-45ac-86a6-33c2821188c7 \ No newline at end of file + id:: 6757f761-f508-45ac-86a6-33c2821188c7 diff --git a/pages/Foreign Body in Esophagus.md b/pages/Foreign Body in Esophagus.md index 644e9c3..78ab8fc 100644 --- a/pages/Foreign Body in Esophagus.md +++ b/pages/Foreign Body in Esophagus.md @@ -3,83 +3,83 @@ tags:: #Disease - ## Etiology background-color:: blue - - ## Common Foreign Bodies that may introduced in the Oesophagus #ent-prof-card #ent-prof-written #unanswered #card - id:: 6756b3d0-6307-466a-a856-af9b4a6ef67c - deck:: #ENT - - In oldage - - ## Where are the esophageal Foreign Body found commonly #ent-prof-written #unanswered #card - deck:: #ENT - id:: 67581348-bcd7-4fa6-bb26-526d2e32d786 - - ### Causative Agents - - ### Risk Factors + - ## Common Foreign Bodies that may introduced in the Oesophagus #ent-prof-card #ent-prof-written #unanswered #card + id:: 6756b3d0-6307-466a-a856-af9b4a6ef67c + deck:: #ENT + - In oldage + - ## Where are the esophageal Foreign Body found commonly #ent-prof-written #unanswered #card + deck:: #ENT + id:: 67581348-bcd7-4fa6-bb26-526d2e32d786 + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: fcaf4274-5a62-4051-bb53-6838993f76b1 - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis - ## Management and Treatment #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue id:: 6dfa3abe-e61f-4f44-bf88-55cc2d38780e deck:: #ENT - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications #ent-prof-written #unanswered #card - deck:: #ENT - id:: b42c502a-a704-4ce8-a75c-694ca18e15b0 - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications #ent-prof-written #unanswered #card + deck:: #ENT + id:: b42c502a-a704-4ce8-a75c-694ca18e15b0 + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 6758138c-9ac2-4045-89ea-9389dde02a04 \ No newline at end of file + id:: 6758138c-9ac2-4045-89ea-9389dde02a04 diff --git a/pages/Foreign Body in Nose.md b/pages/Foreign Body in Nose.md index 531ef3b..20f1277 100644 --- a/pages/Foreign Body in Nose.md +++ b/pages/Foreign Body in Nose.md @@ -3,77 +3,77 @@ tags:: #Disease - ## Etiology background-color:: blue - - ### Causative Agents - - ### Names of Foreign Bodies in Nose #ent-prof-card #unanswered #card - deck:: #ENT - id:: 6756c608-aef3-4c0d-a3a3-ecc8abd74751 - - ### Risk Factors + - ### Causative Agents + - ### Names of Foreign Bodies in Nose #ent-prof-card #unanswered #card + deck:: #ENT + id:: 6756c608-aef3-4c0d-a3a3-ecc8abd74751 + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: 2825038c-36a6-4d14-bc37-11cff7ba062a - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis - ## Management and Treatment #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: 75f55c1e-b022-41f2-864f-518b3d6e6db5 - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 67580948-5e8e-43cf-b726-b358427d9d85 \ No newline at end of file + id:: 67580948-5e8e-43cf-b726-b358427d9d85 diff --git a/pages/Functional Endoscopic Sinus Surgery.md b/pages/Functional Endoscopic Sinus Surgery.md index cfa2ace..4ccae7b 100644 --- a/pages/Functional Endoscopic Sinus Surgery.md +++ b/pages/Functional Endoscopic Sinus Surgery.md @@ -10,6 +10,6 @@ tags:: #[[Surgical Procedure]] - # Complications #ent-prof-card #ent-prof-written #unanswered #card id:: 6756cf38-c69d-4a54-ac79-21ddb2e7b4bf deck:: #ENT -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 67580d41-b5bd-436b-b1b2-a8d630eacf9a \ No newline at end of file + id:: 67580d41-b5bd-436b-b1b2-a8d630eacf9a diff --git a/pages/Furunculosis.md b/pages/Furunculosis.md index 712f7db..21ca9bb 100644 --- a/pages/Furunculosis.md +++ b/pages/Furunculosis.md @@ -2,7 +2,7 @@ alias:: Localized Acute Otitis Externa ICD-11_Code:: tags:: #Disease -- #definition {{c1 A furuncle is a staphylococcal infection of the hair follicle of the outer 1/3rd of the external ear}} #ent-prof-card #card #[[External Ear]] +- #definition {{c1 A furuncle is a staphylococcal infection of the hair follicle of the outer 1/3rd of the external ear(cartilagenous)}} #ent-prof-card #card #[[External Ear]] id:: 67579687-462c-4d72-a007-b7aabc820878 deck:: #ENT - ## Etiology @@ -32,6 +32,11 @@ tags:: #Disease id:: 4c306545-036f-47cd-920c-f0c4f03dc15c - ### Signs and Symptoms - #### Symptoms + - Severe Pain during movement. of pina + - Painful jaw movement + - Earache + - Blokage of Ear, Deafness + - Spread of Infection to Mastoid - #### Signs - ### Stages or Classification - ### Diagnostic Criteria @@ -49,7 +54,7 @@ tags:: #Disease deck:: #ENT id:: 3af07f85-c7db-408f-a49b-e78a42fe5ebd - ### Medical Treatment - - Systemic Antibiotics + - Systemic Antibiotics [[Flucloxacillin]] 500 mg [[BDS]] for 7 days - Analgesics - Local Heat - Ear pack of 10% ichthammol glycerine provides splintage and reduces pain @@ -58,10 +63,10 @@ tags:: #Disease - ### Surgical Options if abscess formed - incision and drainage of abscess - - If recurrent [[Furunculosis]] - - Exclude diabetes - - Attention paid to the patient's nasal vestibules which may harbour staphylococci and the infection transferred by patient's fingers - - Staphylococcal infections of the skin as a possible source should also be excluded and suitably treated +- If recurrent [[Furunculosis]] + - Exclude diabetes + - Attention paid to the patient's nasal vestibules which may harbour staphylococci and the infection transferred by patient's fingers + - Staphylococcal infections of the skin as a possible source should also be excluded and suitably treated - ## Prognosis background-color:: blue - ### Expected Course diff --git a/pages/Gestational Diabetes Mellitus.md b/pages/Gestational Diabetes Mellitus.md index 89daf01..d8c0afa 100644 --- a/pages/Gestational Diabetes Mellitus.md +++ b/pages/Gestational Diabetes Mellitus.md @@ -2,11 +2,11 @@ alias:: GDM ICD-11_Code:: tags:: #Disease -- #definition GDM is defined as carbohydrate intolerance of variable severity with onset or first recognition during the present pregnancy #obspc +- #definition GDM is defined as carbohydrate intolerance of variable severity with onset or first recognition during the present pregnancy #obs-prof-card - ## Etiology background-color:: blue - ### Causative Agents - - ### Risk Factors #obspc + - ### Risk Factors #obs-prof-card - Positive family history of diabetes(parents or sibling). Family history should include uncles, aunts and grandparents. - Having a still birth with pancreatic islet hyperplasia revealed on autopsy - Unexplained perinatal loss @@ -38,7 +38,7 @@ tags:: #Disease - ### Laboratory Tests - ### Imaging Studies - ### Differential Diagnosis -- ## Management and Treatment #obspc +- ## Management and Treatment #obs-prof-card background-color:: blue - ### Medical Treatment - [[Insulin]] @@ -57,7 +57,7 @@ tags:: #Disease - Monitoring - Women should perform self-blood glucose monitoring using reflectance meter. - ### Obstetric Management - - #### Time of Termination of Pregnancy #obspc + - #### Time of Termination of Pregnancy #obs-prof-card - Women with good glycemic control and who do not require insulin may wait for spontaneous onset of labor. However, elective delivery (induction or cesarean section) is considered in patients requiring insulin or with complications (macrosomia) at around 38 weeks - ## Prognosis background-color:: blue @@ -73,7 +73,7 @@ tags:: #Disease - ### Quality of Life Considerations - ## Complications background-color:: blue - - ### Possible Complications in pregnancy #obspc + - ### Possible Complications in pregnancy #obs-prof-card - Maternal - During Pregnancy collapsed:: true @@ -107,7 +107,7 @@ tags:: #Disease background-color:: blue - ### Health Education - ### Community Approach - - ### Screening Programs #obspc + - ### Screening Programs #obs-prof-card - WHO screening method - Random blood sugar, Urine for sugar, $\ce{HbA1C}$ - We follow [[OGTT]] diff --git a/pages/Glue Ear.md b/pages/Glue Ear.md index 03e912c..fe692c2 100644 --- a/pages/Glue Ear.md +++ b/pages/Glue Ear.md @@ -1,6 +1,7 @@ -- alias:: - ICD-11_Code:: - tags:: #Disease +alias:: CNSOM +ICD-11_Code:: +tags:: #Disease + - #definition {{c1 }} #ent-prof-card #unanswered #card deck:: #ENT id:: 6756ac3f-1083-4687-90f9-a2cdab6b164a @@ -8,71 +9,71 @@ background-color:: blue deck:: #ENT id:: 6756cf31-1f68-4244-96cc-dfd7e64c4524 - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: ac1bf438-7d4d-491b-8b45-ec06249d8f79 - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis - ## Management and Treatment #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: 97b8658f-ca53-4b25-a8cc-6afa90810b3c - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols - background-color:: blue + background-color:: blue \ No newline at end of file diff --git a/pages/Grand Multipara.md b/pages/Grand Multipara.md index 0d5471a..bac45f3 100644 --- a/pages/Grand Multipara.md +++ b/pages/Grand Multipara.md @@ -1,26 +1,26 @@ -- #definition ((6718cab3-f79c-4b0c-8a70-8ab207166200)) #obspw -- # Complications #obspw - - Abortion - logseq.order-list-type:: number - - Inherent Obstetric hazards such as - logseq.order-list-type:: number - - malpresentation - logseq.order-list-type:: number - - multiple pregnancy - logseq.order-list-type:: number - - placenta previa - logseq.order-list-type:: number - - medical disorders such as - logseq.order-list-type:: number - - anemia(both iron deficiency and megaloblastic) - logseq.order-list-type:: number - - hypertension with or without superimposed pre-eclampsia - logseq.order-list-type:: number - - cardiac disability - logseq.order-list-type:: number - - exaggerated manifestations of hemorrhoids and varicose veins - logseq.order-list-type:: number - - hiatus hernia - logseq.order-list-type:: number - - Prematurity - logseq.order-list-type:: number \ No newline at end of file +- #definition ((6718cab3-f79c-4b0c-8a70-8ab207166200)) #obs-prof-written +- # Complications #obs-prof-written + - Abortion + logseq.order-list-type:: number + - Inherent Obstetric hazards such as + logseq.order-list-type:: number + - malpresentation + logseq.order-list-type:: number + - multiple pregnancy + logseq.order-list-type:: number + - placenta previa + logseq.order-list-type:: number + - medical disorders such as + logseq.order-list-type:: number + - anemia(both iron deficiency and megaloblastic) + logseq.order-list-type:: number + - hypertension with or without superimposed pre-eclampsia + logseq.order-list-type:: number + - cardiac disability + logseq.order-list-type:: number + - exaggerated manifestations of hemorrhoids and varicose veins + logseq.order-list-type:: number + - hiatus hernia + logseq.order-list-type:: number + - Prematurity + logseq.order-list-type:: number diff --git a/pages/High Risk Pregnancy.md b/pages/High Risk Pregnancy.md index f31bc8d..75c19ee 100644 --- a/pages/High Risk Pregnancy.md +++ b/pages/High Risk Pregnancy.md @@ -1,7 +1,17 @@ -- #definition ((6718c95f-0b6b-4f7f-914f-1ed96c4f6459)) #obspw -- # Causes #obspw +- #definition ((6718c95f-0b6b-4f7f-914f-1ed96c4f6459)) #obs-prof-written +- # Causes #obs-prof-written - ((6718c9cf-b713-4414-9a0f-8758a665108d)) -- # High Risk Factors of Pregnacy #obspc +- # High Risk Factors of Pregnacy(6) #obs-prof-card #card + deck:: #Obstetrics + id:: 6733cced-ac63-4107-b125-0113b55af2ae + - During Pregnancy + - Short statured primi + - Malpresentation + - Pre-eclampsia and eclampsia + - During Labor + - PROM + - Hand feet or cord prolapse + - PPH - ((671a3612-cba8-48dd-84ee-005be6ca7df2)) -- # Danger Signs of Pregnancy #obspw +- # Danger Signs of Pregnancy #obs-prof-written - \ No newline at end of file diff --git a/pages/IUFGR.md b/pages/IUFGR.md index c549b5e..d629bfb 100644 --- a/pages/IUFGR.md +++ b/pages/IUFGR.md @@ -1,46 +1,46 @@ alias:: Intra-Uterine Fetal Growth Retardation -- #definition IUFGR is said to be present in those babies whose birth wegiht is below the 10th percentile of the average for the gestational age #obspc -- # Difference between symmetrical & asymmetrical IUFGR #obspc - - |Symmetric IUFGR|Asymmetrical IUFGR| - |--|--| - |Uniformly small|Head larger than abdomen| - |Ponderal index (Birth weight/Crown-heel length) - normal|Low| - |HC : AC and[:br]FL : AC ratios - normal|Elevated| - |Etiology : Genetic disease or infection - (Intrinsic to fetus)|Chronic placental insufficiency - (Extrinsic to fetus)| - |Total cell number - less[:br]Cell size - normal|Normal[:br]Smaller| - |Neonatal course - complicated with poor prognosis|Usually uncomplicated having good prognosis| -- # Complications #obspc - - Fetal - - Antenatal - - Chronic fetal distress, fetal death - - Intranatal - - Hypoxia - - Acidosis - - Postnatal - - Immediate - - Asphyxia, Bronchopulmonary Dysplasia and RDS - - Hypoglycemia due to shortage of glycogen reserve in the liver - - Meconium aspiration syndrome - - Microcoagulation leading to DIC - - Hypothermia - - Pulmonary hemorrhage - - Polycythemia, anemia, thrombocytopenia - - Hyper viscosity-thrombosis - - Necrotizing enterocolitis due to reduced intestinal blood flow - - Intraventricular hemorrhage (IVH) - - Electrolyte abnormalities - - Hypocalcemia - - Hyperphosphatemia - - Hypokalemia - - Multiorgan failure - - Increased perinatal morbidity and mortality - - Late - - Retarded neurological and intellectual development infancy - - Increased risk of metabolic syndrome in adult life - - Obesity - - Hypertension - - Diabetes - - Coronary Heart Disease - - LBW infants have an altered orexigenic mechanism that causes increased appetite and reduced satiety - - Reduced number of nephrons - causes renal vascular hypertension \ No newline at end of file +- #definition IUFGR is said to be present in those babies whose birth wegiht is below the 10th percentile of the average for the gestational age #obs-prof-card +- # Difference between symmetrical & asymmetrical IUFGR #obs-prof-card + - | Symmetric IUFGR | Asymmetrical IUFGR | + | -------------------------------------------------------------- | ------------------------------------------------------ | + | Uniformly small | Head larger than abdomen | + | Ponderal index (Birth weight/Crown-heel length) - normal | Low | + | HC : AC and[:br]FL : AC ratios - normal | Elevated | + | Etiology : Genetic disease or infection - (Intrinsic to fetus) | Chronic placental insufficiency - (Extrinsic to fetus) | + | Total cell number - less[:br]Cell size - normal | Normal[:br]Smaller | + | Neonatal course - complicated with poor prognosis | Usually uncomplicated having good prognosis | +- # Complications #obs-prof-card + - Fetal + - Antenatal + - Chronic fetal distress, fetal death + - Intranatal + - Hypoxia + - Acidosis + - Postnatal + - Immediate + - Asphyxia, Bronchopulmonary Dysplasia and RDS + - Hypoglycemia due to shortage of glycogen reserve in the liver + - Meconium aspiration syndrome + - Microcoagulation leading to DIC + - Hypothermia + - Pulmonary hemorrhage + - Polycythemia, anemia, thrombocytopenia + - Hyper viscosity-thrombosis + - Necrotizing enterocolitis due to reduced intestinal blood flow + - Intraventricular hemorrhage (IVH) + - Electrolyte abnormalities + - Hypocalcemia + - Hyperphosphatemia + - Hypokalemia + - Multiorgan failure + - Increased perinatal morbidity and mortality + - Late + - Retarded neurological and intellectual development infancy + - Increased risk of metabolic syndrome in adult life + - Obesity + - Hypertension + - Diabetes + - Coronary Heart Disease + - LBW infants have an altered orexigenic mechanism that causes increased appetite and reduced satiety + - Reduced number of nephrons - causes renal vascular hypertension diff --git a/pages/Impedance Audiogram.md b/pages/Impedance Audiogram.md index 0cce5e4..acd3585 100644 --- a/pages/Impedance Audiogram.md +++ b/pages/Impedance Audiogram.md @@ -1,3 +1,3 @@ -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 67580575-9992-4646-9d82-3e223fe3f083 \ No newline at end of file + id:: 67580575-9992-4646-9d82-3e223fe3f083 diff --git a/pages/Jones II test.md b/pages/Jones II test.md index 761dc78..4a586d6 100644 --- a/pages/Jones II test.md +++ b/pages/Jones II test.md @@ -1 +1 @@ -- SN: #eye-prof-written \ No newline at end of file +- #SN Short Note #eye-prof-written diff --git a/pages/LASIK.md b/pages/LASIK.md index 1d676f6..3c688ca 100644 --- a/pages/LASIK.md +++ b/pages/LASIK.md @@ -1,2 +1,3 @@ # Criteria for suitable case of LASIK patient #eye-prof-written -- SN: LASIK #eye-prof-written \ No newline at end of file + +- #SN Short Note LASIK #eye-prof-written diff --git a/pages/Labor Pain.md b/pages/Labor Pain.md index 4ea0903..2623cda 100644 --- a/pages/Labor Pain.md +++ b/pages/Labor Pain.md @@ -1,21 +1,21 @@ # True Labor Pain -id:: 67134327-4e96-4637-a126-a918578bba77 - - #definition ((6713bf44-e7b6-4b14-90d2-83b3d81ee3d0)) #obs-prof-written - - ## Confirmation #obs-prof-written #unanswered - id:: 67225f9e-fa22-4363-92aa-bd374e2084fe + +id:: 67134327-4e96-4637-a126-a918578bba77 - #definition ((6713bf44-e7b6-4b14-90d2-83b3d81ee3d0)) #obs-prof-written - ## Confirmation #obs-prof-written #unanswered +id:: 67225f9e-fa22-4363-92aa-bd374e2084fe + - # False Labor Pain id:: 6713433b-2673-45bb-bb8f-3b5b868e6757 - - #definition ((6713bf5b-4eb1-4a17-8e45-033848ac8fde)) - - ## Causes #obs-prof-written #unanswered - - ## Classical Presentation #classical-presentation #obspc - - Near Term/Term lower abdominal Pain without ((671347fa-4c45-4263-aa88-3ec7cb590a45)), Uterine contraction absent & os closed - - # Management #obspc - - Reassurance & mental support - logseq.order-list-type:: number - - Clarify the nature & characteristics of actual labour pain - logseq.order-list-type:: number - - If the patient is near term & if possible, patient should be hospitalized till term & delivery - logseq.order-list-type:: number + - #definition ((6713bf5b-4eb1-4a17-8e45-033848ac8fde)) + - ## Causes #obs-prof-written #unanswered + - ## Classical Presentation #classical-presentation #obs-prof-card + - Near Term/Term lower abdominal Pain without ((671347fa-4c45-4263-aa88-3ec7cb590a45)), Uterine contraction absent & os closed + - # Management #obs-prof-card + - Reassurance & mental support + logseq.order-list-type:: number + - Clarify the nature & characteristics of actual labour pain + logseq.order-list-type:: number + - If the patient is near term & if possible, patient should be hospitalized till term & delivery + logseq.order-list-type:: number - Near Term/Term lower abdominal Pain without show, Uterine contraction absent & os closed - Reassurance & mental support logseq.order-list-type:: number @@ -23,17 +23,17 @@ id:: 67134327-4e96-4637-a126-a918578bba77 logseq.order-list-type:: number - If the patient is near term & if possible, patient should be hospitalized till term & delivery logseq.order-list-type:: number -- ### Difference between ((67134327-4e96-4637-a126-a918578bba77)) and ((6713433b-2673-45bb-bb8f-3b5b868e6757)) #obspw - - | Traits | True Labor Pain | False Labor Pain | - | ------------------- | ------------------------------------------------------------------------------------------------------------------------------------- | ---------------------------------------------- | - | Site | Back & Front of the abdomen | Lower abdomen & groin | - | Radiation | ((6713c205-60a8-433e-b1ef-268ccf5cbea5)) | Localized | - | Character | Colicky | Dull | - | Duration | Intermittent | Persistent/continuous | - | Intensity | Severe | Less severe | - | Progression | Increasing intensity & duration | Continuous and non-progressive | - | Relieving factor | Nothing | Sedative, analgesic & enema | - | Associated features | - Progressive effacement & dilation of the cervix[:br]- ((671347fa-4c45-4263-aa88-3ec7cb590a45)) [:br]- Formation of bag of forewater | May be assocaited with hardening of the uterus | +- ### Difference between ((67134327-4e96-4637-a126-a918578bba77)) and ((6713433b-2673-45bb-bb8f-3b5b868e6757)) #obs-prof-written + - | Traits | True Labor Pain | False Labor Pain | + | ------------------- | ------------------------------------------------------------------------------------------------------------------------------------- | ---------------------------------------------- | + | Site | Back & Front of the abdomen | Lower abdomen & groin | + | Radiation | ((6713c205-60a8-433e-b1ef-268ccf5cbea5)) | Localized | + | Character | Colicky | Dull | + | Duration | Intermittent | Persistent/continuous | + | Intensity | Severe | Less severe | + | Progression | Increasing intensity & duration | Continuous and non-progressive | + | Relieving factor | Nothing | Sedative, analgesic & enema | + | Associated features | - Progressive effacement & dilation of the cervix[:br]- ((671347fa-4c45-4263-aa88-3ec7cb590a45)) [:br]- Formation of bag of forewater | May be assocaited with hardening of the uterus | - ### Show id:: 671347fa-4c45-4263-aa88-3ec7cb590a45 - - #definition ((6713bf80-6436-49c4-a37e-93d37edb7996)) \ No newline at end of file + - #definition ((6713bf80-6436-49c4-a37e-93d37edb7996)) diff --git a/pages/Labor.md b/pages/Labor.md index 981f06e..d17c1d8 100644 --- a/pages/Labor.md +++ b/pages/Labor.md @@ -1,6 +1,9 @@ +alias:: Labour contrast:: [[Braxton Hicks contraction]] , not regular and without cervical change -- #definition ((6713bc8d-10b6-4544-9313-75cc8efac4ea)) #obspw +- #definition {{c1 Series of events that take place in the genital organs in an effort to expel the viable products of conception (fetus, placenta and the membranes) out of the womb through the vagina into the outer world is called ‘labor’}} #obs-prof-written #obs-prof-card #card + id:: 67542d3d-a847-4b44-aa30-652a82f3c2f8 + deck:: #Obstetrics - [[Normal Labor]] & ((67225810-2ee9-4dee-8e5d-714fd84d2b1a)) - [[Fetal Orientation]] - # Presentation #classical-presentation #obs-prof-written #unanswered @@ -27,11 +30,11 @@ contrast:: [[Braxton Hicks contraction]] , not regular and without cervical chan - Cervical ripening agents - [[Misoprostol]] - [[Laminaria]] -- # Lower Segement of Uterus #obspw +- # Lower Segement of Uterus #obs-prof-written alias:: LS - #definition #obs-prof-written ((6713c79b-ba93-455e-af98-77ccb7eb6139)) - SN : #obs-prof-written #unanswered - # Engagement - - #definition #obspw - - ## Causes of non-engaged head in a primae #obspw - - Complications if labor occurs in primae #obspw \ No newline at end of file + - #definition #obs-prof-written + - ## Causes of non-engaged head in a primae #obs-prof-written + - Complications if labor occurs in primae #obs-prof-written \ No newline at end of file diff --git a/pages/Littles Area.md b/pages/Littles Area.md index 21bcb14..1091c4a 100644 --- a/pages/Littles Area.md +++ b/pages/Littles Area.md @@ -7,6 +7,6 @@ - # Clinical Importance #ent-prof-card #ent-prof-written #unanswered #card id:: 6756cf35-249b-42d1-853d-a57a518fa977 deck:: #ENT -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 67580700-cfda-4772-a1cf-33c6109c5cd9 \ No newline at end of file + id:: 67580700-cfda-4772-a1cf-33c6109c5cd9 diff --git a/pages/Ludwig's Angina.md b/pages/Ludwig's Angina.md index b9661f5..8c9cfdf 100644 --- a/pages/Ludwig's Angina.md +++ b/pages/Ludwig's Angina.md @@ -6,72 +6,72 @@ id:: 6756b8b1-7ab0-4520-b4a3-4cda026d234c - ## Etiology background-color:: blue - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features background-color:: blue - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis - ## Management and Treatment #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: bde4b4a6-a339-4cd2-8e9a-5718408a868d - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 6758158a-e90c-4bef-bd9c-7ecac5e0e50f \ No newline at end of file + id:: 6758158a-e90c-4bef-bd9c-7ecac5e0e50f diff --git a/pages/Mastoid Abscess.md b/pages/Mastoid Abscess.md index ced32e1..a02ae0e 100644 --- a/pages/Mastoid Abscess.md +++ b/pages/Mastoid Abscess.md @@ -3,74 +3,74 @@ tags:: #Disease - ## Etiology background-color:: blue - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features background-color:: blue - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - [[Furunculosis]] - - Differentiate #ent-prof-written #unanswered #card - deck:: #ENT - id:: 6757f854-6d93-4975-9e3c-2d16ad361ffb - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - [[Furunculosis]] + - Differentiate #ent-prof-written #unanswered #card + deck:: #ENT + id:: 6757f854-6d93-4975-9e3c-2d16ad361ffb + - ### Confirmation of Diagnosis - ## Management and Treatment background-color:: blue - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 6757f861-7242-4f50-9e37-e8f431f7acb9 \ No newline at end of file + id:: 6757f861-7242-4f50-9e37-e8f431f7acb9 diff --git a/pages/Mastoidectomy.md b/pages/Mastoidectomy.md index 8c1e52b..f514b67 100644 --- a/pages/Mastoidectomy.md +++ b/pages/Mastoidectomy.md @@ -13,7 +13,7 @@ - # Complication #ent-prof-written #unanswered #card deck:: #ENT id:: 675805be-d972-4904-9e77-546bf17e5707 -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT id:: 67580655-70fe-4807-b22f-f0deeb621cb5 -- \ No newline at end of file +- diff --git a/pages/Meniere's Disease.md b/pages/Meniere's Disease.md index 7c43a6f..7ae370c 100644 --- a/pages/Meniere's Disease.md +++ b/pages/Meniere's Disease.md @@ -6,74 +6,74 @@ deck:: #ENT - ## Etiology background-color:: blue - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features background-color:: blue - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: cacace2a-0212-4b4f-8198-80c2164bb44f - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis - ## Management and Treatment #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue id:: 3abf9902-4436-4be6-ad4c-1ad09cab3a65 deck:: #ENT - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 675800ff-fe62-48ff-98ef-df6ef1e4aa43 \ No newline at end of file + id:: 675800ff-fe62-48ff-98ef-df6ef1e4aa43 diff --git a/pages/Multiple Papilloma of Larynx.md b/pages/Multiple Papilloma of Larynx.md index 424a03b..24ee3cf 100644 --- a/pages/Multiple Papilloma of Larynx.md +++ b/pages/Multiple Papilloma of Larynx.md @@ -3,74 +3,74 @@ tags:: #Disease - ## Etiology background-color:: blue - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features #ent-prof-written #unanswered #card background-color:: blue deck:: #ENT id:: 59f69b52-7bf6-43ba-b5b6-1d93d37f677b - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis - ## Management and Treatment #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue id:: 042c3d7d-5137-411a-9c18-72e8dc5973c7 deck:: #ENT - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue -- SN: Inverted Papilloma #ent-prof-written #unanswered #card +- #SN Short Note Inverted Papilloma #ent-prof-written #unanswered #card deck:: #ENT - id:: 6758152f-13ba-497e-a307-a1b2a2605320 \ No newline at end of file + id:: 6758152f-13ba-497e-a307-a1b2a2605320 diff --git a/pages/Myringoplasty.md b/pages/Myringoplasty.md index 4a61603..183985c 100644 --- a/pages/Myringoplasty.md +++ b/pages/Myringoplasty.md @@ -1,3 +1,3 @@ -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 67580581-9ea8-462a-9f67-1e27ec9ca67a \ No newline at end of file + id:: 67580581-9ea8-462a-9f67-1e27ec9ca67a diff --git a/pages/Myringotomy.md b/pages/Myringotomy.md index 665abe3..291a793 100644 --- a/pages/Myringotomy.md +++ b/pages/Myringotomy.md @@ -1,3 +1,3 @@ -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 67580589-6a65-4393-9e78-e600770e0bc3 \ No newline at end of file + id:: 67580589-6a65-4393-9e78-e600770e0bc3 diff --git a/pages/Nephrotic Syndrome.md b/pages/Nephrotic Syndrome.md index d330faf..62e6181 100644 --- a/pages/Nephrotic Syndrome.md +++ b/pages/Nephrotic Syndrome.md @@ -6,225 +6,227 @@ Here by Nephrotic Syndrome, [[Minimal Change Nephrotic Syndrome]] is meant for m - ## Etiology background-color:: blue - - ## Idiopathic Nephrotic Syndrome - - Minimal Change Disease - - Mesangial Proliferation - - Focal Segmental glomerulosclerosis - - Membranous nephropathy - - Glomerulonephritis associated with nephrotic syndrome membranoproliferative glomerulonephritis, crescentic glomerulonephritis, immunoglobulin A nephropathy - - ## Secondary causes - - ### Infections - - Endocarditis - - Post- streptococcal - - Hepatitides B, C - - HIV- 1 - - Infectious mononucleosis - - Cytomegalovirus - - Malaria - - Syphilis (congenital and secondary) - - Toxoplasmosis - - Tuberculosis - - Schistosomiasis - - Filariasis - - ### Drugs - - [[Captopril]] - - [[Penicillamine]] - - [[Gold]] - - [[NSAIDS]] - - [[Pamidronate]], other bisphosphates - - [[Interferon]] - - [[Mercury]] - - [[Heroin]] - - [[Lithium]] - - [[Rifampicin]] - - [[Sulfasalazine]] - - ### Immunological or Allergic Disorders - - [[Vasculitis Syndromes]] - - [[Castleman Disease]] - - [[Kimura Disease]] - - [[Bee Sting]] - - [[Snake Venom]] - - Food Allergens - - [[Serum Sickness]] - - Poison ivy - - Poison oak - - ### Associated with Malignant Disease - - _[[Wilms Tumor]]_ - - [[Lymphoma]] - - [[Pheochromocytoma]] - - [[Leukemia]] - - [[Thymoma]] - - Solid Tumors + - ## Idiopathic Nephrotic Syndrome + - Minimal Change Disease + - Mesangial Proliferation + - Focal Segmental glomerulosclerosis + - Membranous nephropathy + - Glomerulonephritis associated with nephrotic syndrome membranoproliferative glomerulonephritis, crescentic glomerulonephritis, immunoglobulin A nephropathy + - ## Secondary causes + - ### Infections + - Endocarditis + - Post- streptococcal + - Hepatitides B, C + - HIV- 1 + - Infectious mononucleosis + - Cytomegalovirus + - Malaria + - Syphilis (congenital and secondary) + - Toxoplasmosis + - Tuberculosis + - Schistosomiasis + - Filariasis + - ### Drugs + - [[Captopril]] + - [[Penicillamine]] + - [[Gold]] + - [[NSAIDS]] + - [[Pamidronate]], other bisphosphates + - [[Interferon]] + - [[Mercury]] + - [[Heroin]] + - [[Lithium]] + - [[Rifampicin]] + - [[Sulfasalazine]] + - ### Immunological or Allergic Disorders + - [[Vasculitis Syndromes]] + - [[Castleman Disease]] + - [[Kimura Disease]] + - [[Bee Sting]] + - [[Snake Venom]] + - Food Allergens + - [[Serum Sickness]] + - Poison ivy + - Poison oak + - ### Associated with Malignant Disease + - _[[Wilms Tumor]]_ + - [[Lymphoma]] + - [[Pheochromocytoma]] + - [[Leukemia]] + - [[Thymoma]] + - Solid Tumors - ## Epidemiology background-color:: blue - - ### Incidence - - The commonest kidney problem in children - - Incidence: 2-7 per 100, 000 children <16 years of age - - Common in between 2 to 8 years - - Peak age of onset: Around 3 year - - 85% of total nephrotic syndrome in children is [[MCNS]] - - ((673919e2-2a88-45ae-ba9f-a2b48d3e4a8e)) - ((67391a0f-8b9c-4d27-950e-64c7a30f6688)) - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - The commonest kidney problem in children + - Incidence: 2-7 per 100, 000 children <16 years of age + - Common in between 2 to 8 years + - Peak age of onset: Around 3 year + - 85% of total nephrotic syndrome in children is [[MCNS]] + - ((673919e2-2a88-45ae-ba9f-a2b48d3e4a8e)) + ((67391a0f-8b9c-4d27-950e-64c7a30f6688)) + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - Pathogenesis - - Immune-mediated - logseq.order-list-type:: number - - Systemic circulating factors (eg, suPAR) - logseq.order-list-type:: number - - Podocyte related factors (eg, ANGPTL4) - logseq.order-list-type:: number - - Genetic Variants - logseq.order-list-type:: number - - Mutant proteins play roles in - - Nucleus - logseq.order-list-type:: number - - Mitochondria - logseq.order-list-type:: number - - Lysosomes - logseq.order-list-type:: number - - Actin - logseq.order-list-type:: number - - Slit diaphragm - logseq.order-list-type:: number - - Basement membrane - logseq.order-list-type:: number - - ### Affected Systems/Organs - - Damage to the podocytes (effacement of foot process) - - Increase permeability of GFB - - ↑↑passage of albumin across GFB into the urinary space - - This massive albumin loss in urine(Albuminuria) gives rise to hypoalbuminemia with fall of plasma Colloidal osmotic pressure. As a result, fluid shifts from plasma to interstitial space, resulting in - - [[Generalized Edema]] - - [[Haemoconcentration]] as reduced blood colloidal osmotic pressure - - Further retaining of fluid leading to Edema - - The Haemoconcentration in turn activates the renin angiotensin aldosterone system and promotes release of ADH - - This causes the body to retain more fluid, reduced GFR and oligouria - - Raised Cholesterol and Triglycerides - - Hypoalbuminaemia induces lipoprotein synthesis in liver which causes elevation of cholesterol and triglycerides in blood + - ### Mechanism of Disease + - Pathogenesis + - Immune-mediated + logseq.order-list-type:: number + - Systemic circulating factors (eg, suPAR) + logseq.order-list-type:: number + - Podocyte related factors (eg, ANGPTL4) + logseq.order-list-type:: number + - Genetic Variants + logseq.order-list-type:: number + - Mutant proteins play roles in + - Nucleus + logseq.order-list-type:: number + - Mitochondria + logseq.order-list-type:: number + - Lysosomes + logseq.order-list-type:: number + - Actin + logseq.order-list-type:: number + - Slit diaphragm + logseq.order-list-type:: number + - Basement membrane + logseq.order-list-type:: number + - ### Affected Systems/Organs + - Damage to the podocytes (effacement of foot process) + - Increase permeability of GFB + - ↑↑passage of albumin across GFB into the urinary space + - This massive albumin loss in urine(Albuminuria) gives rise to hypoalbuminemia with fall of plasma Colloidal osmotic pressure. As a result, fluid shifts from plasma to interstitial space, resulting in + - [[Generalized Edema]] + - [[Haemoconcentration]] as reduced blood colloidal osmotic pressure + - Further retaining of fluid leading to Edema + - The Haemoconcentration in turn activates the renin angiotensin aldosterone system and promotes release of ADH + - This causes the body to retain more fluid, reduced GFR and oligouria + - Raised Cholesterol and Triglycerides + - Hypoalbuminaemia induces lipoprotein synthesis in liver which causes elevation of cholesterol and triglycerides in blood - # Essential Characteristics of MCNS - - No appreciable glomerular pathology, noted in light microscopy but effacement of foot processes of podocytes in GBM seen under electron microscope - - Prompt respose to steroid but high tendency to relapse - - Not associated with hypertension, hematuria and azoteaemia + - No appreciable glomerular pathology, noted in light microscopy but effacement of foot processes of podocytes in GBM seen under electron microscope + - Prompt respose to steroid but high tendency to relapse + - Not associated with hypertension, hematuria and azoteaemia - ## Clinical Features background-color:: blue - - ### Signs and Symptoms - - The affected children may present as initial case or may present with History of recurrent attacks(replapse) with - - #### Symptoms - - Anorexia - - Irritability - - Abdominal pain - - Diarrhoea - - Scanty urination (color usually normal) - - #### Signs - - Facial puffiness, massive peri-orbital swelling - - Generalized oedema - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - The affected children may present as initial case or may present with History of recurrent attacks(replapse) with + - #### Symptoms + - Anorexia + - Irritability + - Abdominal pain + - Diarrhoea + - Scanty urination (color usually normal) + - #### Signs + - Facial puffiness, massive peri-orbital swelling + - Generalized oedema + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - Following minor infections and uncommonly reactions to insect bites, bee stings, or poison ivy - - Mild edema, initially periorbital which decreases throughout the day and the edema becomes generalized - possibly misdiagnosed as allergic disorder - - Anorexia, irritability, abdominal pain, diarrhoea - - #### Probable Diagnosis - - Diagnosis other than [[MCNS]] should be considered in children <1 year of age, with a positive family history of nephrotic syndrome, and/or presence of extrarenal findings (e.g., arthritis, rash, anemia), hypertension or pulmonary edema, acute or chronic renal insufficiency, and gross hematuria - - ### Laboratory Tests - - Urine RME with the first morning urine : 3+ or 4+ (20% sensitive) - - 24 hour timed collection of urine for protein quantification - - spot Urine Protein : Creatinine ratio >2.0 - - Creatinine : normal - may be abnormally elevated if there is diminished renal perfusion from contractiion of teh intravascular volume - - Serum Albumin : < 2/5 g/dL - - Serum Cholesterol and Triglycerides : elevated - - complement C3 and C4 levels : normal - (decreased C3 in glomerulonephritis) - - CBC - - Serum electrolytes - - BUN - - Glomerular filtration rate - - Antinuclear and anti-streptococcal antibodies - - Antineutrophilic cytoplastic antibodies - - ### Imaging Studies - - Kidney ultrasound may be considered to exclude renal maformations and venous thrombosis but is not mandatory - - ### Renal Biopsy - - Renal biopsy is not routinely performed if the patient fits the standard clinical picture of MCNS - - should be considered for renal biopsy if - - Age <1 year or >12 years - - Persistent or sustained elevation in creatinine - - Significant hematuria or gross hematuria - - sustained hypertension - - Hypocomplementemia - - Findings indicative of another autoimmune disease - - Infection with Hepatitis B or C, HIV, or tuberculosis - - Glucocorticoid resistance - - [[AKI]] - - Arthritis - - Rash - - ### Differential Diagnosis - - #### Differential Diagnosis - _child with marked edema_ - - Protein losing enteropathy - - Hepatic Failure - - Heart Failure - - Acute or chronic glomerulonephritis - - Protein malnutrition - - ### Confirmation of Diagnosis - - labs, imaging and biopsy not necessary + - ### Clinical Diagnosis + - #### Classical Presentation + - Following minor infections and uncommonly reactions to insect bites, bee stings, or poison ivy + - Mild edema, initially periorbital which decreases throughout the day and the edema becomes generalized + possibly misdiagnosed as allergic disorder + - Anorexia, irritability, abdominal pain, diarrhoea + - #### Probable Diagnosis + - Diagnosis other than [[MCNS]] should be considered in children <1 year of age, with a positive family history of nephrotic syndrome, and/or presence of extrarenal findings (e.g., arthritis, rash, anemia), hypertension or pulmonary edema, acute or chronic renal insufficiency, and gross hematuria + - ### Laboratory Tests + - Urine RME with the first morning urine : 3+ or 4+ (20% sensitive) + - 24 hour timed collection of urine for protein quantification + - spot Urine Protein : Creatinine ratio >2.0 + - Creatinine : normal + may be abnormally elevated if there is diminished renal perfusion from contractiion of teh intravascular volume + - Serum Albumin : < 2/5 g/dL + - Serum Cholesterol and Triglycerides : elevated + - complement C3 and C4 levels : normal + (decreased C3 in glomerulonephritis) + - CBC + - Serum electrolytes + - BUN + - Glomerular filtration rate + - Antinuclear and anti-streptococcal antibodies + - Antineutrophilic cytoplastic antibodies + - ### Imaging Studies + - Kidney ultrasound may be considered to exclude renal maformations and venous thrombosis but is not mandatory + - ### Renal Biopsy + - Renal biopsy is not routinely performed if the patient fits the standard clinical picture of MCNS + - should be considered for renal biopsy if + - Age <1 year or >12 years + - Persistent or sustained elevation in creatinine + - Significant hematuria or gross hematuria + - sustained hypertension + - Hypocomplementemia + - Findings indicative of another autoimmune disease + - Infection with Hepatitis B or C, HIV, or tuberculosis + - Glucocorticoid resistance + - [[AKI]] + - Arthritis + - Rash + - ### Differential Diagnosis + - #### Differential Diagnosis + _child with marked edema_ + - Protein losing enteropathy + - Hepatic Failure + - Heart Failure + - Acute or chronic glomerulonephritis + - Protein malnutrition + - ### Confirmation of Diagnosis + - labs, imaging and biopsy not necessary - ## Management and Treatment background-color:: blue - - First episode of nephrotic syndroem and mild to moderate edema may be managed as outpatients. - - But, not practiced as outpatient, as educating parents regarding all aspects of the condition can require a short period of hospitalization - - The child's parents must be able to recognize the signs and symptoms of the complications of the disease and may be taught how to use a dipstick and interpret the results to monitor for the degree of proteinuria - - ### Medical Treatment - - More than 95% of children with minimal change disease respond to corticosteroid therapy - - Tuberculosis must be ruled out before starting immunosuppressive therapy with corticosteoids by placing a purified protein derivative skin test or obtaining an interferon-gamma release assay and confirming a negative result - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - First episode of nephrotic syndrome and mild to moderate edema may be managed as outpatients. + - But, not practiced as outpatient, as educating parents regarding all aspects of the condition can require a short period of hospitalization + - The child's parents must be able to recognize the signs and symptoms of the complications of the disease and may be taught how to use a dipstick and interpret the results to monitor for the degree of proteinuria + - ### Medical Treatment + - More than 95% of children with minimal change disease respond to corticosteroid therapy + - Prednisone : {{c1 60}} mg/m2/day (max {{c1 60}} mg) for 4-6 weeks followed by alternate day prednisone {{c1 40}} mg/m2 every other day for 4-6 weeks #pedi-prof-written #card #dose + deck:: #Pediatrics + - Tuberculosis must be ruled out before starting immunosuppressive therapy with corticosteoids by placing a purified protein derivative skin test or obtaining an interferon-gamma release assay and confirming a negative result + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - Cough & respiratory distress (pneumonia, pleural effusion, huge ascites) - - Abdominal pain(gut ischemia, peritonitis, renal vein thrombosis) - - Pain, redness & tendreness of skin(cellulitis) - - Fever & dysuria (UTI) - - Diarrhoea(impaired absorption of foods due to oedema of the bowel wall) - - Neurodeficit like hemiplegia (stroke from thrombo-embolism due to haemoconcentration) - - ### Survival Rates - - #### With Treatment - - Remission achieved after 8 week of oral corticosteroid therapy : 90% - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - Cough & respiratory distress (pneumonia, pleural effusion, huge ascites) + - Abdominal pain(gut ischemia, peritonitis, renal vein thrombosis) + - Pain, redness & tendreness of skin(cellulitis) + - Fever & dysuria (UTI) + - Diarrhoea(impaired absorption of foods due to oedema of the bowel wall) + - Neurodeficit like hemiplegia (stroke from thrombo-embolism due to haemoconcentration) + - ### Survival Rates + - #### With Treatment + - Remission achieved after 8 week of oral corticosteroid therapy : 90% + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Quality of Life Considerations - ## Complications background-color:: blue - - ### Possible Complications - - ### Long-term Effects + - ### Possible Complications + - ### Long-term Effects - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols - background-color:: blue + background-color:: blue \ No newline at end of file diff --git a/pages/Obstructed Labor.md b/pages/Obstructed Labor.md index a32007f..350f6eb 100644 --- a/pages/Obstructed Labor.md +++ b/pages/Obstructed Labor.md @@ -1,10 +1,10 @@ -- #definition Obstructed Labor is one where in spite of good uterine contractions, the progressive descent of the presenting part is arrested due to mechanical obstruction #obspc +- #definition Obstructed Labor is one where in spite of good uterine contractions, the progressive descent of the presenting part is arrested due to mechanical obstruction #obs-prof-card - alias:: ICD-11_Code:: tags:: #Disease - ## Etiology background-color:: blue - - ### Causative Agents #obspc + - ### Causative Agents #obs-prof-card collapsed:: true - Fault in the passage - Bony : Cephalopelvic disproportion @@ -43,7 +43,7 @@ - ### Laboratory Tests - ### Imaging Studies - ### Differential Diagnosis -- ## Management #obspc +- ## Management #obs-prof-card background-color:: blue - ### Medical Management - Fluid Electrolyte Balance and correction of dehydration and ketoacidosis @@ -68,7 +68,7 @@ - ### Quality of Life Considerations - ## Complications background-color:: blue - - ### Possible Complications #obspc + - ### Possible Complications #obs-prof-card - #### Maternal - ###### Immediate - Exhaustion diff --git a/pages/Otitis Media with Effusion.md b/pages/Otitis Media with Effusion.md index 154bd29..b63fcf8 100644 --- a/pages/Otitis Media with Effusion.md +++ b/pages/Otitis Media with Effusion.md @@ -43,10 +43,19 @@ tags:: #Disease - ### Confirmation of Diagnosis - ## Management and Treatment #ent-prof-written #unanswered #card background-color:: blue - deck:: #ENT id:: 721febf5-0538-48d5-ab55-5a624f78a3b9 + deck:: #ENT - ### Medical Treatment + - Systemic Antibiotics + - Topical Steroid Spray + - Nasal Decongestants + - Antihistamine - ### Surgical Options + - Myringotomy & evacuation of fluid under GA + - Insertion of grommets + - Also, Surgical Treatment for Underlying Cause + - Adenoidectomy + - Tonsillectomy - ### Lifestyle and Dietary Recommendations - ### Follow-up - ## Prognosis @@ -79,6 +88,6 @@ tags:: #Disease background-color:: blue - ## Guidelines and Protocols background-color:: blue -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT id:: 6757ff5f-3b11-438c-a3eb-314789142181 \ No newline at end of file diff --git a/pages/Otitis Media.md b/pages/Otitis Media.md index 5dbfce4..9d4ae69 100644 --- a/pages/Otitis Media.md +++ b/pages/Otitis Media.md @@ -1,9 +1,9 @@ - alias:: ICD-11_Code:: tags:: #Disease -- #definition {{c1 }} #ent-prof-written #unanswered #card - deck:: #ENT +- #definition {{c1 Inflammation of Middle Ear}} #ent-prof-written #[[Middle Ear]] #card id:: 6757fa25-24af-43c9-8ce7-c49306615a0c + deck:: #ENT - ## Etiology background-color:: blue - ### Causative Agents @@ -23,9 +23,18 @@ - ### Signs and Symptoms - #### Symptoms - #### Signs - - ### Stages or Classification #ent-prof-written #unanswered #card - deck:: #ENT + - ### Stages or Classification #ent-prof-written #[[Middle Ear]] #card id:: d1209344-b8fc-499e-a376-447fb4a003a2 + deck:: #ENT + - [[Acute Otitis Media]] + - [[Acute Suppurative Otitis Media]] + - [[Acute Non Suppurative Otitis Media]] + - [[Recurrent Acute Otitis Media]] + - [[Chronic Otitis Media]] + - [[Chronic Suppurative Otitis Media]] + - [[Tubotympanic variety CSOM]] + - [[Anticoantral variety CSOM]] + - [[Glue Ear]] - ### Diagnostic Criteria - ## Diagnosis background-color:: blue diff --git a/pages/Otomycosis.md b/pages/Otomycosis.md index 82ded31..a4398d1 100644 --- a/pages/Otomycosis.md +++ b/pages/Otomycosis.md @@ -1,13 +1,13 @@ -- #definition It is a fungal infection of external auditory canal #ent-prof-written #unanswered #card - deck:: #ENT +- #definition It is a fungal infection of external auditory canal #ent-prof-written #[[External Ear]] #card id:: 6733ccee-4455-4ccc-aecc-9123043c28a7 + deck:: #ENT - alias:: AA03 ICD-11_Code:: [[AA03]] tags:: #Disease -- ## Etiology #ent-prof-written #unanswered #card +- ## Etiology #ent-prof-written #[[External Ear]] #card background-color:: blue - deck:: #ENT id:: 6733ccee-75c3-49a6-8adf-01d9db0dbc53 + deck:: #ENT - ### Causative Agents - _[[Aspergillus niger]]_ (black fungal ball) - _[[Aspergillus fumigatus]]_ (green) @@ -45,20 +45,20 @@ - ## Diagnosis background-color:: blue - ### Clinical Diagnosis : S/S + - ### Otoscope Findings + - Fungal ball or otomycotic plug - wet filter paper/ newspaper + - A. niger appears black headed filamentous growth + - A. fumigatus as pale blue or green + - Candida as white or creamy deposit + - Meatal skin appear, _sodden, red_ and _oedematous_ - ### Investigations - - Otoscope Findings - - Fungal ball or otomycotic plug - wet filter paper/ newspaper - - A. niger appears black headed filamentous growth - - A. fumigatus as pale blue or green - - Candida as white or creamy deposit - - Meatal skin appear, *sodden, red* and *oedematous* - Wet film preparation - Hyphae are found in aspergillus - Small ovoid budding is found in candida - Aural swab for C/S - ### Imaging Studies - ### Differential Diagnosis -- ## Management and Treatment #ent-prof-card #ent-prof-written #card #[[External Ear]] +- ## Management and Treatment #ent-prof-card #ent-prof-written #card #[[External Ear]] background-color:: blue id:: 6733ccee-2f53-4849-b192-14e354d05c13 deck:: #ENT @@ -74,6 +74,7 @@ - Other borad-spectrum antifungal agents : Cotrimazole and Povidone Iodine - Two percent salicylic acid in alcohol is also effective - Antifungal treatment should be continued for a week even after apparent cure to avoid recurrences + - AntiHistamine if edema in external auditory canal - Antibiotic/steroid preparation for secondary bacterial infections - ### Lifestyle and Dietary Recommendations - Ear must be kept dry @@ -109,6 +110,6 @@ background-color:: blue - ## Guidelines and Protocols background-color:: blue -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT id:: 6757f8d6-dc67-41ec-b250-9de12becf15c \ No newline at end of file diff --git a/pages/Pathology.md b/pages/Pathology.md index a6bfdd5..f77073f 100644 --- a/pages/Pathology.md +++ b/pages/Pathology.md @@ -1,6 +1,6 @@ - [[Female Reproductive System]] - - Pathological Conditions of the [[Fallopian Tube]] #obspw - - [[Salphingitis]] - - [[Ectopic Pregnancy]] + - Pathological Conditions of the [[Fallopian Tube]] #obs-prof-written + - [[Salphingitis]] + - [[Ectopic Pregnancy]] - [[Neoplasm]] -- \ No newline at end of file +- diff --git a/pages/Perinatal Mortality.md b/pages/Perinatal Mortality.md index d4cb0c7..feeac73 100644 --- a/pages/Perinatal Mortality.md +++ b/pages/Perinatal Mortality.md @@ -1,27 +1,27 @@ -- #definition Perinatal mortality is defined as deaths among fetuses weighing 100 g or more at brith (28 weeks gestation) who die before or during delivery or within the first 7 days of delivery #obspc +- #definition Perinatal mortality is defined as deaths among fetuses weighing 100 g or more at brith (28 weeks gestation) who die before or during delivery or within the first 7 days of delivery #obs-prof-card - The perinatal mortality rate is expressed in terms of such deaths per 1000 total births - # Causes - - Chronic hypoxia(30%) - - Pregnancy complications(30%) - - Congenital malformations(15%) - - Infection (5%) and - - Unexplained (20%) + - Chronic hypoxia(30%) + - Pregnancy complications(30%) + - Congenital malformations(15%) + - Infection (5%) and + - Unexplained (20%) - # Prevention - - Pre-Pregnancy health care and counselling - logseq.order-list-type:: number - - Genetic counselling in high-risk cases and prenatal diagnosis to detect genetic, chromosomal or structural abnormalities are essential - logseq.order-list-type:: number - - Regular antenatal care, with advice regarding health, diet and rest - logseq.order-list-type:: number - - Detection and management of medical disorders in pregnancy: anemia, diabetes, infections and preeclampsia-eclampsia. Immunization against tetanus should be done as routine - logseq.order-list-type:: number - - Screening of high-risk patients those of poor socioeconomic status or high parity, extremes of age, and twins, etc. and their mandatory hospital delivery - logseq.order-list-type:: number - - Careful monitoring in labor to detect hypoxia eraly and avoidance of traumatic vaginal delivery - logseq.order-list-type:: number - - Skilled birth attendant - To minimize sepsis, at least three cleans are to be maintained - logseq.order-list-type:: number - - Provision of referral neonatal service specially to look after the preterm babies - logseq.order-list-type:: number - - Health care education of the mother about the care of the newborn. Early and exclusive breastfeeding, prevention of hypothermia - logseq.order-list-type:: number \ No newline at end of file + - Pre-Pregnancy health care and counselling + logseq.order-list-type:: number + - Genetic counselling in high-risk cases and prenatal diagnosis to detect genetic, chromosomal or structural abnormalities are essential + logseq.order-list-type:: number + - Regular antenatal care, with advice regarding health, diet and rest + logseq.order-list-type:: number + - Detection and management of medical disorders in pregnancy: anemia, diabetes, infections and preeclampsia-eclampsia. Immunization against tetanus should be done as routine + logseq.order-list-type:: number + - Screening of high-risk patients those of poor socioeconomic status or high parity, extremes of age, and twins, etc. and their mandatory hospital delivery + logseq.order-list-type:: number + - Careful monitoring in labor to detect hypoxia eraly and avoidance of traumatic vaginal delivery + logseq.order-list-type:: number + - Skilled birth attendant - To minimize sepsis, at least three cleans are to be maintained + logseq.order-list-type:: number + - Provision of referral neonatal service specially to look after the preterm babies + logseq.order-list-type:: number + - Health care education of the mother about the care of the newborn. Early and exclusive breastfeeding, prevention of hypothermia + logseq.order-list-type:: number diff --git a/pages/Peurperial Pyrexia.md b/pages/Peurperial Pyrexia.md index c20a3b2..dc025f2 100644 --- a/pages/Peurperial Pyrexia.md +++ b/pages/Peurperial Pyrexia.md @@ -1,20 +1,20 @@ -- #definition A rise of temperature reaching 100.4 ºF (38 ºC) #pyrexia or more (measured orally) on two separate occasions at 24 hours apart (excluding first 24 hours) within first 10 days following delivery is called puerperal pyrexia. #obspc -- # Causes #obspc #reminder (might have to classify on days basis) - - Puerperal sepsis - - Urinary tract infections: Cystitis, Pyelonephritis - - Mastitis, Breast abscess - - Wound infections: CS or Episiotomy - - Pulmonary infections: Atelectasis, Pneumonia - - Septic pelvic thrombophlebitis - - A recrudescence of malaria or pulmonary tuberculosis - - Others: Pharyngitis, Gastroenteritis -- # Complications #obspc - - Breast engorgement - logseq.order-list-type:: number - - Cracked and retracted nipple leading to difficulty in breastfeeding - logseq.order-list-type:: number - - Mastitis and Breast abscess - logseq.order-list-type:: number - - Lactation failure - logseq.order-list-type:: number -- \ No newline at end of file +- #definition A rise of temperature reaching 100.4 ºF (38 ºC) #pyrexia or more (measured orally) on two separate occasions at 24 hours apart (excluding first 24 hours) within first 10 days following delivery is called puerperal pyrexia. #obs-prof-card +- # Causes #obs-prof-card #reminder (might have to classify on days basis) + - Puerperal sepsis + - Urinary tract infections: Cystitis, Pyelonephritis + - Mastitis, Breast abscess + - Wound infections: CS or Episiotomy + - Pulmonary infections: Atelectasis, Pneumonia + - Septic pelvic thrombophlebitis + - A recrudescence of malaria or pulmonary tuberculosis + - Others: Pharyngitis, Gastroenteritis +- # Complications #obs-prof-card + - Breast engorgement + logseq.order-list-type:: number + - Cracked and retracted nipple leading to difficulty in breastfeeding + logseq.order-list-type:: number + - Mastitis and Breast abscess + logseq.order-list-type:: number + - Lactation failure + logseq.order-list-type:: number +- diff --git a/pages/Phylectenular Conjunctivitis.md b/pages/Phylectenular Conjunctivitis.md index 761dc78..4a586d6 100644 --- a/pages/Phylectenular Conjunctivitis.md +++ b/pages/Phylectenular Conjunctivitis.md @@ -1 +1 @@ -- SN: #eye-prof-written \ No newline at end of file +- #SN Short Note #eye-prof-written diff --git a/pages/Placenta Praevia.md b/pages/Placenta Praevia.md index 5ec7e45..c71b10c 100644 --- a/pages/Placenta Praevia.md +++ b/pages/Placenta Praevia.md @@ -2,8 +2,8 @@ title:: Placenta Praevia ICD-11_Code:: tags:: #Disease -- #definition When the placenta is implanted partially or completely over the lower uterine segment (over and adjacent to the internal os) it is called placenta previa #obspc -- # Morbidly Adherent Placenta #obspw #unanswered +- #definition When the placenta is implanted partially or completely over the lower uterine segment (over and adjacent to the internal os) it is called placenta previa #obs-prof-card +- # Morbidly Adherent Placenta #obs-prof-written #unanswered - q : name 3 morbidly adherent placenta - ## Etiology background-color:: blue @@ -25,8 +25,8 @@ tags:: #Disease - ### Signs and Symptoms - #### Symptoms - #### Signs - - ### Stages or Classification #obspc - - # Types #obspc + - ### Stages or Classification #obs-prof-card + - # Types #obs-prof-card based-on:: depending upon the degree of extension of placenta to the lower segment - Type-I Placenta Previa alias:: Low-lying @@ -51,7 +51,7 @@ tags:: #Disease - Major Degree include:: ((671a1d7f-856e-44e4-8e7d-faf35ac5e699)), ((671a1d7f-856e-44e4-8e7d-faf35ac5e699)), ((6718ed85-3d32-46f7-b74c-40c0cfe78d98)), [[Type-IV Placenta Previa]] - ### Diagnostic Criteria -- ## Diagnosis #obspw #unanswered +- ## Diagnosis #obs-prof-written #unanswered background-color:: blue - ### Clinical Diagnosis - ((671a158b-14d5-41ea-bc14-924f7589074d)) @@ -61,7 +61,7 @@ tags:: #Disease - [[Abdominal Ultrasonography]] - ### Differential Diagnosis collapsed:: true - - [[Abruptio Placentae]] #obspc + - [[Abruptio Placentae]] #obs-prof-card id:: 6718edc1-f69a-40e0-9826-ec8d0995a444 - | Parameters | Placenta Previa | Abruptio Placentae | | ---------------------------- | ------------------------------------------------------------------------------ | ---------------------------------------------------------------------------------------------------------------- | @@ -77,14 +77,14 @@ tags:: #Disease | FHS | Usually present | Usually absent especially in concealed type | | Placentography (USG) | Placenta in lower segment | Placenta in upper segment | | Vaginal Examination | Placenta is felt on the lower segment | Placenta is not felt on lower segment. Blood clots should not be confused with placenta | - - # [[Accidental Hemorrhage]] #obspw #unanswered + - # [[Accidental Hemorrhage]] #obs-prof-written #unanswered - | Accidental hemorrhage | Placenta Preveia | | --------------------- | ---------------- | | | | | | | | | | | | | -- ## Management and Treatment #obspw #unanswered +- ## Management and Treatment #obs-prof-written #unanswered background-color:: blue - ### Medical Treatment - ### Surgical Options diff --git a/pages/Plummer Vinson Syndrome.md b/pages/Plummer Vinson Syndrome.md index 10ac01e..c3a37c6 100644 --- a/pages/Plummer Vinson Syndrome.md +++ b/pages/Plummer Vinson Syndrome.md @@ -1,3 +1,3 @@ -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 67581274-8b47-479f-93b0-5edf85d77c61 \ No newline at end of file + id:: 67581274-8b47-479f-93b0-5edf85d77c61 diff --git a/pages/Pre-auricular Sinus.md b/pages/Pre-auricular Sinus.md index a0d5809..4d101a3 100644 --- a/pages/Pre-auricular Sinus.md +++ b/pages/Pre-auricular Sinus.md @@ -3,70 +3,70 @@ tags:: #Disease - ## Etiology background-color:: blue - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features background-color:: blue - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis - ## Management and Treatment background-color:: blue - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 67580553-dc10-46d6-b1f3-37887c42e645 \ No newline at end of file + id:: 67580553-dc10-46d6-b1f3-37887c42e645 diff --git a/pages/Pterygium.md b/pages/Pterygium.md index d249cb0..bc53fca 100644 --- a/pages/Pterygium.md +++ b/pages/Pterygium.md @@ -7,85 +7,85 @@ icd-11-code:: deck:: #Eye - ## Etiology background-color:: blue - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features background-color:: blue - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis - ## Management and Treatment #eye-prof-written background-color:: blue - - ### Medical Treatment (Symptomatic Relief) - recurrence:: - - Low Potent steroid drop - - Artificial Tear - - Advice the patient to stay away from aggravating factors (Heat, Dust) - - Follow up - - ### Surgical Options #eye-prof-written - - Small : {{c1 Excision of Pterygium with conjunctival autograft}} from {{c2 same}} #card - id:: 675351eb-458f-441e-b5d0-62fb96e65bda - deck:: #Eye - - Large : {{c1 Excision of Pterygium with amniotic membrane graft}} #card - deck:: #Eye - id:: 67535203-19de-45d7-8d92-4fc6b6c5a0fc - - Recurrent : {{c1 Excision of Pterygium with Mitomycin C and conjunctival autograft}} #card - deck:: #Eye - id:: 6753521e-81a7-47d8-8133-0bcb1765cb04 - - Adjunctive Radiotherapy with ß-radiation - - Excision of Pterygium with bear sclera - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment (Symptomatic Relief) + recurrence:: + - Low Potent steroid drop + - Artificial Tear + - Advice the patient to stay away from aggravating factors (Heat, Dust) + - Follow up + - ### Surgical Options #eye-prof-written + - Small : {{c1 Excision of Pterygium with conjunctival autograft}} from {{c2 same}} #card + id:: 675351eb-458f-441e-b5d0-62fb96e65bda + deck:: #Eye + - Large : {{c1 Excision of Pterygium with amniotic membrane graft}} #card + deck:: #Eye + id:: 67535203-19de-45d7-8d92-4fc6b6c5a0fc + - Recurrent : {{c1 Excision of Pterygium with Mitomycin C and conjunctival autograft}} #card + deck:: #Eye + id:: 6753521e-81a7-47d8-8133-0bcb1765cb04 + - Adjunctive Radiotherapy with ß-radiation + - Excision of Pterygium with bear sclera + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment #eye-prof-written - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment #eye-prof-written + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue collapsed:: true - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue -- SN: #eye-prof-written \ No newline at end of file +- #SN Short Note #eye-prof-written diff --git a/pages/Pure Tone Audiometry.md b/pages/Pure Tone Audiometry.md index 5b650c2..7d6c482 100644 --- a/pages/Pure Tone Audiometry.md +++ b/pages/Pure Tone Audiometry.md @@ -1,5 +1,5 @@ alias:: PTA -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 67580298-d5e4-4c7a-b8cf-ecce2a3bf3cc \ No newline at end of file + id:: 67580298-d5e4-4c7a-b8cf-ecce2a3bf3cc diff --git a/pages/Quinsy.md b/pages/Quinsy.md index 604d0c1..a38c174 100644 --- a/pages/Quinsy.md +++ b/pages/Quinsy.md @@ -77,6 +77,6 @@ tags:: #Disease background-color:: blue - ## Guidelines and Protocols background-color:: blue -- SN: #ent-prof-written #card +- #SN Short Note #ent-prof-written #card deck:: #ENT id:: 6756d165-7510-43dd-9c23-5bf2e574f25a diff --git a/pages/Ranula.md b/pages/Ranula.md index 1ad2f3f..7cc2a80 100644 --- a/pages/Ranula.md +++ b/pages/Ranula.md @@ -1,3 +1,3 @@ -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 675816e2-5b7d-481f-83a9-8e20a55a39b3 \ No newline at end of file + id:: 675816e2-5b7d-481f-83a9-8e20a55a39b3 diff --git a/pages/Recurrent Miscarriage.md b/pages/Recurrent Miscarriage.md index edddd9c..aa1ae07 100644 --- a/pages/Recurrent Miscarriage.md +++ b/pages/Recurrent Miscarriage.md @@ -2,4 +2,5 @@ alias:: Habitual Abortion - #definition {{c1 Recurrent Miscarriage is defined as a sequence of three or more consecutive spontaneous abortion before 20 weeks.}} #gyn-prof-card #card deck:: #Gynecology + id:: 6754303b-81d1-42b3-a59f-2087ff6eee0f - \ No newline at end of file diff --git a/pages/Referred Otalgia.md b/pages/Referred Otalgia.md index 049b733..e558b7c 100644 --- a/pages/Referred Otalgia.md +++ b/pages/Referred Otalgia.md @@ -4,6 +4,6 @@ - # Causes #ent-prof-card #unanswered #card deck:: #ENT id:: 6756cf34-9c7c-44ec-99e7-9e06e1a0eb22 -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 675804e8-a0f0-4856-b49a-972069eed24c \ No newline at end of file + id:: 675804e8-a0f0-4856-b49a-972069eed24c diff --git a/pages/Retropharyngeal abscess.md b/pages/Retropharyngeal abscess.md index fb49f83..bf89e5c 100644 --- a/pages/Retropharyngeal abscess.md +++ b/pages/Retropharyngeal abscess.md @@ -6,74 +6,74 @@ id:: 675810b0-fc80-45f7-806c-f4764d7c82be - ## Etiology background-color:: blue - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features background-color:: blue - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification #ent-prof-written #unanswered #card - deck:: #ENT - id:: 7f32f9e9-ccda-4242-aad5-0eedb0b3cb43 - - [[Acute Retropharyngeal Abscess]] - - [[Chronic Retropharyngeal Abscess]] - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification #ent-prof-written #unanswered #card + deck:: #ENT + id:: 7f32f9e9-ccda-4242-aad5-0eedb0b3cb43 + - [[Acute Retropharyngeal Abscess]] + - [[Chronic Retropharyngeal Abscess]] + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis - ## Management and Treatment background-color:: blue - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 67581171-79d1-475c-a2f2-827bd0568291 \ No newline at end of file + id:: 67581171-79d1-475c-a2f2-827bd0568291 diff --git a/pages/Rhinoplasty.md b/pages/Rhinoplasty.md index 16847b3..eb64fc3 100644 --- a/pages/Rhinoplasty.md +++ b/pages/Rhinoplasty.md @@ -1,3 +1,3 @@ -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 67580d39-411f-4213-b2c9-25d117ce3e16 \ No newline at end of file + id:: 67580d39-411f-4213-b2c9-25d117ce3e16 diff --git a/pages/Rhinosporidiosis.md b/pages/Rhinosporidiosis.md index 0feec16..6e621f3 100644 --- a/pages/Rhinosporidiosis.md +++ b/pages/Rhinosporidiosis.md @@ -8,74 +8,74 @@ background-color:: blue deck:: #ENT id:: 120242e6-8089-4346-a09b-24c41a65d894 - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue id:: d15cc573-58c4-4954-9664-4ee4841c91f8 deck:: #ENT - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis - ## Management and Treatment #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue id:: 95047ab4-df72-4522-9526-e1fe19c4e9b6 deck:: #ENT - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 67580c43-adc9-4abd-985f-da2724930a4d \ No newline at end of file + id:: 67580c43-adc9-4abd-985f-da2724930a4d diff --git a/pages/Rinne's Test.md b/pages/Rinne's Test.md index 9b47dc9..be2582a 100644 --- a/pages/Rinne's Test.md +++ b/pages/Rinne's Test.md @@ -1,9 +1,11 @@ # Procedure #ent-prof-written #unanswered #card + deck:: #ENT id:: 67580220-8cf9-417b-8718-a11493550724 + - # Interference #ent-prof-written #unanswered #card deck:: #ENT id:: 67580224-8c14-432f-8875-7683d9f1cefd -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 6758023b-32da-4a25-9014-9ddc0f1f112c \ No newline at end of file + id:: 6758023b-32da-4a25-9014-9ddc0f1f112c diff --git a/pages/Rough Query.md b/pages/Rough Query.md index 286371b..c157105 100644 --- a/pages/Rough Query.md +++ b/pages/Rough Query.md @@ -1,3 +1,4 @@ -- {{query (and [[ent-prof-card]] [[ent-prof-written]])}} +- {{query (and [[ent-prof-card]] [[ent-prof-written]] )}} + query-table:: false query-properties:: [:block :page :deck] - query-table:: false \ No newline at end of file +- \ No newline at end of file diff --git a/pages/Septal Abscess.md b/pages/Septal Abscess.md index 71183e6..117c085 100644 --- a/pages/Septal Abscess.md +++ b/pages/Septal Abscess.md @@ -8,76 +8,76 @@ background-color:: blue deck:: #ENT id:: 6756cf32-bc6a-478e-b20d-f7f4b03ce19c - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: 9cf87f7c-b5ea-4dd9-a176-292616919594 - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis - ## Management and Treatment #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue id:: da63716d-c270-4810-9403-4f1b6f1c1073 deck:: #ENT - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications #ent-prof-written #unanswered #card - deck:: #ENT - id:: 35f613dd-1108-499c-af39-932f6168400f - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications #ent-prof-written #unanswered #card + deck:: #ENT + id:: 35f613dd-1108-499c-af39-932f6168400f + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 67580834-84ac-437b-9a11-14d51d49267e \ No newline at end of file + id:: 67580834-84ac-437b-9a11-14d51d49267e diff --git a/pages/Septal Hematoma.md b/pages/Septal Hematoma.md index e804713..3e17479 100644 --- a/pages/Septal Hematoma.md +++ b/pages/Septal Hematoma.md @@ -4,76 +4,76 @@ - #definition - ## Etiology background-color:: blue - - ### Causative Agents #ent-prof-card #unanswered #card - deck:: #ENT - id:: 64266b0a-1aaa-42f1-8753-bdefd8d0e31a - - ### Risk Factors + - ### Causative Agents #ent-prof-card #unanswered #card + deck:: #ENT + id:: 64266b0a-1aaa-42f1-8753-bdefd8d0e31a + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features #ent-prof-card #unanswered #card background-color:: blue deck:: #ENT id:: 932292be-6531-4121-a91b-8f88bd317a67 - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis - ## Management and Treatment #ent-prof-card #ent-prof-written #unanswered #card background-color:: blue id:: a9a2e6bf-5e0f-4758-9453-efb3537e2918 deck:: #ENT - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 6758093e-1bc3-48e4-9ca4-62f6d2ae503e \ No newline at end of file + id:: 6758093e-1bc3-48e4-9ca4-62f6d2ae503e diff --git a/pages/Septoplasty.md b/pages/Septoplasty.md index 09229e2..52615a4 100644 --- a/pages/Septoplasty.md +++ b/pages/Septoplasty.md @@ -13,6 +13,6 @@ - # Complications #ent-prof-written #unanswered #card deck:: #ENT id:: 67580c64-3671-45dc-921b-d12f0a939656 -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 67580d2a-5aa6-4808-950e-684bf8b0e35f \ No newline at end of file + id:: 67580d2a-5aa6-4808-950e-684bf8b0e35f diff --git a/pages/Stages of Labor.md b/pages/Stages of Labor.md index a56bbc4..5027bfe 100644 --- a/pages/Stages of Labor.md +++ b/pages/Stages of Labor.md @@ -1,5 +1,14 @@ -tags:: #obspw #obspc +tags:: #obs-prof-written #obs-prof-card +- Names of Stages with Duration #obs-prof-card #card + deck:: #Obstetrics + id:: 67587aae-7fa9-4f7a-b075-10ea7b2fb1d6 + - | Stage of Labor | Duration Primi | Duration Multigravida | + | -------------- | -------------- | --------------------- | + | Stage 1 | 12 hours | 6 hours | + | Stage 2 | 2 hours | 30 minutes | + | Stage 3 | 15 minutes | | + | Stage 4 | 1 hour | | - # Stage One of Labor id:: 6711ec95-ab78-44a9-97ff-cb303010369c duration-primigarvida:: 12 hours @@ -14,7 +23,7 @@ tags:: #obspw #obspc - ### Active Stage One of Labor - #definition 3-4 cm to full dilation (dilation accelerates) - Cardinal movements begin to occur - - ## Management #obspw + - ## Management #obs-prof-written - ### Principles collapsed:: true - ((6713de39-95ed-4e4b-97d4-1e5ca784dce1)) @@ -103,7 +112,7 @@ tags:: #obspw #obspc - #definition Full dilation to delivery of fetus - ## Events #obs-prof-written #unanswered - ## Causes of Delay #obs-prof-written #unanswered - - ## Management #obspw + - ## Management #obs-prof-written - ### Principle collapsed:: true - ((671499fd-6751-4332-9b99-3ef50bc95c2b)) @@ -128,7 +137,7 @@ tags:: #obspw #obspc start-event:: expulsion of the fetus from the birth canal end-event:: expulsion of the placenta and membranes (afterbirths) - #definition Delivery of fetus to delivery of placenta - - ### Complications #obspw #obspc + - ### Complications #obs-prof-written #obs-prof-card - Postpartum hemorrhage logseq.order-list-type:: number - Retention of placenta diff --git a/pages/Stillbirth.md b/pages/Stillbirth.md index 63516f7..371965f 100644 --- a/pages/Stillbirth.md +++ b/pages/Stillbirth.md @@ -1,5 +1,9 @@ -- #definition A stillbirth is the birht of a newborn after 28th completred week (weighing 1000 g or more) when the baby does not breathe or show any sign of life after delivery. #obspc -- # Causes #obspc +- #definition {{c1 A stillbirth is the birht of a newborn after 28th completred week (weighing 1000 g or more) when the baby does not breathe or show any sign of life after delivery.}} #obs-prof-card #card + id:: 6733ccee-0ce7-4dc3-a2df-41336c54d417 + deck:: #Obstetrics +- # Causes #obs-prof-card #card + deck:: #Obstetrics + id:: 67587bb6-76c1-48d6-8fdb-f5f2f1cca8c6 - Birth asphyxia and trauma logseq.order-list-type:: number - Pregnancy complications ([[Abruptio Placentae]], [[Pre-Eclampsia]], [[Diabetes Mellitus]] ) diff --git a/pages/Stridor.md b/pages/Stridor.md index e3f72ce..d89e9b0 100644 --- a/pages/Stridor.md +++ b/pages/Stridor.md @@ -6,14 +6,14 @@ tags:: #Signs - # Causes #ent-prof-card #ent-prof-written #unanswered #card id:: 6756b3bf-1f1a-4151-a1a2-dee3068c5861 deck:: #ENT - - In Children + - In Children - # Investigation #ent-prof-written #unanswered #card deck:: #ENT id:: 6758149f-ebc1-44f7-a02d-70f044729e25 - # Management #ent-prof-written #unanswered #card deck:: #ENT id:: 675814a7-b326-4e67-ac7d-be0491e1cb78 -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT id:: 6756bba6-f30d-4b1a-9c28-e005696fde64 -- \ No newline at end of file +- diff --git a/pages/Thryroglossal Duct.md b/pages/Thryroglossal Duct.md index 9a16dc4..9ba7c65 100644 --- a/pages/Thryroglossal Duct.md +++ b/pages/Thryroglossal Duct.md @@ -3,70 +3,70 @@ tags:: #Disease - ## Etiology background-color:: blue - - ### Causative Agents - - ### Risk Factors + - ### Causative Agents + - ### Risk Factors - ## Epidemiology background-color:: blue - - ### Incidence - - ### Prevalence - - ### Demographics - - ### Geographic Distribution + - ### Incidence + - ### Prevalence + - ### Demographics + - ### Geographic Distribution - ## Pathophysiology background-color:: blue - - ### Mechanism of Disease - - ### Affected Systems/Organs + - ### Mechanism of Disease + - ### Affected Systems/Organs - ## Clinical Features background-color:: blue - - ### Signs and Symptoms - - #### Symptoms - - #### Signs - - ### Stages or Classification - - ### Diagnostic Criteria + - ### Signs and Symptoms + - #### Symptoms + - #### Signs + - ### Stages or Classification + - ### Diagnostic Criteria - ## Diagnosis background-color:: blue - - ### Clinical Diagnosis - - #### Classical Presentation - - #### Probable Diagnosis - - ### Laboratory Tests - - ### Imaging Studies - - ### Differential Diagnosis - - ### Confirmation of Diagnosis + - ### Clinical Diagnosis + - #### Classical Presentation + - #### Probable Diagnosis + - ### Laboratory Tests + - ### Imaging Studies + - ### Differential Diagnosis + - ### Confirmation of Diagnosis - ## Management and Treatment background-color:: blue - - ### Medical Treatment - - ### Surgical Options - - ### Lifestyle and Dietary Recommendations - - ### Follow-up + - ### Medical Treatment + - ### Surgical Options + - ### Lifestyle and Dietary Recommendations + - ### Follow-up - ## Prognosis background-color:: blue - - ### Expected Course - - #### With Treatment - - #### Without Treatment - - ##### Possible Complications - - ##### Long-Term Effects - - ### Survival Rates - - #### With Treatment - - #### Without Treatment - - ### Quality of Life Considerations + - ### Expected Course + - #### With Treatment + - #### Without Treatment + - ##### Possible Complications + - ##### Long-Term Effects + - ### Survival Rates + - #### With Treatment + - #### Without Treatment + - ### Quality of Life Considerations - ## Prevention background-color:: blue - - ### Health Education - - ### Community Approach - - ### Screening Programs - - ### Lifestyle Modifications + - ### Health Education + - ### Community Approach + - ### Screening Programs + - ### Lifestyle Modifications - ## Patient Education and Support background-color:: blue - - ### Educational Resources - - ### Support Groups - - ### Counseling Options + - ### Educational Resources + - ### Support Groups + - ### Counseling Options - ## Recent Research and Developments background-color:: blue - - ### Ongoing Clinical Trials - - ### Recent Advances + - ### Ongoing Clinical Trials + - ### Recent Advances - ## Key Literature background-color:: blue - ## Guidelines and Protocols background-color:: blue -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 675816dc-76d2-4cef-a2ca-1e3160849887 \ No newline at end of file + id:: 675816dc-76d2-4cef-a2ca-1e3160849887 diff --git a/pages/Tongue Ulcer.md b/pages/Tongue Ulcer.md index be754b4..2785d42 100644 --- a/pages/Tongue Ulcer.md +++ b/pages/Tongue Ulcer.md @@ -1,3 +1,3 @@ -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 67581046-5be0-4710-b623-401ccef414af \ No newline at end of file + id:: 67581046-5be0-4710-b623-401ccef414af diff --git a/pages/Tracheostomy.md b/pages/Tracheostomy.md index cb06bd8..df4c121 100644 --- a/pages/Tracheostomy.md +++ b/pages/Tracheostomy.md @@ -18,11 +18,11 @@ tags:: #[[Surgical Procedure]] - # Complications #ent-prof-card #ent-prof-written #unanswered #card id:: 6756cf31-13c8-4242-aff7-89c661a83299 deck:: #ENT - - peroperative - - Postoperative + - peroperative + - Postoperative - # Postoperative Care of a Tracheostomized Patient #ent-prof-card #ent-prof-written #unanswered #card id:: 6756cf31-300d-4849-9162-7cfa687f441a deck:: #ENT -- SN: Emergency Tracheostomy/Tracheostomy #ent-prof-written #unanswered #card +- #SN Short Note Emergency Tracheostomy/Tracheostomy #ent-prof-written #unanswered #card deck:: #ENT - id:: 67581832-6df8-4455-9370-c9197f2c9a91 \ No newline at end of file + id:: 67581832-6df8-4455-9370-c9197f2c9a91 diff --git a/pages/Tubotympanic Chronic Suppurative Otitis Media.md b/pages/Tubotympanic Chronic Suppurative Otitis Media.md index 015befa..6eb8443 100644 --- a/pages/Tubotympanic Chronic Suppurative Otitis Media.md +++ b/pages/Tubotympanic Chronic Suppurative Otitis Media.md @@ -39,9 +39,19 @@ tags:: #Disease - ## Management and Treatment background-color:: blue - ### Medical Treatment - - ### Surgical Options + - Antibiotic ear drops: Gentamicin + - Systemic Antibiotics: Amoxicillin + - Nasal decongestants + - Antihistamine + - Analgesic - ### Lifestyle and Dietary Recommendations + - Keep water out of the eye + - Maintian aural hygine - ### Follow-up + - 14 days later + - ### Surgical Options + - After drying : Myringoplasty/Tympanoplasty + - If Discharge : Simple/Cortical Mastoidectomy - ## Prognosis background-color:: blue - ### Expected Course diff --git a/pages/Twin Pregnancy.md b/pages/Twin Pregnancy.md index 82cc777..ddacd66 100644 --- a/pages/Twin Pregnancy.md +++ b/pages/Twin Pregnancy.md @@ -1,35 +1,34 @@ -- Antenatal Complications of Twin Pregnancy #obspc - - ## Maternal - - During Pregnancy - - Nausea and vomiting - - Anemia - - Preeclampsia (25%) - - Hydramnios (10%) - - Antepartum hemorrhage - - Malpresentation - - Preterm Labor(50%) - - Mechanical distress increased compared to a singleton pregnancy - - Palpitation - - Dyspnea - - Varicosities and hemorrhoids - - During Labor - - Early rupture of the membranes and cord prolapse - - Prolonged labor - - Increased operative interference - - Bleeding (intrapartum) - - Postpartum hemorrhage is the real danger - - During Peurperium - - There is increased incidence of - - Subinvolution - because of bigger size of the uterus - - Infection because of increased operative interference, preexisting anemia and blood loss during delivery - - Lactation failure - this is minimized by reassurance and giving her additional support - - ## Fetal - - Miscarriage rate is increased especially with monozygotic twins - - Premature rate (80%) - - Discordant twin growth (25%) - - Intrauterine death of one fetus - - Appearing twin - - Fetal anomalies are increased by 2-4% - - Asphyxia and childbirth are more common -- Delivery of Second baby of twin pregnancy - - \ No newline at end of file +- Antenatal Complications of Twin Pregnancy #obs-prof-card + - ## Maternal + - During Pregnancy + - Nausea and vomiting + - Anemia + - Preeclampsia (25%) + - Hydramnios (10%) + - Antepartum hemorrhage + - Malpresentation + - Preterm Labor(50%) + - Mechanical distress increased compared to a singleton pregnancy + - Palpitation + - Dyspnea + - Varicosities and hemorrhoids + - During Labor + - Early rupture of the membranes and cord prolapse + - Prolonged labor + - Increased operative interference + - Bleeding (intrapartum) + - Postpartum hemorrhage is the real danger + - During Peurperium + - There is increased incidence of + - Subinvolution - because of bigger size of the uterus + - Infection because of increased operative interference, preexisting anemia and blood loss during delivery + - Lactation failure - this is minimized by reassurance and giving her additional support + - ## Fetal + - Miscarriage rate is increased especially with monozygotic twins + - Premature rate (80%) + - Discordant twin growth (25%) + - Intrauterine death of one fetus + - Appearing twin + - Fetal anomalies are increased by 2-4% + - Asphyxia and childbirth are more common +- ## Delivery of Second baby of twin pregnancy diff --git a/pages/Tympanoplasty.md b/pages/Tympanoplasty.md index d25893e..c1afd61 100644 --- a/pages/Tympanoplasty.md +++ b/pages/Tympanoplasty.md @@ -1,3 +1,3 @@ -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 67580594-4015-4ff4-a19b-d09f07eec7b6 \ No newline at end of file + id:: 67580594-4015-4ff4-a19b-d09f07eec7b6 diff --git a/pages/Uterus.md b/pages/Uterus.md index 1b20355..f4d546a 100644 --- a/pages/Uterus.md +++ b/pages/Uterus.md @@ -1,31 +1,33 @@ # Measurements - - length : 7.5 cm - - fundus & body : 5 cm - - cervix : 2.5 cm - - length of uterine cavity : 6 cm - - maximum breadth at fundus : 5 cm - - thickness : 2.5 cm - - weight : 30-40 gm -- # Parts #obspw - - Fundus of the uterus - - Isthmus of the uterus - - Cornu of uterus - - Body of the uterus - - Uterine Cavity - - continuous to uterine tube - - communicated below with the cervix - - Surface - - Anterior Surface - - Posterior Surface - - Two lateral borders - - Cervix of the Uterus - - Internal Os - - External Os - - Layers - - Endometrium - - Myometrium - - Perimetrius -- # Support #obspw - - |Primary|Secondary| - |--|--| - |Ligaments[:br]- transverse cervical ligaments[:br]- Round ligaments of uterus[:br]- Uterosacral ligaments[:br]- Pubocervical ligamentts[:br]Muscular[:br]- Pelvic diaphragm[:br]- Perineal Body[:br]- Urogenital Diaphragm[:br]Visceral[:br]- Urinary Bladder[:br]- Rectum|Broad Ligaments[:br]Uterocesical fold of peritoneum[:br]Rectovaginal folds of peritoneum| \ No newline at end of file + + - length : 7.5 cm + - fundus & body : 5 cm + - cervix : 2.5 cm + - length of uterine cavity : 6 cm + - maximum breadth at fundus : 5 cm + - thickness : 2.5 cm + - weight : 30-40 gm + +- # Parts #obs-prof-written + - Fundus of the uterus + - Isthmus of the uterus + - Cornu of uterus + - Body of the uterus + - Uterine Cavity + - continuous to uterine tube + - communicated below with the cervix + - Surface + - Anterior Surface + - Posterior Surface + - Two lateral borders + - Cervix of the Uterus + - Internal Os + - External Os + - Layers + - Endometrium + - Myometrium + - Perimetrius +- # Support #obs-prof-written + - | Primary | Secondary | + | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ---------------------------------------------------------------------------------------- | + | Ligaments[:br]- transverse cervical ligaments[:br]- Round ligaments of uterus[:br]- Uterosacral ligaments[:br]- Pubocervical ligamentts[:br]Muscular[:br]- Pelvic diaphragm[:br]- Perineal Body[:br]- Urogenital Diaphragm[:br]Visceral[:br]- Urinary Bladder[:br]- Rectum | Broad Ligaments[:br]Uterocesical fold of peritoneum[:br]Rectovaginal folds of peritoneum | diff --git a/pages/Waldeyer's Ring.md b/pages/Waldeyer's Ring.md index 7b2b6b7..ae56b3d 100644 --- a/pages/Waldeyer's Ring.md +++ b/pages/Waldeyer's Ring.md @@ -10,6 +10,6 @@ - # Clinical Importance #ent-prof-card #unanswered #card deck:: #ENT id:: 6756cf30-0c4d-4a7d-b90c-8ed2e058783f -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 67580db4-8ec4-4061-a7fc-d56c2d831c7a \ No newline at end of file + id:: 67580db4-8ec4-4061-a7fc-d56c2d831c7a diff --git a/pages/White Patches on the tonsil.md b/pages/White Patches on the tonsil.md index de39cc3..ac1e5a0 100644 --- a/pages/White Patches on the tonsil.md +++ b/pages/White Patches on the tonsil.md @@ -3,6 +3,6 @@ tags:: #Signs - # Differential Diagnosis #ent-prof-card #unanswered #ent-prof-written #card deck:: #ENT id:: 6756b1ae-51e0-4ba9-9220-dc162ef3b54e -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 67580f8a-746d-4c4f-9cfb-9db49c65b8a1 \ No newline at end of file + id:: 67580f8a-746d-4c4f-9cfb-9db49c65b8a1 diff --git a/pages/contents.md b/pages/contents.md index 4a1780b..52ca00f 100644 --- a/pages/contents.md +++ b/pages/contents.md @@ -1,4 +1,5 @@ - - {{renderer :tocgen2, [[library]], calc(100vh - 135px)}} - {{renderer :tocgen2, [[rough query]], calc(100vh - 135px)}} +- {{renderer :tocgen2, [[rough query]], calc(100vh - 135px)}} - {{renderer :tocgen2, [[rough query]], calc(100vh - 135px)}} \ No newline at end of file diff --git a/pages/juvenile nasopharyngeal angiofibroma.md b/pages/juvenile nasopharyngeal angiofibroma.md index 2c9febc..0d45746 100644 --- a/pages/juvenile nasopharyngeal angiofibroma.md +++ b/pages/juvenile nasopharyngeal angiofibroma.md @@ -3,6 +3,6 @@ - male adolescent - profuse nose bleed(epitaxis) - bipsy may be contraindicated -- SN: #ent-prof-written #unanswered #card +- #SN Short Note #ent-prof-written #unanswered #card deck:: #ENT - id:: 67580efb-a12a-4496-907a-890dbbe8effa \ No newline at end of file + id:: 67580efb-a12a-4496-907a-890dbbe8effa diff --git a/pages/mydriasis.md b/pages/mydriasis.md index e5718e6..30bba6f 100644 --- a/pages/mydriasis.md +++ b/pages/mydriasis.md @@ -2,4 +2,4 @@ contrast:: [[Cycloplegia]] - # Causes #eye-prof-written - # Differentiation from [[Cycloplegia]] -- SN: #eye-prof-written \ No newline at end of file +- #SN Short Note #eye-prof-written diff --git a/pages/oligohydramnios.md b/pages/oligohydramnios.md index 8750513..0e8a073 100644 --- a/pages/oligohydramnios.md +++ b/pages/oligohydramnios.md @@ -1,12 +1,12 @@ -- #definition Where the liquor amnii is deficient in amount to the extent of less than 200 mL at term. Sonographically, it is defined when the maximum vertical pocket of liquir is less than >2cm or when amniotic fluid index(AFI) is less than 5 cm (less than 5 percentile) #obspc -- # Maternal Causes of Oligohydramnios #obspc - - Hypertensive Disorders - - Uteroplacental insufficiency - - Dehydration - - Idiopathic -- # Diagnosis of Oligohydramnios #obspc - - Uterine size is much smaller than the period of amenorrhea - - Less fetal movements - - The uterus is "full of fetus" because of scanty liquor - - Malpresentation (breech) is common - - Evidences of intrauterine growth retardation of the fetus \ No newline at end of file +- #definition Where the liquor amnii is deficient in amount to the extent of less than 200 mL at term. Sonographically, it is defined when the maximum vertical pocket of liquir is less than >2cm or when amniotic fluid index(AFI) is less than 5 cm (less than 5 percentile) #obs-prof-card +- # Maternal Causes of Oligohydramnios #obs-prof-card + - Hypertensive Disorders + - Uteroplacental insufficiency + - Dehydration + - Idiopathic +- # Diagnosis of Oligohydramnios #obs-prof-card + - Uterine size is much smaller than the period of amenorrhea + - Less fetal movements + - The uterus is "full of fetus" because of scanty liquor + - Malpresentation (breech) is common + - Evidences of intrauterine growth retardation of the fetus